	Query	Target	Query-Cov	Align-From	Align-To	DrugBank ID	Reg.Status	Mol.Name	SMILES
0	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00127	experimental; nutraceutical	Spermine	NCCCNCCCCNCCCN
1	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00195	approved; investigational	Betaxolol	CC(C)NCC(O)COc1ccc(cc1)CCOCC2CC2
2	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00221	approved	Isoetharine	CC(C)NC(CC)C(O)c1cc(O)c(O)cc1
3	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
4	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00264	approved; investigational	Metoprolol	COCCc1ccc(cc1)OCC(O)CNC(C)C
5	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00335	approved	Atenolol	CC(C)NCC(O)COc1ccc(cc1)CC(=O)N
6	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00368	approved	Norepinephrine	NC[C@H](O)c1cc(O)c(O)cc1
7	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00373	approved	Timolol	CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2
8	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00397	approved; vet_approved; withdrawn	Phenylpropanolamine	C[C@H](N)[C@H](O)c1ccccc1
9	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00449	approved	Dipivefrin	CNCC(O)c1cc(OC(=O)C(C)(C)C)c(cc1)OC(=O)C(C)(C)C
10	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00489	approved	Sotalol	CC(C)NCC(O)c1ccc(cc1)NS(=O)(=O)C
11	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00521	approved	Carteolol	CC(C)(C)NCC(O)COc1cccc(c12)NC(=O)CC2
12	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00571	approved; investigational	Propranolol	CC(C)NCC(O)COc1cccc(c12)cccc2
13	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00598	approved	Labetalol	c1ccccc1CCC(C)NCC(O)c2cc(C(=O)N)c(O)cc2
14	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00612	approved	Bisoprolol	CC(C)NCC(O)COc1ccc(cc1)COCCOC(C)C
15	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00668	approved; vet_approved	Epinephrine	CNC[C@H](O)c1cc(O)c(O)cc1
16	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00816	approved	Orciprenaline	CC(C)NCC(O)c1cc(O)cc(O)c1
17	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00841	approved	Dobutamine	Oc1ccc(cc1)CCC(C)NCCc2cc(O)c(O)cc2
18	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00852	approved	Pseudoephedrine	CN[C@@H](C)[C@@H](O)c1ccccc1
19	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00866	experimental; withdrawn	Alprenolol	CC(C)NCC(O)COc1ccccc1CC=C
20	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00867	approved; investigational	Ritodrine	Oc1ccc(cc1)[C@@H](O)[C@H](C)NCCc2ccc(O)cc2
21	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00871	approved	Terbutaline	CC(C)(C)NCC(O)c1cc(O)cc(O)c1
22	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00901	withdrawn	Bitolterol	Cc1ccc(cc1)C(=O)Oc2c(cc(cc2)C(O)CNC(C)(C)C)OC(=O)c3ccc(C)cc3
23	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00925	approved	Phenoxybenzamine	c1ccccc1CN(CCCl)C(C)COc2ccccc2
24	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00938	approved	Salmeterol	OCc1c(O)ccc(c1)C(O)CNCCCCCCOCCCCc2ccccc2
25	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00960	approved; investigational	Pindolol	CC(C)NCC(O)COc1cccc(c12)[nH]cc2
26	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00983	approved; investigational	Formoterol	COc1ccc(cc1)CC(C)NCC(O)c2cc(NC=O)c(O)cc2
27	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01001	approved; vet_approved	Salbutamol	CC(C)(C)NCC(O)c1cc(CO)c(O)cc1
28	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01064	approved; investigational	Isoprenaline	CC(C)NCC(O)c1cc(O)c(O)cc1
29	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01102	approved	Arbutamine	Oc1ccc(cc1O)[C@@H](O)CNCCCCc2ccc(O)cc2
30	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01136	approved; investigational	Carvedilol	COc1ccccc1OCCNCC(O)COc2cccc(c23)[nH]c4c3cccc4
31	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01151	approved; investigational	Desipramine	CNCCCN1c(cccc2)c2CCc(c13)cccc3
32	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01182	approved	Propafenone	CCCNCC(O)COc1c(cccc1)C(=O)CCc2ccccc2
33	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01193	approved; investigational	Acebutolol	CCCC(=O)Nc1ccc(c(c1)C(=O)C)OCC(O)CNC(C)C
34	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01203	approved	Nadolol	CC(C)(C)NCC(O)COc1cccc(c12)C[C@@H](O)[C@H](C2)O
35	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01210	approved	Levobunolol	CC(C)(C)NC[C@H](O)COc1cccc(c12)C(=O)CCC2
36	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01214	approved	Metipranolol	CC(C)NCC(O)COc1c(C)c(C)c(c(C)c1)OC(=O)C
37	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
38	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01274	approved; investigational	Arformoterol	COc1ccc(cc1)C[C@@H](C)NC[C@H](O)c2cc(NC=O)c(O)cc2
39	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01288	approved; investigational	Fenoterol	Oc1ccc(cc1)CC(C)NCC(O)c2cc(O)cc(O)c2
40	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01291	approved	Pirbuterol	CC(C)(C)NCC(O)c1nc(CO)c(O)cc1
41	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01295	experimental	Bevantolol	COc1c(OC)cc(cc1)CCNCC(O)COc2cccc(C)c2
42	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01359	approved; investigational	Penbutolol	CC(C)(C)NC[C@H](O)COc1ccccc1C2CCCC2
44	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01364	approved	Ephedrine	CN[C@@H](C)[C@H](O)c1ccccc1
45	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01366	approved; investigational	Procaterol	CC(C)N[C@@H](CC)[C@H](O)c(ccc1O)c(c12)ccc(=O)[nH]2
46	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01407	approved; investigational; vet_approved	Clenbuterol	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1
47	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01408	investigational	Bambuterol	CN(C)C(=O)Oc1cc(C(O)CNC(C)(C)C)cc(c1)OC(=O)N(C)C
48	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01580	approved	Oxprenolol	CC(C)NCC(O)COc1ccccc1OCC=C
49	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01917	experimental	Putrescine	NCCCCN
50	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB03566	experimental	Spermidine	NCCCCNCCCN
51	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB04846	approved; investigational	Celiprolol	CCN(CC)C(=O)Nc1ccc(c(c1)C(=O)C)OCC(O)CNC(C)(C)C
52	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB04861	approved; investigational	Nebivolol	c1cc(F)cc(c12)CCC(O2)C(O)CNCC(O)C(O3)CCc(c34)cc(F)cc4
53	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB05039	approved	Indacaterol	CCc(c1)c(CC)cc(c12)CC(C2)NC[C@H](O)c(ccc3O)c(c34)ccc(=O)[nH]4
54	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB05590	investigational	Bedoradrine	CN(C)C(=O)COc(c1)ccc(c12)CC[C@@H](C2)NC[C@H](O)c3ccc(O)c(c3)CCO
55	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB05849	investigational	NCX 950	 
56	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
57	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB06262	approved; investigational	Droxidopa	OC(=O)[C@@H](N)[C@H](O)c1cc(O)c(O)cc1
58	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB06814	approved; vet_approved	Protokylol	O1COc(c12)ccc(c2)CC(C)NCC(O)c3ccc(O)c(O)c3
59	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB07543	experimental	(S)-carazolol	CC(C)NC[C@H](O)COc1cccc(c12)[nH]c3c2cccc3
60	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB08807	experimental	Bopindolol	Cc([nH]1)cc(c12)c(ccc2)OCC(CNC(C)(C)C)OC(=O)c3ccccc3
61	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB08808	experimental	Bupranolol	Cc1cc(c(Cl)cc1)OCC(O)CNC(C)(C)C
62	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB09013	experimental	Befunolol	CC(C)NCC(O)COc1cccc(c12)cc(o2)C(=O)C
63	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB09080	approved	Olodaterol	COc1ccc(cc1)CC(C)(C)NC[C@H](O)c(cc(O)c2)c(c23)OCC(=O)N3
64	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB09082	approved	Vilanterol	OCc1c(O)ccc(c1)[C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl
65	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB09204	investigational	Arotinolol	CC(C)(C)NCC(O)CSc1nc(cs1)-c2ccc(s2)C(=O)N
66	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB09273	experimental	Doxofylline	O=c1n(C)c(=O)n(C)c(c12)ncn2CC3OCCO3
67	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB11124	approved	Racepinephrine	 
68	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB11587	approved	Etafedrine	CCN(C)[C@@H](C)[C@H](O)c1ccccc1
69	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB12248	investigational	Tulobuterol	CC(C)(C)NCC(O)c1ccccc1Cl
70	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB13139	approved; investigational	Levosalbutamol	CC(C)(C)NC[C@H](O)c1cc(CO)c(O)cc1
71	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00182	approved; illicit; investigational	Amphetamine	CC(N)Cc1ccccc1
72	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00217	approved	Bethanidine	CN/C(=N\C)NCc1ccccc1
73	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
74	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00540	approved	Nortriptyline	CNCCC=C1c(cccc2)c2CCc(c13)cccc3
75	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
76	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00726	approved	Trimipramine	CN(C)CC(C)CN1c(cccc2)c2CCc(c13)cccc3
77	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB00785	approved	Cryptenamine	 
78	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01049	approved	Ergoloid mesylate	 
79	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01118	approved; investigational	Amiodarone	c1cccc(c12)c(c(o2)CCCC)C(=O)c3cc(I)c(c(I)c3)OCCN(CC)CC
80	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB01365	approved	Mephentermine	CNC(C)(C)Cc1ccccc1
81	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB06726	experimental	Bufuralol	CCc1cccc(c12)cc(o2)C(O)CNC(C)(C)C
82	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
83	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB11278	approved	DL-Methylephedrine	CN(C)[C@@H](C)[C@H](O)c1ccccc1
84	sp|P07550|ADRB2_HU	P07550	99.76	1.0	413.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
85	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00127	experimental; nutraceutical	Spermine	NCCCNCCCCNCCCN
86	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00187	approved	Esmolol	COC(=O)CCc1ccc(cc1)OCC(O)CNC(C)C
87	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00195	approved; investigational	Betaxolol	CC(C)NCC(O)COc1ccc(cc1)CCOCC2CC2
88	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00221	approved	Isoetharine	CC(C)NC(CC)C(O)c1cc(O)c(O)cc1
89	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00243	approved; investigational	Ranolazine	COc1ccccc1OCC(O)CN2CCN(CC2)CC(=O)Nc3c(C)cccc3C
90	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
91	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00264	approved; investigational	Metoprolol	COCCc1ccc(cc1)OCC(O)CNC(C)C
92	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00335	approved	Atenolol	CC(C)NCC(O)COc1ccc(cc1)CC(=O)N
93	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00368	approved	Norepinephrine	NC[C@H](O)c1cc(O)c(O)cc1
94	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00373	approved	Timolol	CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2
95	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00397	approved; vet_approved; withdrawn	Phenylpropanolamine	C[C@H](N)[C@H](O)c1ccccc1
96	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
97	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00489	approved	Sotalol	CC(C)NCC(O)c1ccc(cc1)NS(=O)(=O)C
98	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00521	approved	Carteolol	CC(C)(C)NCC(O)COc1cccc(c12)NC(=O)CC2
99	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00555	approved; investigational	Lamotrigine	Nc1nc(N)c(nn1)-c2c(Cl)c(Cl)ccc2
100	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00571	approved; investigational	Propranolol	CC(C)NCC(O)COc1cccc(c12)cccc2
101	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00598	approved	Labetalol	c1ccccc1CCC(C)NCC(O)c2cc(C(=O)N)c(O)cc2
102	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00612	approved	Bisoprolol	CC(C)NCC(O)COc1ccc(cc1)COCCOC(C)C
103	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00668	approved; vet_approved	Epinephrine	CNC[C@H](O)c1cc(O)c(O)cc1
104	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00841	approved	Dobutamine	Oc1ccc(cc1)CCC(C)NCCc2cc(O)c(O)cc2
105	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00852	approved	Pseudoephedrine	CN[C@@H](C)[C@@H](O)c1ccccc1
106	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00866	experimental; withdrawn	Alprenolol	CC(C)NCC(O)COc1ccccc1CC=C
107	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00871	approved	Terbutaline	CC(C)(C)NCC(O)c1cc(O)cc(O)c1
108	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00938	approved	Salmeterol	OCc1c(O)ccc(c1)C(O)CNCCCCCCOCCCCc2ccccc2
109	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00960	approved; investigational	Pindolol	CC(C)NCC(O)COc1cccc(c12)[nH]cc2
110	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00983	approved; investigational	Formoterol	COc1ccc(cc1)CC(C)NCC(O)c2cc(NC=O)c(O)cc2
111	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01001	approved; vet_approved	Salbutamol	CC(C)(C)NCC(O)c1cc(CO)c(O)cc1
112	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01064	approved; investigational	Isoprenaline	CC(C)NCC(O)c1cc(O)c(O)cc1
113	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01102	approved	Arbutamine	Oc1ccc(cc1O)[C@@H](O)CNCCCCc2ccc(O)cc2
114	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01136	approved; investigational	Carvedilol	COc1ccccc1OCCNCC(O)COc2cccc(c23)[nH]c4c3cccc4
115	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01151	approved; investigational	Desipramine	CNCCCN1c(cccc2)c2CCc(c13)cccc3
116	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01182	approved	Propafenone	CCCNCC(O)COc1c(cccc1)C(=O)CCc2ccccc2
117	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01193	approved; investigational	Acebutolol	CCCC(=O)Nc1ccc(c(c1)C(=O)C)OCC(O)CNC(C)C
118	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01203	approved	Nadolol	CC(C)(C)NCC(O)COc1cccc(c12)C[C@@H](O)[C@H](C2)O
119	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01210	approved	Levobunolol	CC(C)(C)NC[C@H](O)COc1cccc(c12)C(=O)CCC2
120	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01214	approved	Metipranolol	CC(C)NCC(O)COc1c(C)c(C)c(c(C)c1)OC(=O)C
121	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
122	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01288	approved; investigational	Fenoterol	Oc1ccc(cc1)CC(C)NCC(O)c2cc(O)cc(O)c2
123	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01291	approved	Pirbuterol	CC(C)(C)NCC(O)c1nc(CO)c(O)cc1
124	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01295	experimental	Bevantolol	COc1c(OC)cc(cc1)CCNCC(O)COc2cccc(C)c2
125	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01297	approved	Practolol	CC(C)NCC(O)COc1ccc(cc1)NC(=O)C
126	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01359	approved; investigational	Penbutolol	CC(C)(C)NC[C@H](O)COc1ccccc1C2CCCC2
128	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01364	approved	Ephedrine	CN[C@@H](C)[C@H](O)c1ccccc1
129	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01407	approved; investigational; vet_approved	Clenbuterol	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1
130	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01580	approved	Oxprenolol	CC(C)NCC(O)COc1ccccc1OCC=C
131	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01917	experimental	Putrescine	NCCCCN
132	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB03566	experimental	Spermidine	NCCCCNCCCN
133	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB04846	approved; investigational	Celiprolol	CCN(CC)C(=O)Nc1ccc(c(c1)C(=O)C)OCC(O)CNC(C)(C)C
134	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB04855	approved	Dronedarone	CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c(CCCC)oc(c23)ccc(c3)NS(=O)(=O)C
135	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB04861	approved; investigational	Nebivolol	c1cc(F)cc(c12)CCC(O2)C(O)CNCC(O)C(O3)CCc(c34)cc(F)cc4
136	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
137	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB06262	approved; investigational	Droxidopa	OC(=O)[C@@H](N)[C@H](O)c1cc(O)c(O)cc1
138	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB08347	experimental	4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile	CC(C)(C)NC[C@H](O)COc1cccc(c12)N=C(C2)C#N
139	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB08558	experimental	2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCCC
140	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB08807	experimental	Bopindolol	Cc([nH]1)cc(c12)c(ccc2)OCC(CNC(C)(C)C)OC(=O)c3ccccc3
141	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB08808	experimental	Bupranolol	Cc1cc(c(Cl)cc1)OCC(O)CNC(C)(C)C
142	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB09013	experimental	Befunolol	CC(C)NCC(O)COc1cccc(c12)cc(o2)C(=O)C
143	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB09068	approved; investigational	Vortioxetine	Cc1ccc(c(C)c1)Sc2ccccc2N3CCNCC3
144	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB09204	investigational	Arotinolol	CC(C)(C)NCC(O)CSc1nc(cs1)-c2ccc(s2)C(=O)N
145	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB09351	approved; investigational	Levobetaxolol	CC(C)NC[C@H](O)COc1ccc(cc1)CCOCC2CC2
146	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB11124	approved	Racepinephrine	 
147	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB11278	approved	DL-Methylephedrine	CN(C)[C@@H](C)[C@H](O)c1ccccc1
148	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB13781	approved	Xamoterol	Oc1ccc(cc1)OCC(O)CNCCNC(=O)N2CCOCC2
149	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00182	approved; illicit; investigational	Amphetamine	CC(N)Cc1ccccc1
150	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00217	approved	Bethanidine	CN/C(=N\C)NCc1ccccc1
151	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
152	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00540	approved	Nortriptyline	CNCCC=C1c(cccc2)c2CCc(c13)cccc3
153	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
154	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00726	approved	Trimipramine	CN(C)CC(C)CN1c(cccc2)c2CCc(c13)cccc3
155	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB00785	approved	Cryptenamine	 
156	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01049	approved	Ergoloid mesylate	 
157	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01118	approved; investigational	Amiodarone	c1cccc(c12)c(c(o2)CCCC)C(=O)c3cc(I)c(c(I)c3)OCCN(CC)CC
158	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB01365	approved	Mephentermine	CNC(C)(C)Cc1ccccc1
159	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB06726	experimental	Bufuralol	CCc1cccc(c12)cc(o2)C(O)CNC(C)(C)C
160	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
162	sp|P07550|ADRB2_HU	P08588	86.92	45.0	404.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
163	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00211	approved	Midodrine	COc1cc(c(OC)cc1)C(O)CNC(=O)CN
164	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
165	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
166	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00298	approved	Dapiprazole	Cc1ccccc1N2CCN(CC2)CCc3nnc(n34)CCCC4
167	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
168	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
169	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00346	approved; investigational	Alfuzosin	COc(c1)c(OC)cc(c12)nc(nc2N)N(C)CCCNC(=O)C3CCCO3
170	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
171	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00368	approved	Norepinephrine	NC[C@H](O)c1cc(O)c(O)cc1
172	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00388	approved	Phenylephrine	CNC[C@H](O)c1cc(O)ccc1
173	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
174	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00420	approved; vet_approved	Promazine	CN(C)CCCN1c(cccc2)c2Sc(c13)cccc3
175	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00449	approved	Dipivefrin	CNCC(O)c1cc(OC(=O)C(C)(C)C)c(cc1)OC(=O)C(C)(C)C
176	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00450	approved; vet_approved	Droperidol	Fc1ccc(cc1)C(=O)CCCN2CCC(=CC2)n3c(=O)[nH]c(c34)cccc4
177	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00457	approved	Prazosin	COc(c1)c(OC)cc(c12)c(N)nc(n2)N3CCN(CC3)C(=O)c4ccco4
178	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00458	approved	Imipramine	CN(C)CCCN1c(cccc2)c2CCc(c13)cccc3
179	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00477	approved; investigational; vet_approved	Chlorpromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(Cl)c3
180	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00502	approved	Haloperidol	Clc1ccc(cc1)C2(O)CCN(CC2)CCCC(=O)c3ccc(F)cc3
181	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00540	approved	Nortriptyline	CNCCC=C1c(cccc2)c2CCc(c13)cccc3
182	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
183	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00555	approved; investigational	Lamotrigine	Nc1nc(N)c(nn1)-c2c(Cl)c(Cl)ccc2
184	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00575	approved	Clonidine	Clc1cccc(Cl)c1NC2=NCCN2
185	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00590	approved	Doxazosin	COc(c1)c(OC)cc(c12)c(N)nc(n2)N3CCN(CC3)C(=O)C(O4)COc(c45)cccc5
186	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00610	approved; investigational	Metaraminol	C[C@H](N)[C@H](O)c1cc(O)ccc1
187	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00622	approved; investigational	Nicardipine	COC(=O)C1=C(C)NC(C)=C(C1c2cc([N+]([O-])=O)ccc2)C(=O)OCCN(C)Cc3ccccc3
188	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00656	approved; investigational	Trazodone	Clc1cccc(c1)N2CCN(CC2)CCCn(c3=O)nc(n34)cccc4
189	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00661	approved	Verapamil	COc1c(OC)cc(cc1)CCN(C)CCCC(C#N)(C(C)C)c2cc(OC)c(OC)cc2
190	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00668	approved; vet_approved	Epinephrine	CNC[C@H](O)c1cc(O)c(O)cc1
191	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00679	approved; withdrawn	Thioridazine	c1cccc(S2)c1N(c(c23)cc(SC)cc3)CCC4CCCCN4C
192	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00692	approved	Phentolamine	Oc1cccc(c1)N(c2ccc(C)cc2)CC3=NCCN3
193	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00696	approved	Ergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C=5)CN(C)[C@@H](C56)Cc7c8c6cccc8[nH]c7
194	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00699	approved; investigational	Nicergoline	CO[C@@]12c3c4c(ccc3)n(C)cc4C[C@H]1N(C)C[C@@H](C2)COC(=O)c5cncc(Br)c5
195	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00706	approved; investigational	Tamsulosin	CCOc1ccccc1OCCN[C@H](C)Cc2cc(S(=O)(=O)N)c(OC)cc2
196	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00723	approved; investigational	Methoxamine	COc1cc(C(O)C(C)N)c(OC)cc1
197	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00726	approved	Trimipramine	CN(C)CC(C)CN1c(cccc2)c2CCc(c13)cccc3
198	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00734	approved; investigational	Risperidone	C1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
199	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00751	approved; investigational	Epinastine	NC1=NCC(N12)c3c(cccc3)Cc4c2cccc4
200	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00777	approved	Propiomazine	CCC(=O)c(cc1)cc(c12)N(CC(C)N(C)C)c3c(S2)cccc3
201	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00797	approved; vet_approved	Tolazoline	N1CCN=C1Cc2ccccc2
202	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00800	approved	Fenoldopam	Oc1ccc(cc1)C2CNCCc(c23)c(Cl)c(O)c(c3)O
203	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00831	approved; investigational	Trifluoperazine	CN1CCN(CC1)CCCN2c(cccc3)c3Sc(c24)ccc(c4)C(F)(F)F
204	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00852	approved	Pseudoephedrine	CN[C@@H](C)[C@@H](O)c1ccccc1
205	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00865	approved; illicit	Benzphetamine	c1ccccc1C[C@H](C)N(C)Cc2ccccc2
206	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00875	approved; investigational; withdrawn	Flupentixol	FC(F)(F)c(c1)ccc(S2)c1C(\c(c23)cccc3)=C/CCN4CCN(CC4)CCO
207	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00908	approved; investigational	Quinidine	C=C[C@@H](CN12)[C@@H](CC1)C[C@@H]2[C@@H](O)c(ccn3)c(c34)cc(cc4)OC
208	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00925	approved	Phenoxybenzamine	c1ccccc1CN(CCCl)C(C)COc2ccccc2
209	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00935	approved; investigational	Oxymetazoline	Cc1cc(C(C)(C)C)c(O)c(C)c1CC2=NCCN2
210	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00964	approved	Apraclonidine	Nc1cc(Cl)c(c(Cl)c1)NC2=NCCN2
211	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01136	approved; investigational	Carvedilol	COc1ccccc1OCCNCC(O)COc2cccc(c23)[nH]c4c3cccc4
212	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01142	approved; investigational	Doxepin	CN(C)CC/C=C\1c(cccc2)c2COc(c13)cccc3
213	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01149	approved; withdrawn	Nefazodone	c1ccccc1OCCn2c(=O)n(nc2CC)CCCN3CCN(CC3)c4cc(Cl)ccc4
214	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01162	approved	Terazosin	COc(c1)c(OC)cc(c12)c(N)nc(n2)N3CCN(CC3)C(=O)C4CCCO4
215	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01186	approved; investigational; vet_approved; withdrawn	Pergolide	CSC[C@H](C1)CN(CCC)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
216	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01200	approved; investigational	Bromocriptine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](CC(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C=4)CN(C)[C@@H](C45)Cc6c7c5cccc7[nH]c6Br
217	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
218	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01253	approved	Ergometrine	OC[C@H](C)NC(=O)[C@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4[nH]c3
219	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01267	approved	Paliperidone	OC1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
220	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01295	experimental	Bevantolol	COc1c(OC)cc(cc1)CCNCC(O)COc2cccc(C)c2
221	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01364	approved	Ephedrine	CN[C@@H](C)[C@H](O)c1ccccc1
222	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01403	approved; investigational	Methotrimeprazine	COc(cc1)cc(c12)N(C[C@H](C)CN(C)C)c3c(S2)cccc3
223	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01472	experimental; illicit	4-Methoxyamphetamine	COc1ccc(cc1)CC(C)N
224	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01579	approved; illicit	Phendimetrazine	CN1CCO[C@H]([C@@H]1C)c2ccccc2
225	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01614	experimental; vet_approved	Acepromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(c3)C(=O)C
226	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01622	experimental	Thioproperazine	CN(C)S(=O)(=O)c(cc1)cc(c12)N(c3c(S2)cccc3)CCCN4CCN(C)CC4
227	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01624	approved; investigational	Zuclopenthixol	OCCN1CCN(CC1)CC/C=C\2c(cccc3)c3Sc(c24)ccc(Cl)c4
228	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB04855	approved	Dronedarone	CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c(CCCC)oc(c23)ccc(c3)NS(=O)(=O)C
229	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB04946	approved	Iloperidone	CC(=O)c1cc(OC)c(cc1)OCCCN2CCC(CC2)c3noc(c34)cc(F)cc4
230	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB04948	approved; investigational	Lofexidine	N1CCN=C1C(C)Oc2c(Cl)cccc2Cl
231	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB05469	investigational	R450	 
232	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB05492	investigational	Epicept NP-1	Cc1cc([N+]([O-])=O)c(cc1)NCCCN
233	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB06144	approved; investigational; withdrawn	Sertindole	Fc1ccc(cc1)-n2cc(c(c23)cc(Cl)cc3)C4CCN(CC4)CCN5CCNC5=O
234	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB06153	approved	Pizotifen	CN1CCC(CC1)=C2c(ccs3)c3CCc(c24)cccc4
235	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB06207	approved	Silodosin	OCCCN1CCc(c12)cc(cc2C(=O)N)C[C@@H](C)NCCOc3ccccc3OCC(F)(F)F
236	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
237	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB06229	investigational	Ocaperidone	Cc1cccn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
238	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB06262	approved; investigational	Droxidopa	OC(=O)[C@@H](N)[C@H](O)c1cc(O)c(O)cc1
239	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB06694	approved; investigational	Xylometazoline	Cc1cc(C(C)(C)C)cc(C)c1CC2=NCCN2
240	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB06706	approved	Isometheptene	CNC(C)CCC=C(C)C
241	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB06711	approved; investigational	Naphazoline	N1CCN=C1Cc2cccc(c23)cccc3
242	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB06764	approved	Tetryzoline	N1CCN=C1C2CCCc(c23)cccc3
243	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB08950	approved; withdrawn	Indoramin	c1ccccc1C(=O)NC2CCN(CC2)CCc3c[nH]c(c34)cccc4
244	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB09202	experimental	Cirazoline	N1CCN=C1COc2ccccc2C3CC3
245	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB09239	experimental	Niguldipine	[O-][N+](=O)c1cccc(c1)[C@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
246	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB11124	approved	Racepinephrine	 
247	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB12278	approved; investigational	Propiverine	c1ccccc1C(OCCC)(c2ccccc2)C(=O)OC3CCN(C)CC3
248	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB14185	approved; investigational	Aripiprazole lauroxil	CCCCCCCCCCCC(=O)OCN1C(=O)CCc(c12)ccc(c2)OCCCCN3CCN(CC3)c4c(Cl)c(Cl)ccc4
249	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00243	approved; investigational	Ranolazine	COc1ccccc1OCC(O)CN2CCN(CC2)CC(=O)Nc3c(C)cccc3C
250	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00370	approved	Mirtazapine	CN(C1)CCN(C12)c3c(cccn3)Cc4c2cccc4
251	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00433	approved; vet_approved	Prochlorperazine	CN1CCN(CC1)CCCN2c(cccc3)c3Sc(c24)ccc(Cl)c4
254	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00490	approved; investigational	Buspirone	C1CCCC12CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)c4ncccn4
256	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00598	approved	Labetalol	c1ccccc1CCC(C)NCC(O)c2cc(C(=O)N)c(O)cc2
257	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00697	approved; investigational	Tizanidine	n1snc(c12)c(c(Cl)cc2)NC3=NCCN3
258	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
259	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00841	approved	Dobutamine	Oc1ccc(cc1)CCC(C)NCCc2cc(O)c(O)cc2
260	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00934	approved; investigational	Maprotiline	CNCCCC12c3c(cccc3)C(CC1)c4c2cccc4
262	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01151	approved; investigational	Desipramine	CNCCCN1c(cccc2)c2CCc(c13)cccc3
263	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01175	approved	Escitalopram	Fc1ccc(cc1)[C@]2(CCCN(C)C)OCc(c23)cc(C#N)cc3
264	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
265	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
266	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB08922	experimental	Perospirone	C1CCC[C@H]([C@H]12)C(=O)N(C2=O)CCCCN3CCN(CC3)c4nsc(c45)cccc5
267	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB09167	approved	Dosulepin	CN(C)CC/C=C/1c(cccc2)c2CSc(c13)cccc3
268	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB09194	withdrawn	Etoperidone	CCn1c(=O)n(nc1CC)CCCN2CCN(CC2)c3cccc(Cl)c3
269	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB09195	approved	Lorpiprazole	C1CC[C@H]([C@H]12)Cn3c2nnc3CCN4CCN(CC4)c5cccc(c5)C(F)(F)F
270	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB09203	experimental	Synephrine	CNCC(O)c1ccc(O)cc1
271	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB09204	investigational	Arotinolol	CC(C)(C)NCC(O)CSc1nc(cs1)-c2ccc(s2)C(=O)N
272	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB09286	investigational	Pipamperone	C1CCCCN1C2(C(=O)N)CCN(CC2)CCCC(=O)c3ccc(F)cc3
273	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
274	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00182	approved; illicit; investigational	Amphetamine	CC(N)Cc1ccccc1
275	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB00268	approved; investigational	Ropinirole	CCCN(CCC)CCc(ccc1)c(c12)CC(=O)N2
276	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01049	approved	Ergoloid mesylate	 
277	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
278	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01365	approved	Mephentermine	CNC(C)(C)Cc1ccccc1
279	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB01576	approved; illicit	Dextroamphetamine	C[C@H](N)Cc1ccccc1
280	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB09205	approved; investigational	Moxisylyte	CN(C)CCOc1c(C(C)C)cc(c(c1)C)OC(=O)C
281	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB09229	experimental	Aranidipine	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(=O)C)C1c2ccccc2[N+]([O-])=O
282	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
283	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB11278	approved	DL-Methylephedrine	CN(C)[C@@H](C)[C@H](O)c1ccccc1
284	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB11577	approved	Indigotindisulfonic acid	OS(=O)(=O)c(cc1)cc(c12)C(=O)C(\N2)=C(C3=O)/Nc(c34)ccc(c4)S(=O)(=O)O
285	sp|P07550|ADRB2_HU	P35348	88.86	4.0	371.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
289	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00211	approved	Midodrine	COc1cc(c(OC)cc1)C(O)CNC(=O)CN
290	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
291	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
292	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00298	approved	Dapiprazole	Cc1ccccc1N2CCN(CC2)CCc3nnc(n34)CCCC4
293	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
294	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
295	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00346	approved; investigational	Alfuzosin	COc(c1)c(OC)cc(c12)nc(nc2N)N(C)CCCNC(=O)C3CCCO3
296	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
297	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00368	approved	Norepinephrine	NC[C@H](O)c1cc(O)c(O)cc1
298	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00388	approved	Phenylephrine	CNC[C@H](O)c1cc(O)ccc1
299	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
300	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00457	approved	Prazosin	COc(c1)c(OC)cc(c12)c(N)nc(n2)N3CCN(CC3)C(=O)c4ccco4
301	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00458	approved	Imipramine	CN(C)CCCN1c(cccc2)c2CCc(c13)cccc3
302	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00477	approved; investigational; vet_approved	Chlorpromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(Cl)c3
303	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00540	approved	Nortriptyline	CNCCC=C1c(cccc2)c2CCc(c13)cccc3
304	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00575	approved	Clonidine	Clc1cccc(Cl)c1NC2=NCCN2
305	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00590	approved	Doxazosin	COc(c1)c(OC)cc(c12)c(N)nc(n2)N3CCN(CC3)C(=O)C(O4)COc(c45)cccc5
306	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00622	approved; investigational	Nicardipine	COC(=O)C1=C(C)NC(C)=C(C1c2cc([N+]([O-])=O)ccc2)C(=O)OCCN(C)Cc3ccccc3
307	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00661	approved	Verapamil	COc1c(OC)cc(cc1)CCN(C)CCCC(C#N)(C(C)C)c2cc(OC)c(OC)cc2
308	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00668	approved; vet_approved	Epinephrine	CNC[C@H](O)c1cc(O)c(O)cc1
309	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00679	approved; withdrawn	Thioridazine	c1cccc(S2)c1N(c(c23)cc(SC)cc3)CCC4CCCCN4C
310	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00692	approved	Phentolamine	Oc1cccc(c1)N(c2ccc(C)cc2)CC3=NCCN3
311	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00696	approved	Ergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C=5)CN(C)[C@@H](C56)Cc7c8c6cccc8[nH]c7
312	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00706	approved; investigational	Tamsulosin	CCOc1ccccc1OCCN[C@H](C)Cc2cc(S(=O)(=O)N)c(OC)cc2
313	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00723	approved; investigational	Methoxamine	COc1cc(C(O)C(C)N)c(OC)cc1
314	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00726	approved	Trimipramine	CN(C)CC(C)CN1c(cccc2)c2CCc(c13)cccc3
315	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00734	approved; investigational	Risperidone	C1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
316	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00745	approved; investigational	Modafinil	c1ccccc1C(S(=O)CC(=O)N)c2ccccc2
317	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00800	approved	Fenoldopam	Oc1ccc(cc1)C2CNCCc(c23)c(Cl)c(O)c(c3)O
318	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00908	approved; investigational	Quinidine	C=C[C@@H](CN12)[C@@H](CC1)C[C@@H]2[C@@H](O)c(ccn3)c(c34)cc(cc4)OC
319	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00925	approved	Phenoxybenzamine	c1ccccc1CN(CCCl)C(C)COc2ccccc2
320	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00935	approved; investigational	Oxymetazoline	Cc1cc(C(C)(C)C)c(O)c(C)c1CC2=NCCN2
321	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01136	approved; investigational	Carvedilol	COc1ccccc1OCCNCC(O)COc2cccc(c23)[nH]c4c3cccc4
322	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01142	approved; investigational	Doxepin	CN(C)CC/C=C\1c(cccc2)c2COc(c13)cccc3
323	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01149	approved; withdrawn	Nefazodone	c1ccccc1OCCn2c(=O)n(nc2CC)CCCN3CCN(CC3)c4cc(Cl)ccc4
324	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01162	approved	Terazosin	COc(c1)c(OC)cc(c12)c(N)nc(n2)N3CCN(CC3)C(=O)C4CCCO4
325	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01186	approved; investigational; vet_approved; withdrawn	Pergolide	CSC[C@H](C1)CN(CCC)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
326	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01200	approved; investigational	Bromocriptine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](CC(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C=4)CN(C)[C@@H](C45)Cc6c7c5cccc7[nH]c6Br
327	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
328	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01267	approved	Paliperidone	OC1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
329	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01403	approved; investigational	Methotrimeprazine	COc(cc1)cc(c12)N(C[C@H](C)CN(C)C)c3c(S2)cccc3
330	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01576	approved; illicit	Dextroamphetamine	C[C@H](N)Cc1ccccc1
331	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01579	approved; illicit	Phendimetrazine	CN1CCO[C@H]([C@@H]1C)c2ccccc2
332	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01608	approved; investigational	Periciazine	OC1CCN(CC1)CCCN2c(cccc3)c3Sc(c24)ccc(c4)C#N
333	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01614	experimental; vet_approved	Acepromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(c3)C(=O)C
334	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01622	experimental	Thioproperazine	CN(C)S(=O)(=O)c(cc1)cc(c12)N(c3c(S2)cccc3)CCCN4CCN(C)CC4
335	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB04855	approved	Dronedarone	CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c(CCCC)oc(c23)ccc(c3)NS(=O)(=O)C
336	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB05469	investigational	R450	 
337	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB05492	investigational	Epicept NP-1	Cc1cc([N+]([O-])=O)c(cc1)NCCCN
338	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB06144	approved; investigational; withdrawn	Sertindole	Fc1ccc(cc1)-n2cc(c(c23)cc(Cl)cc3)C4CCN(CC4)CCN5CCNC5=O
339	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB06153	approved	Pizotifen	CN1CCC(CC1)=C2c(ccs3)c3CCc(c24)cccc4
340	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB06207	approved	Silodosin	OCCCN1CCc(c12)cc(cc2C(=O)N)C[C@@H](C)NCCOc3ccccc3OCC(F)(F)F
341	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB06229	investigational	Ocaperidone	Cc1cccn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
342	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB06262	approved; investigational	Droxidopa	OC(=O)[C@@H](N)[C@H](O)c1cc(O)c(O)cc1
343	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB06694	approved; investigational	Xylometazoline	Cc1cc(C(C)(C)C)cc(C)c1CC2=NCCN2
344	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB09128	approved; investigational	Brexpiprazole	c1cc(=O)[nH]c(c12)cc(cc2)OCCCCN3CCN(CC3)c(ccc4)c(c45)ccs5
345	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB09202	experimental	Cirazoline	N1CCN=C1COc2ccccc2C3CC3
346	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB11124	approved	Racepinephrine	 
347	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB14185	approved; investigational	Aripiprazole lauroxil	CCCCCCCCCCCC(=O)OCN1C(=O)CCc(c12)ccc(c2)OCCCCN3CCN(CC3)c4c(Cl)c(Cl)ccc4
348	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00243	approved; investigational	Ranolazine	COc1ccccc1OCC(O)CN2CCN(CC2)CC(=O)Nc3c(C)cccc3C
349	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00370	approved	Mirtazapine	CN(C1)CCN(C12)c3c(cccn3)Cc4c2cccc4
350	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00433	approved; vet_approved	Prochlorperazine	CN1CCN(CC1)CCCN2c(cccc3)c3Sc(c24)ccc(Cl)c4
353	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00490	approved; investigational	Buspirone	C1CCCC12CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)c4ncccn4
354	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
355	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00598	approved	Labetalol	c1ccccc1CCC(C)NCC(O)c2cc(C(=O)N)c(O)cc2
356	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00697	approved; investigational	Tizanidine	n1snc(c12)c(c(Cl)cc2)NC3=NCCN3
357	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
358	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00841	approved	Dobutamine	Oc1ccc(cc1)CCC(C)NCCc2cc(O)c(O)cc2
359	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00934	approved; investigational	Maprotiline	CNCCCC12c3c(cccc3)C(CC1)c4c2cccc4
361	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01151	approved; investigational	Desipramine	CNCCCN1c(cccc2)c2CCc(c13)cccc3
362	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01175	approved	Escitalopram	Fc1ccc(cc1)[C@]2(CCCN(C)C)OCc(c23)cc(C#N)cc3
363	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
364	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
365	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB08922	experimental	Perospirone	C1CCC[C@H]([C@H]12)C(=O)N(C2=O)CCCCN3CCN(CC3)c4nsc(c45)cccc5
366	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB09167	approved	Dosulepin	CN(C)CC/C=C/1c(cccc2)c2CSc(c13)cccc3
367	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB09194	withdrawn	Etoperidone	CCn1c(=O)n(nc1CC)CCCN2CCN(CC2)c3cccc(Cl)c3
368	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB09195	approved	Lorpiprazole	C1CC[C@H]([C@H]12)Cn3c2nnc3CCN4CCN(CC4)c5cccc(c5)C(F)(F)F
369	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB09203	experimental	Synephrine	CNCC(O)c1ccc(O)cc1
370	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB09204	investigational	Arotinolol	CC(C)(C)NCC(O)CSc1nc(cs1)-c2ccc(s2)C(=O)N
371	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB09286	investigational	Pipamperone	C1CCCCN1C2(C(=O)N)CCN(CC2)CCCC(=O)c3ccc(F)cc3
372	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
373	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00182	approved; illicit; investigational	Amphetamine	CC(N)Cc1ccccc1
374	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB00268	approved; investigational	Ropinirole	CCCN(CCC)CCc(ccc1)c(c12)CC(=O)N2
375	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01049	approved	Ergoloid mesylate	 
376	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
377	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB01365	approved	Mephentermine	CNC(C)(C)Cc1ccccc1
379	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB09205	approved; investigational	Moxisylyte	CN(C)CCOc1c(C(C)C)cc(c(c1)C)OC(=O)C
380	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB09229	experimental	Aranidipine	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(=O)C)C1c2ccccc2[N+]([O-])=O
381	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
382	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB11278	approved	DL-Methylephedrine	CN(C)[C@@H](C)[C@H](O)c1ccccc1
383	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB11577	approved	Indigotindisulfonic acid	OS(=O)(=O)c(cc1)cc(c12)C(=O)C(\N2)=C(C3=O)/Nc(c34)ccc(c4)S(=O)(=O)O
384	sp|P07550|ADRB2_HU	P35368	84.5	29.0	378.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
385	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00368	approved	Norepinephrine	NC[C@H](O)c1cc(O)c(O)cc1
386	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00571	approved; investigational	Propranolol	CC(C)NCC(O)COc1cccc(c12)cccc2
387	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00866	experimental; withdrawn	Alprenolol	CC(C)NCC(O)COc1ccccc1CC=C
388	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00871	approved	Terbutaline	CC(C)(C)NCC(O)c1cc(O)cc(O)c1
389	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00938	approved	Salmeterol	OCc1c(O)ccc(c1)C(O)CNCCCCCCOCCCCc2ccccc2
390	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00960	approved; investigational	Pindolol	CC(C)NCC(O)COc1cccc(c12)[nH]cc2
391	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00983	approved; investigational	Formoterol	COc1ccc(cc1)CC(C)NCC(O)c2cc(NC=O)c(O)cc2
392	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB01001	approved; vet_approved	Salbutamol	CC(C)(C)NCC(O)c1cc(CO)c(O)cc1
393	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB01064	approved; investigational	Isoprenaline	CC(C)NCC(O)c1cc(O)c(O)cc1
394	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB01102	approved	Arbutamine	Oc1ccc(cc1O)[C@@H](O)CNCCCCc2ccc(O)cc2
395	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB01288	approved; investigational	Fenoterol	Oc1ccc(cc1)CC(C)NCC(O)c2cc(O)cc(O)c2
397	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB01407	approved; investigational; vet_approved	Clenbuterol	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1
398	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB01580	approved	Oxprenolol	CC(C)NCC(O)COc1ccccc1OCC=C
399	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB04846	approved; investigational	Celiprolol	CCN(CC)C(=O)Nc1ccc(c(c1)C(=O)C)OCC(O)CNC(C)(C)C
400	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB04861	approved; investigational	Nebivolol	c1cc(F)cc(c12)CCC(O2)C(O)CNCC(O)C(O3)CCc(c34)cc(F)cc4
401	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB05395	investigational	Amibegron	Clc1cccc(c1)[C@@H](O)CN[C@H](C2)CCc(c23)ccc(c3)OCC(=O)OCC
402	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB06190	investigational	Solabegron	Clc1cc(ccc1)[C@@H](O)CNCCNc2cc(ccc2)-c3cc(C(=O)O)ccc3
403	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB06262	approved; investigational	Droxidopa	OC(=O)[C@@H](N)[C@H](O)c1cc(O)c(O)cc1
404	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB08807	experimental	Bopindolol	Cc([nH]1)cc(c12)c(ccc2)OCC(CNC(C)(C)C)OC(=O)c3ccccc3
405	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB08808	experimental	Bupranolol	Cc1cc(c(Cl)cc1)OCC(O)CNC(C)(C)C
406	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB08893	approved	Mirabegron	Nc1nc(cs1)CC(=O)Nc2ccc(cc2)CCNC[C@H](O)c3ccccc3
407	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB11124	approved	Racepinephrine	 
408	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00182	approved; illicit; investigational	Amphetamine	CC(N)Cc1ccccc1
409	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00217	approved	Bethanidine	CN/C(=N\C)NCc1ccccc1
410	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
411	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00540	approved	Nortriptyline	CNCCC=C1c(cccc2)c2CCc(c13)cccc3
412	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
413	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00726	approved	Trimipramine	CN(C)CC(C)CN1c(cccc2)c2CCc(c13)cccc3
414	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB00785	approved	Cryptenamine	 
415	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB01049	approved	Ergoloid mesylate	 
416	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB01118	approved; investigational	Amiodarone	c1cccc(c12)c(c(o2)CCCC)C(=O)c3cc(I)c(c(I)c3)OCCN(CC)CC
417	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB01365	approved	Mephentermine	CNC(C)(C)Cc1ccccc1
418	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB06726	experimental	Bufuralol	CCc1cccc(c12)cc(o2)C(O)CNC(C)(C)C
419	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
420	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB11278	approved	DL-Methylephedrine	CN(C)[C@@H](C)[C@H](O)c1ccccc1
421	sp|P07550|ADRB2_HU	P13945	80.15	35.0	366.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
422	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00272	approved	Betazole	NCCc1ccn[nH]1
423	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
424	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
425	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00501	approved; investigational	Cimetidine	N#C/N=C(/NC)NCCSCc1c(C)[nH]cn1
426	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00585	approved	Nizatidine	[O-][N+](=O)/C=C(\NC)NCCSCc1csc(n1)CN(C)C
427	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00751	approved; investigational	Epinastine	NC1=NCC(N12)c3c(cccc3)Cc4c2cccc4
428	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00768	approved	Olopatadine	CN(C)CC/C=C\1c(cccc2)c2COc(c13)ccc(c3)CC(=O)O
429	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00797	approved; vet_approved	Tolazoline	N1CCN=C1Cc2ccccc2
430	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00863	approved; withdrawn	Ranitidine	[O-][N+](=O)/C=C(\NC)NCCSCc1ccc(o1)CN(C)C
431	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00927	approved	Famotidine	NC(N)=Nc1nc(cs1)CSCC/C(N)=N/S(=O)(=O)N
432	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00940	approved; investigational	Methantheline	CC[N+](C)(CC)CCOC(=O)C1c(cccc2)c2Oc(c13)cccc3
433	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB00972	approved	Azelastine	CN1CCCC(CC1)n(c2=O)nc(c(c23)cccc3)Cc4ccc(Cl)cc4
434	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
435	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB01142	approved; investigational	Doxepin	CN(C)CC/C=C\1c(cccc2)c2COc(c13)cccc3
436	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
437	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB05369	investigational	HZT-501	 
438	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB05381	approved; investigational	Histamine	NCCc1c[nH]cn1
439	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
440	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB08805	experimental	Metiamide	CNC(=S)NCCSCc1c(C)[nH]cn1
441	sp|P07550|ADRB2_HU	P25021	81.6	13.0	350.0	DB08806	experimental	Roxatidine acetate	CC(=O)OCC(=O)NCCCOc1cccc(c1)CN2CCCCC2
442	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00211	approved	Midodrine	COc1cc(c(OC)cc1)C(O)CNC(=O)CN
443	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
444	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00298	approved	Dapiprazole	Cc1ccccc1N2CCN(CC2)CCc3nnc(n34)CCCC4
445	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
446	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00346	approved; investigational	Alfuzosin	COc(c1)c(OC)cc(c12)nc(nc2N)N(C)CCCNC(=O)C3CCCO3
447	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00368	approved	Norepinephrine	NC[C@H](O)c1cc(O)c(O)cc1
448	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00388	approved	Phenylephrine	CNC[C@H](O)c1cc(O)ccc1
449	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00457	approved	Prazosin	COc(c1)c(OC)cc(c12)c(N)nc(n2)N3CCN(CC3)C(=O)c4ccco4
450	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00458	approved	Imipramine	CN(C)CCCN1c(cccc2)c2CCc(c13)cccc3
451	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00540	approved	Nortriptyline	CNCCC=C1c(cccc2)c2CCc(c13)cccc3
452	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00575	approved	Clonidine	Clc1cccc(Cl)c1NC2=NCCN2
453	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00590	approved	Doxazosin	COc(c1)c(OC)cc(c12)c(N)nc(n2)N3CCN(CC3)C(=O)C(O4)COc(c45)cccc5
454	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00622	approved; investigational	Nicardipine	COC(=O)C1=C(C)NC(C)=C(C1c2cc([N+]([O-])=O)ccc2)C(=O)OCCN(C)Cc3ccccc3
455	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00661	approved	Verapamil	COc1c(OC)cc(cc1)CCN(C)CCCC(C#N)(C(C)C)c2cc(OC)c(OC)cc2
456	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00668	approved; vet_approved	Epinephrine	CNC[C@H](O)c1cc(O)c(O)cc1
457	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00692	approved	Phentolamine	Oc1cccc(c1)N(c2ccc(C)cc2)CC3=NCCN3
458	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00696	approved	Ergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C=5)CN(C)[C@@H](C56)Cc7c8c6cccc8[nH]c7
459	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00706	approved; investigational	Tamsulosin	CCOc1ccccc1OCCN[C@H](C)Cc2cc(S(=O)(=O)N)c(OC)cc2
460	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00723	approved; investigational	Methoxamine	COc1cc(C(O)C(C)N)c(OC)cc1
461	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00800	approved	Fenoldopam	Oc1ccc(cc1)C2CNCCc(c23)c(Cl)c(O)c(c3)O
462	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00908	approved; investigational	Quinidine	C=C[C@@H](CN12)[C@@H](CC1)C[C@@H]2[C@@H](O)c(ccn3)c(c34)cc(cc4)OC
463	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00925	approved	Phenoxybenzamine	c1ccccc1CN(CCCl)C(C)COc2ccccc2
464	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00935	approved; investigational	Oxymetazoline	Cc1cc(C(C)(C)C)c(O)c(C)c1CC2=NCCN2
465	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01136	approved; investigational	Carvedilol	COc1ccccc1OCCNCC(O)COc2cccc(c23)[nH]c4c3cccc4
466	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01142	approved; investigational	Doxepin	CN(C)CC/C=C\1c(cccc2)c2COc(c13)cccc3
467	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01162	approved	Terazosin	COc(c1)c(OC)cc(c12)c(N)nc(n2)N3CCN(CC3)C(=O)C4CCCO4
468	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01186	approved; investigational; vet_approved; withdrawn	Pergolide	CSC[C@H](C1)CN(CCC)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
469	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01200	approved; investigational	Bromocriptine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](CC(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C=4)CN(C)[C@@H](C45)Cc6c7c5cccc7[nH]c6Br
470	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01403	approved; investigational	Methotrimeprazine	COc(cc1)cc(c12)N(C[C@H](C)CN(C)C)c3c(S2)cccc3
471	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB04855	approved	Dronedarone	CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c(CCCC)oc(c23)ccc(c3)NS(=O)(=O)C
472	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB05469	investigational	R450	 
473	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB05492	investigational	Epicept NP-1	Cc1cc([N+]([O-])=O)c(cc1)NCCCN
474	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB06144	approved; investigational; withdrawn	Sertindole	Fc1ccc(cc1)-n2cc(c(c23)cc(Cl)cc3)C4CCN(CC4)CCN5CCNC5=O
475	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB06153	approved	Pizotifen	CN1CCC(CC1)=C2c(ccs3)c3CCc(c24)cccc4
476	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB06207	approved	Silodosin	OCCCN1CCc(c12)cc(cc2C(=O)N)C[C@@H](C)NCCOc3ccccc3OCC(F)(F)F
477	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB06229	investigational	Ocaperidone	Cc1cccn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
478	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB06262	approved; investigational	Droxidopa	OC(=O)[C@@H](N)[C@H](O)c1cc(O)c(O)cc1
479	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB06694	approved; investigational	Xylometazoline	Cc1cc(C(C)(C)C)cc(C)c1CC2=NCCN2
480	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB09202	experimental	Cirazoline	N1CCN=C1COc2ccccc2C3CC3
481	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB11124	approved	Racepinephrine	 
482	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00243	approved; investigational	Ranolazine	COc1ccccc1OCC(O)CN2CCN(CC2)CC(=O)Nc3c(C)cccc3C
483	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00370	approved	Mirtazapine	CN(C1)CCN(C12)c3c(cccn3)Cc4c2cccc4
484	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00433	approved; vet_approved	Prochlorperazine	CN1CCN(CC1)CCCN2c(cccc3)c3Sc(c24)ccc(Cl)c4
486	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00477	approved; investigational; vet_approved	Chlorpromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(Cl)c3
487	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00490	approved; investigational	Buspirone	C1CCCC12CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)c4ncccn4
488	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
489	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00598	approved	Labetalol	c1ccccc1CCC(C)NCC(O)c2cc(C(=O)N)c(O)cc2
490	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00697	approved; investigational	Tizanidine	n1snc(c12)c(c(Cl)cc2)NC3=NCCN3
491	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
492	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00841	approved	Dobutamine	Oc1ccc(cc1)CCC(C)NCCc2cc(O)c(O)cc2
493	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00934	approved; investigational	Maprotiline	CNCCCC12c3c(cccc3)C(CC1)c4c2cccc4
495	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01151	approved; investigational	Desipramine	CNCCCN1c(cccc2)c2CCc(c13)cccc3
496	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01175	approved	Escitalopram	Fc1ccc(cc1)[C@]2(CCCN(C)C)OCc(c23)cc(C#N)cc3
497	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
498	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
499	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB08922	experimental	Perospirone	C1CCC[C@H]([C@H]12)C(=O)N(C2=O)CCCCN3CCN(CC3)c4nsc(c45)cccc5
500	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB09167	approved	Dosulepin	CN(C)CC/C=C/1c(cccc2)c2CSc(c13)cccc3
501	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB09194	withdrawn	Etoperidone	CCn1c(=O)n(nc1CC)CCCN2CCN(CC2)c3cccc(Cl)c3
502	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB09195	approved	Lorpiprazole	C1CC[C@H]([C@H]12)Cn3c2nnc3CCN4CCN(CC4)c5cccc(c5)C(F)(F)F
503	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB09203	experimental	Synephrine	CNCC(O)c1ccc(O)cc1
504	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB09204	investigational	Arotinolol	CC(C)(C)NCC(O)CSc1nc(cs1)-c2ccc(s2)C(=O)N
505	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB09286	investigational	Pipamperone	C1CCCCN1C2(C(=O)N)CCN(CC2)CCCC(=O)c3ccc(F)cc3
506	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
507	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00182	approved; illicit; investigational	Amphetamine	CC(N)Cc1ccccc1
508	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB00268	approved; investigational	Ropinirole	CCCN(CCC)CCc(ccc1)c(c12)CC(=O)N2
509	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01049	approved	Ergoloid mesylate	 
510	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
511	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01365	approved	Mephentermine	CNC(C)(C)Cc1ccccc1
512	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB01576	approved; illicit	Dextroamphetamine	C[C@H](N)Cc1ccccc1
513	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB09205	approved; investigational	Moxisylyte	CN(C)CCOc1c(C(C)C)cc(c(c1)C)OC(=O)C
514	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB09229	experimental	Aranidipine	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(=O)C)C1c2ccccc2[N+]([O-])=O
515	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
516	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB11278	approved	DL-Methylephedrine	CN(C)[C@@H](C)[C@H](O)c1ccccc1
517	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB11577	approved	Indigotindisulfonic acid	OS(=O)(=O)c(cc1)cc(c12)C(=O)C(\N2)=C(C3=O)/Nc(c34)ccc(c4)S(=O)(=O)O
518	sp|P07550|ADRB2_HU	P25100	81.11	94.0	429.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
522	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00216	approved; investigational	Eletriptan	CN1CCC[C@@H]1Cc2c[nH]c(c23)ccc(c3)CCS(=O)(=O)c4ccccc4
523	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
524	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
525	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00315	approved; investigational	Zolmitriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)C[C@H]3COC(=O)N3
526	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00320	approved; investigational	Dihydroergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
527	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
528	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
529	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
530	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00589	approved; investigational	Lisuride	CCN(CC)C(=O)N[C@@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4[nH]c3
531	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00669	approved; investigational	Sumatriptan	CNS(=O)(=O)Cc(c1)ccc(c12)[nH]cc2CCN(C)C
532	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00696	approved	Ergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C=5)CN(C)[C@@H](C56)Cc7c8c6cccc8[nH]c7
533	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00714	approved; investigational	Apomorphine	c1cc(O)c(O)c(c12)c3c4c(ccc3)CCN(C)[C@@H]4C2
534	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00726	approved	Trimipramine	CN(C)CC(C)CN1c(cccc2)c2CCc(c13)cccc3
535	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00734	approved; investigational	Risperidone	C1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
536	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00918	approved; investigational	Almotriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)CS(=O)(=O)N3CCCC3
537	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00952	approved; investigational	Naratriptan	CNS(=O)(=O)CCc(cc1)cc(c12)c(c[nH]2)C3CCN(C)CC3
538	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00953	approved	Rizatriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)Cn3cncn3
539	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00998	approved; investigational	Frovatriptan	CN[C@@H](C1)CCc(c12)[nH]c3c2cc(cc3)C(=O)N
540	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB01186	approved; investigational; vet_approved; withdrawn	Pergolide	CSC[C@H](C1)CN(CCC)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
541	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB01200	approved; investigational	Bromocriptine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](CC(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C=4)CN(C)[C@@H](C45)Cc6c7c5cccc7[nH]c6Br
542	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
543	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
544	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB01267	approved	Paliperidone	OC1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
545	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB01392	approved; investigational; vet_approved	Yohimbine	COC(=O)[C@H]1[C@@H](O)CC[C@H]([C@@H]12)CN3[C@@H](C2)c4c(CC3)c5c([nH]4)cccc5
546	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB04948	approved; investigational	Lofexidine	N1CCN=C1C(C)Oc2c(Cl)cccc2Cl
547	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB06096	investigational	NXN-188	 
548	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB06153	approved	Pizotifen	CN1CCC(CC1)=C2c(ccs3)c3CCc(c24)cccc4
549	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB14185	approved; investigational	Aripiprazole lauroxil	CCCCCCCCCCCC(=O)OCN1C(=O)CCc(c12)ccc(c2)OCCCCN3CCN(CC3)c4c(Cl)c(Cl)ccc4
550	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
551	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB01049	approved	Ergoloid mesylate	 
552	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB01239	approved; experimental; investigational; withdrawn	Chlorprothixene	CN(C)CC/C=C\1c(cccc2)c2Sc(c13)ccc(Cl)c3
553	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB09304	experimental	Setiptiline	CN(C1)CCC(=C12)c3c(cccc3)Cc4c2cccc4
554	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
555	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB12141	approved; investigational	Gilteritinib	C1COCCC1Nc2c(CC)nc(C(=O)N)c(n2)Nc3ccc(c(c3)OC)N4CCC(CC4)N5CCN(C)CC5
556	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
557	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
558	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
559	sp|P07550|ADRB2_HU	P28221	85.47	22.0	375.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
560	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00216	approved; investigational	Eletriptan	CN1CCC[C@@H]1Cc2c[nH]c(c23)ccc(c3)CCS(=O)(=O)c4ccccc4
561	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
562	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00247	approved	Methysergide	CCC(CO)NC(=O)[C@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4n(c3)C
563	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
564	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00315	approved; investigational	Zolmitriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)C[C@H]3COC(=O)N3
565	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00320	approved; investigational	Dihydroergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
566	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
567	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
568	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
569	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
570	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00571	approved; investigational	Propranolol	CC(C)NCC(O)COc1cccc(c12)cccc2
571	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00589	approved; investigational	Lisuride	CCN(CC)C(=O)N[C@@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4[nH]c3
572	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00669	approved; investigational	Sumatriptan	CNS(=O)(=O)Cc(c1)ccc(c12)[nH]cc2CCN(C)C
573	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00696	approved	Ergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C=5)CN(C)[C@@H](C56)Cc7c8c6cccc8[nH]c7
574	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00714	approved; investigational	Apomorphine	c1cc(O)c(O)c(c12)c3c4c(ccc3)CCN(C)[C@@H]4C2
575	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00904	approved	Ondansetron	c1cccc(c12)c3c(n2C)CCC(C3=O)Cn4ccnc4C
576	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00918	approved; investigational	Almotriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)CS(=O)(=O)N3CCCC3
577	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00952	approved; investigational	Naratriptan	CNS(=O)(=O)CCc(cc1)cc(c12)c(c[nH]2)C3CCN(C)CC3
578	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00953	approved	Rizatriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)Cn3cncn3
579	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00960	approved; investigational	Pindolol	CC(C)NCC(O)COc1cccc(c12)[nH]cc2
580	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00998	approved; investigational	Frovatriptan	CN[C@@H](C1)CCc(c12)[nH]c3c2cc(cc3)C(=O)N
581	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB01186	approved; investigational; vet_approved; withdrawn	Pergolide	CSC[C@H](C1)CN(CCC)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
582	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB01200	approved; investigational	Bromocriptine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](CC(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C=4)CN(C)[C@@H](C45)Cc6c7c5cccc7[nH]c6Br
583	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
584	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
585	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB01359	approved; investigational	Penbutolol	CC(C)(C)NC[C@H](O)COc1ccccc1C2CCCC2
586	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB01392	approved; investigational; vet_approved	Yohimbine	COC(=O)[C@H]1[C@@H](O)CC[C@H]([C@@H]12)CN3[C@@H](C2)c4c(CC3)c5c([nH]4)cccc5
587	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB04884	investigational	Dapoxetine	c1ccccc1[C@@H](N(C)C)CCOc2cccc(c23)cccc3
588	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB06096	investigational	NXN-188	 
589	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB06153	approved	Pizotifen	CN1CCC(CC1)=C2c(ccs3)c3CCc(c24)cccc4
590	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
591	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB08807	experimental	Bopindolol	Cc([nH]1)cc(c12)c(ccc2)OCC(CNC(C)(C)C)OC(=O)c3ccccc3
592	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB09068	approved; investigational	Vortioxetine	Cc1ccc(c(C)c1)Sc2ccccc2N3CCNCC3
593	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB14185	approved; investigational	Aripiprazole lauroxil	CCCCCCCCCCCC(=O)OCN1C(=O)CCc(c12)ccc(c2)OCCCCN3CCN(CC3)c4c(Cl)c(Cl)ccc4
594	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
595	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB01049	approved	Ergoloid mesylate	 
596	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB01239	approved; experimental; investigational; withdrawn	Chlorprothixene	CN(C)CC/C=C\1c(cccc2)c2Sc(c13)ccc(Cl)c3
597	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB09304	experimental	Setiptiline	CN(C1)CCC(=C12)c3c(cccc3)Cc4c2cccc4
598	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
599	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB12141	approved; investigational	Gilteritinib	C1COCCC1Nc2c(CC)nc(C(=O)N)c(n2)Nc3ccc(c(c3)OC)N4CCC(CC4)N5CCN(C)CC5
600	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
601	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
602	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
603	sp|P07550|ADRB2_HU	P28222	88.14	25.0	389.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
604	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
605	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
606	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00320	approved; investigational	Dihydroergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
607	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
608	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
609	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00368	approved	Norepinephrine	NC[C@H](O)c1cc(O)c(O)cc1
610	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00370	approved	Mirtazapine	CN(C1)CCN(C12)c3c(cccn3)Cc4c2cccc4
611	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
612	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00413	approved; investigational	Pramipexole	CCCN[C@H](C1)CCc(c12)nc(s2)N
613	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00449	approved	Dipivefrin	CNCC(O)c1cc(OC(=O)C(C)(C)C)c(cc1)OC(=O)C(C)(C)C
614	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00457	approved	Prazosin	COc(c1)c(OC)cc(c12)c(N)nc(n2)N3CCN(CC3)C(=O)c4ccco4
615	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00484	approved	Brimonidine	n1ccnc(c12)ccc(c2Br)NC3=NCCN3
616	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00502	approved	Haloperidol	Clc1ccc(cc1)C2(O)CCN(CC2)CCCC(=O)c3ccc(F)cc3
617	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
618	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00555	approved; investigational	Lamotrigine	Nc1nc(N)c(nn1)-c2c(Cl)c(Cl)ccc2
619	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00575	approved	Clonidine	Clc1cccc(Cl)c1NC2=NCCN2
620	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00589	approved; investigational	Lisuride	CCN(CC)C(=O)N[C@@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4[nH]c3
621	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00629	approved; investigational	Guanabenz	NC(N)=N/N=C/c1c(Cl)cccc1Cl
622	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00633	approved; vet_approved	Dexmedetomidine	c1[nH]cnc1[C@@H](C)c2c(C)c(C)ccc2
623	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00656	approved; investigational	Trazodone	Clc1cccc(c1)N2CCN(CC2)CCCn(c3=O)nc(n34)cccc4
624	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00668	approved; vet_approved	Epinephrine	CNC[C@H](O)c1cc(O)c(O)cc1
625	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00692	approved	Phentolamine	Oc1cccc(c1)N(c2ccc(C)cc2)CC3=NCCN3
626	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00696	approved	Ergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C=5)CN(C)[C@@H](C56)Cc7c8c6cccc8[nH]c7
627	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00714	approved; investigational	Apomorphine	c1cc(O)c(O)c(c12)c3c4c(ccc3)CCN(C)[C@@H]4C2
628	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00726	approved	Trimipramine	CN(C)CC(C)CN1c(cccc2)c2CCc(c13)cccc3
629	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00751	approved; investigational	Epinastine	NC1=NCC(N12)c3c(cccc3)Cc4c2cccc4
630	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00797	approved; vet_approved	Tolazoline	N1CCN=C1Cc2ccccc2
631	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00800	approved	Fenoldopam	Oc1ccc(cc1)C2CNCCc(c23)c(Cl)c(O)c(c3)O
632	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00852	approved	Pseudoephedrine	CN[C@@H](C)[C@@H](O)c1ccccc1
633	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00865	approved; illicit	Benzphetamine	c1ccccc1C[C@H](C)N(C)Cc2ccccc2
634	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00925	approved	Phenoxybenzamine	c1ccccc1CN(CCCl)C(C)COc2ccccc2
635	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00935	approved; investigational	Oxymetazoline	Cc1cc(C(C)(C)C)c(O)c(C)c1CC2=NCCN2
636	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00964	approved	Apraclonidine	Nc1cc(Cl)c(c(Cl)c1)NC2=NCCN2
637	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00968	approved	Methyldopa	OC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1
638	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01018	approved; investigational	Guanfacine	NC(=N)NC(=O)Cc1c(Cl)cccc1Cl
639	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01136	approved; investigational	Carvedilol	COc1ccccc1OCCNCC(O)COc2cccc(c23)[nH]c4c3cccc4
640	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01149	approved; withdrawn	Nefazodone	c1ccccc1OCCn2c(=O)n(nc2CC)CCCN3CCN(CC3)c4cc(Cl)ccc4
641	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01200	approved; investigational	Bromocriptine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](CC(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C=4)CN(C)[C@@H](C45)Cc6c7c5cccc7[nH]c6Br
642	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
643	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
644	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01267	approved	Paliperidone	OC1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
646	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01392	approved; investigational; vet_approved	Yohimbine	COC(=O)[C@H]1[C@@H](O)CC[C@H]([C@@H]12)CN3[C@@H](C2)c4c(CC3)c5c([nH]4)cccc5
647	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01403	approved; investigational	Methotrimeprazine	COc(cc1)cc(c12)N(C[C@H](C)CN(C)C)c3c(S2)cccc3
648	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01472	experimental; illicit	4-Methoxyamphetamine	COc1ccc(cc1)CC(C)N
649	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01577	approved; illicit	Metamfetamine	CN[C@@H](C)Cc1ccccc1
650	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01608	approved; investigational	Periciazine	OC1CCN(CC1)CCCN2c(cccc3)c3Sc(c24)ccc(c4)C#N
651	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01624	approved; investigational	Zuclopenthixol	OCCN1CCN(CC1)CC/C=C\2c(cccc3)c3Sc(c24)ccc(Cl)c4
652	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB04846	approved; investigational	Celiprolol	CCN(CC)C(=O)Nc1ccc(c(c1)C(=O)C)OCC(O)CNC(C)(C)C
653	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB04855	approved	Dronedarone	CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c(CCCC)oc(c23)ccc(c3)NS(=O)(=O)C
654	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB04948	approved; investigational	Lofexidine	N1CCN=C1C(C)Oc2c(Cl)cccc2Cl
655	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB05492	investigational	Epicept NP-1	Cc1cc([N+]([O-])=O)c(cc1)NCCCN
656	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
657	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB06153	approved	Pizotifen	CN1CCC(CC1)=C2c(ccs3)c3CCc(c24)cccc4
658	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
659	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB06229	investigational	Ocaperidone	Cc1cccn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
660	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB06262	approved; investigational	Droxidopa	OC(=O)[C@@H](N)[C@H](O)c1cc(O)c(O)cc1
661	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB06623	investigational	Flupirtine	CCOC(=O)Nc1c(N)nc(cc1)NCc2ccc(F)cc2
662	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB06694	approved; investigational	Xylometazoline	Cc1cc(C(C)(C)C)cc(C)c1CC2=NCCN2
663	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB06711	approved; investigational	Naphazoline	N1CCN=C1Cc2cccc(c23)cccc3
664	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB08815	approved; investigational	Lurasidone	[C@@H]12[C@H]3CC[C@H](C3)[C@@H]1C(=O)N(C2=O)C[C@@H]4CCCC[C@H]4CN5CCN(CC5)c6nsc(c67)cccc7
665	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB09242	approved; investigational	Moxonidine	COc1nc(C)nc(Cl)c1NC2=NCCN2
666	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB09244	experimental	Pirlindole	Cc(c1)ccc2n(c3c4c12)CCNC3CCC4
667	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB09286	investigational	Pipamperone	C1CCCCN1C2(C(=O)N)CCN(CC2)CCCC(=O)c3ccc(F)cc3
668	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB11124	approved	Racepinephrine	 
669	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB11278	approved	DL-Methylephedrine	CN(C)[C@@H](C)[C@H](O)c1ccccc1
670	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB11738	approved; investigational	Rilmenidine	C1CC1C(C2CC2)NC3=NCCO3
671	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB14185	approved; investigational	Aripiprazole lauroxil	CCCCCCCCCCCC(=O)OCN1C(=O)CCc(c12)ccc(c2)OCCCCN3CCN(CC3)c4c(Cl)c(Cl)ccc4
672	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00193	approved; investigational	Tramadol	COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C
673	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00217	approved	Bethanidine	CN/C(=N\C)NCc1ccccc1
674	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00397	approved; vet_approved; withdrawn	Phenylpropanolamine	C[C@H](N)[C@H](O)c1ccccc1
675	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00433	approved; vet_approved	Prochlorperazine	CN1CCN(CC1)CCCN2c(cccc3)c3Sc(c24)ccc(Cl)c4
676	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00477	approved; investigational; vet_approved	Chlorpromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(Cl)c3
677	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00540	approved	Nortriptyline	CNCCC=C1c(cccc2)c2CCc(c13)cccc3
679	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00697	approved; investigational	Tizanidine	n1snc(c12)c(c(Cl)cc2)NC3=NCCN3
680	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
681	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00934	approved; investigational	Maprotiline	CNCCCC12c3c(cccc3)C(CC1)c4c2cccc4
682	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01151	approved; investigational	Desipramine	CNCCCN1c(cccc2)c2CCc(c13)cccc3
683	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01175	approved	Escitalopram	Fc1ccc(cc1)[C@]2(CCCN(C)C)OCc(c23)cc(C#N)cc3
684	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01186	approved; investigational; vet_approved; withdrawn	Pergolide	CSC[C@H](C1)CN(CCC)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
685	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB06678	investigational	Esmirtazapine	C1CN(C)C[C@@H](N12)c3c(cccc3)Cc4c2nccc4
686	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB06707	approved	Levonordefrin	C[C@H](N)[C@H](O)c1cc(O)c(O)cc1
687	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB09167	approved	Dosulepin	CN(C)CC/C=C/1c(cccc2)c2CSc(c13)cccc3
688	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB09194	withdrawn	Etoperidone	CCn1c(=O)n(nc1CC)CCCN2CCN(CC2)c3cccc(Cl)c3
689	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB09195	approved	Lorpiprazole	C1CC[C@H]([C@H]12)Cn3c2nnc3CCN4CCN(CC4)c5cccc(c5)C(F)(F)F
690	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB09202	experimental	Cirazoline	N1CCN=C1COc2ccccc2C3CC3
691	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB09304	experimental	Setiptiline	CN(C1)CCC(=C12)c3c(cccc3)Cc4c2cccc4
692	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB11477	vet_approved	Xylazine	Cc1cccc(C)c1NC2=NCCCS2
693	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
694	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00182	approved; illicit; investigational	Amphetamine	CC(N)Cc1ccccc1
695	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB00268	approved; investigational	Ropinirole	CCCN(CCC)CCc(ccc1)c(c12)CC(=O)N2
696	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01049	approved	Ergoloid mesylate	 
697	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
698	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01365	approved	Mephentermine	CNC(C)(C)Cc1ccccc1
699	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB01576	approved; illicit	Dextroamphetamine	C[C@H](N)Cc1ccccc1
700	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB09205	approved; investigational	Moxisylyte	CN(C)CCOc1c(C(C)C)cc(c(c1)C)OC(=O)C
701	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB09229	experimental	Aranidipine	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(=O)C)C1c2ccccc2[N+]([O-])=O
702	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
704	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB11577	approved	Indigotindisulfonic acid	OS(=O)(=O)c(cc1)cc(c12)C(=O)C(\N2)=C(C3=O)/Nc(c34)ccc(c4)S(=O)(=O)O
705	sp|P07550|ADRB2_HU	P08913	105.57	10.0	446.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
706	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB00604	approved; investigational; withdrawn	Cisapride	Fc1ccc(cc1)OCCCN2C[C@H](OC)[C@@H](CC2)NC(=O)c3cc(Cl)c(N)cc3OC
707	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB00904	approved	Ondansetron	c1cccc(c12)c3c(n2C)CCC(C3=O)Cn4ccnc4C
708	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB01079	approved; investigational; withdrawn	Tegaserod	CCCCCNC(=N)N/N=C/c1c[nH]c(c12)ccc(c2)OC
709	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB01233	approved; investigational	Metoclopramide	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC
710	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB04873	investigational	Piboserod	CCCCN1CCC(CC1)CNC(=O)c2c(OCCC3)n3c(c24)cccc4
711	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB04917	investigational	Renzapride	Clc1c(N)ccc(c1OC)C(=O)NC(CCN23)C(C2)CCC3
712	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB05542	investigational	Naronapride	Nc1cc(OC)c(cc1Cl)C(=O)N[C@@H]2CCN(C[C@@H]2OC)CCCCCC(=O)O[C@@H](CN34)C(CC3)CC4
713	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB05905	investigational	TD-2749	 
714	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB06422	investigational	Ticalopride	CO[C@H]1CNCC[C@H]1NC(=O)c2cc(Cl)c(N)cc2OC
715	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB06480	approved	Prucalopride	COCCCN1CCC(CC1)NC(=O)c(cc(Cl)c2N)c(c23)OCC3
716	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB08810	investigational	Cinitapride	CCOc1cc(N)c([N+]([O-])=O)cc1C(=O)NC2CCN(CC2)CC3CCC=CC3
717	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB12702	investigational	Velusetrag	c1cccc(c12)cc(c(=O)n2C(C)C)C(=O)N[C@H](C[C@H]34)C[C@@H](CC3)N4C[C@@H](O)CN(C)S(=O)(=O)C
718	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
719	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB01049	approved	Ergoloid mesylate	 
720	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB01239	approved; experimental; investigational; withdrawn	Chlorprothixene	CN(C)CC/C=C\1c(cccc2)c2Sc(c13)ccc(Cl)c3
721	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB09304	experimental	Setiptiline	CN(C1)CCC(=C12)c3c(cccc3)Cc4c2cccc4
722	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
723	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB12141	approved; investigational	Gilteritinib	C1COCCC1Nc2c(CC)nc(C(=O)N)c(n2)Nc3ccc(c(c3)OC)N4CCC(CC4)N5CCN(C)CC5
724	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
725	sp|P07550|ADRB2_HU	Q13639	78.21	16.0	339.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
726	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB00216	approved; investigational	Eletriptan	CN1CCC[C@@H]1Cc2c[nH]c(c23)ccc(c3)CCS(=O)(=O)c4ccccc4
727	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB00247	approved	Methysergide	CCC(CO)NC(=O)[C@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4n(c3)C
728	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB00315	approved; investigational	Zolmitriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)C[C@H]3COC(=O)N3
729	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB00669	approved; investigational	Sumatriptan	CNS(=O)(=O)Cc(c1)ccc(c12)[nH]cc2CCN(C)C
730	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB00696	approved	Ergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C=5)CN(C)[C@@H](C56)Cc7c8c6cccc8[nH]c7
731	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB00952	approved; investigational	Naratriptan	CNS(=O)(=O)CCc(cc1)cc(c12)c(c[nH]2)C3CCN(C)CC3
732	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB00953	approved	Rizatriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)Cn3cncn3
733	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
734	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB11732	approved; investigational	Lasmiditan	CN1CCC(CC1)C(=O)c2cccc(n2)NC(=O)c3c(F)cc(F)cc3F
735	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
736	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB01049	approved	Ergoloid mesylate	 
737	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB01239	approved; experimental; investigational; withdrawn	Chlorprothixene	CN(C)CC/C=C\1c(cccc2)c2Sc(c13)ccc(Cl)c3
738	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB09304	experimental	Setiptiline	CN(C1)CCC(=C12)c3c(cccc3)Cc4c2cccc4
739	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
740	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB12141	approved; investigational	Gilteritinib	C1COCCC1Nc2c(CC)nc(C(=O)N)c(n2)Nc3ccc(c(c3)OC)N4CCC(CC4)N5CCN(C)CC5
741	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
742	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
743	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
744	sp|P07550|ADRB2_HU	P30939	83.78	20.0	366.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
745	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
746	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00247	approved	Methysergide	CCC(CO)NC(=O)[C@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4n(c3)C
747	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
748	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00315	approved; investigational	Zolmitriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)C[C@H]3COC(=O)N3
749	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
750	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
751	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
752	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00370	approved	Mirtazapine	CN(C1)CCN(C12)c3c(cccn3)Cc4c2cccc4
753	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
754	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00409	approved; withdrawn	Remoxipride	CCN1CCC[C@H]1CNC(=O)c2c(OC)ccc(Br)c2OC
755	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00420	approved; vet_approved	Promazine	CN(C)CCCN1c(cccc2)c2Sc(c13)cccc3
756	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00434	approved	Cyproheptadine	CN1CCC(CC1)=C2c(cccc3)c3C=Cc(c24)cccc4
757	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00458	approved	Imipramine	CN(C)CCCN1c(cccc2)c2CCc(c13)cccc3
758	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00477	approved; investigational; vet_approved	Chlorpromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(Cl)c3
759	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00502	approved	Haloperidol	Clc1ccc(cc1)C2(O)CCN(CC2)CCCC(=O)c3ccc(F)cc3
760	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00540	approved	Nortriptyline	CNCCC=C1c(cccc2)c2CCc(c13)cccc3
761	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
762	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00555	approved; investigational	Lamotrigine	Nc1nc(N)c(nn1)-c2c(Cl)c(Cl)ccc2
763	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00574	approved; illicit; investigational; withdrawn	Fenfluramine	CCNC(C)Cc1cccc(c1)C(F)(F)F
764	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00589	approved; investigational	Lisuride	CCN(CC)C(=O)N[C@@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4[nH]c3
765	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00604	approved; investigational; withdrawn	Cisapride	Fc1ccc(cc1)OCCCN2C[C@H](OC)[C@@H](CC2)NC(=O)c3cc(Cl)c(N)cc3OC
766	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00623	approved	Fluphenazine	OCCN1CCN(CC1)CCCN2c(cccc3)c3Sc(c24)ccc(c4)C(F)(F)F
767	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00656	approved; investigational	Trazodone	Clc1cccc(c1)N2CCN(CC2)CCCn(c3=O)nc(n34)cccc4
768	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00679	approved; withdrawn	Thioridazine	c1cccc(S2)c1N(c(c23)cc(SC)cc3)CCC4CCCCN4C
769	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00696	approved	Ergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C=5)CN(C)[C@@H](C56)Cc7c8c6cccc8[nH]c7
770	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00714	approved; investigational	Apomorphine	c1cc(O)c(O)c(c12)c3c4c(ccc3)CCN(C)[C@@H]4C2
771	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
772	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00726	approved	Trimipramine	CN(C)CC(C)CN1c(cccc2)c2CCc(c13)cccc3
773	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00734	approved; investigational	Risperidone	C1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
774	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00751	approved; investigational	Epinastine	NC1=NCC(N12)c3c(cccc3)Cc4c2cccc4
775	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00777	approved	Propiomazine	CCC(=O)c(cc1)cc(c12)N(CC(C)N(C)C)c3c(S2)cccc3
776	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00805	approved	Minaprine	c1ccccc1-c2cc(C)c(nn2)NCCN3CCOCC3
777	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00843	approved	Donepezil	COc(c1)c(OC)cc(c12)C(=O)C(C2)CC3CCN(CC3)Cc4ccccc4
778	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00875	approved; investigational; withdrawn	Flupentixol	FC(F)(F)c(c1)ccc(S2)c1C(\c(c23)cccc3)=C/CCN4CCN(CC4)CCO
779	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00924	approved	Cyclobenzaprine	CN(C)CCC=C1c(cccc2)c2C=Cc(c13)cccc3
780	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00933	approved; investigational	Mesoridazine	CN1CCCCC1CCN2c(cccc3)c3Sc(c24)ccc(c4)S(=O)C
781	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB00934	approved; investigational	Maprotiline	CNCCCC12c3c(cccc3)C(CC1)c4c2cccc4
782	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01079	approved; investigational; withdrawn	Tegaserod	CCCCCNC(=N)N/N=C/c1c[nH]c(c12)ccc(c2)OC
783	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01142	approved; investigational	Doxepin	CN(C)CC/C=C\1c(cccc2)c2COc(c13)cccc3
784	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01149	approved; withdrawn	Nefazodone	c1ccccc1OCCn2c(=O)n(nc2CC)CCCN3CCN(CC3)c4cc(Cl)ccc4
785	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01151	approved; investigational	Desipramine	CNCCCN1c(cccc2)c2CCc(c13)cccc3
786	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01175	approved	Escitalopram	Fc1ccc(cc1)[C@]2(CCCN(C)C)OCc(c23)cc(C#N)cc3
787	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01186	approved; investigational; vet_approved; withdrawn	Pergolide	CSC[C@H](C1)CN(CCC)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
788	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01200	approved; investigational	Bromocriptine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](CC(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C=4)CN(C)[C@@H](C45)Cc6c7c5cccc7[nH]c6Br
789	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
790	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
791	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01239	approved; experimental; investigational; withdrawn	Chlorprothixene	CN(C)CC/C=C\1c(cccc2)c2Sc(c13)ccc(Cl)c3
792	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01242	approved; investigational; vet_approved	Clomipramine	CN(C)CCCN1c(cccc2)c2CCc(c13)ccc(Cl)c3
793	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01267	approved	Paliperidone	OC1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
794	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01392	approved; investigational; vet_approved	Yohimbine	COC(=O)[C@H]1[C@@H](O)CC[C@H]([C@@H]12)CN3[C@@H](C2)c4c(CC3)c5c([nH]4)cccc5
795	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01403	approved; investigational	Methotrimeprazine	COc(cc1)cc(c12)N(C[C@H](C)CN(C)C)c3c(S2)cccc3
796	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01442	experimental; illicit	MMDA	O1COc(c12)cc(CC(C)N)cc2OC
797	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01454	experimental; illicit; investigational	Midomafetamine	CNC(C)Cc(cc1)cc(c12)OCO2
798	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01488	experimental; illicit	Dimethyltryptamine	CN(C)CCc1c[nH]c(c12)cccc2
799	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01537	experimental; illicit	4-Bromo-2,5-dimethoxyphenethylamine	COc1cc(Br)c(OC)cc1CCN
800	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01614	experimental; vet_approved	Acepromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(c3)C(=O)C
801	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01618	approved	Molindone	CCc1c(C)[nH]c(c12)CCC(C2=O)CN3CCOCC3
802	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01621	approved; investigational	Pipotiazine	CN(C)S(=O)(=O)c(cc1)cc(c12)N(c3c(S2)cccc3)CCCN4CCC(CC4)CCO
803	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01622	experimental	Thioproperazine	CN(C)S(=O)(=O)c(cc1)cc(c12)N(c3c(S2)cccc3)CCCN4CCN(C)CC4
804	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01623	approved	Thiothixene	CN(C)S(=O)(=O)c(cc1)cc(c12)/C(c3c(S2)cccc3)=C\CCN4CCN(C)CC4
805	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01624	approved; investigational	Zuclopenthixol	OCCN1CCN(CC1)CC/C=C\2c(cccc3)c3Sc(c24)ccc(Cl)c4
806	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB04599	experimental	Aniracetam	COc1ccc(cc1)C(=O)N2CCCC2=O
807	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB04842	approved; investigational	Fluspirilene	c1cc(F)ccc1C(c(cc2)ccc2F)CCCN(CC3)CCC34N(CNC4=O)c5ccccc5
808	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB04908	approved; investigational	Flibanserin	FC(F)(F)c1cc(ccc1)N2CCN(CC2)CCn3c(=O)[nH]c(c34)cccc4
809	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB04946	approved	Iloperidone	CC(=O)c1cc(OC)c(cc1)OCCCN2CCC(CC2)c3noc(c34)cc(F)cc4
810	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB05079	investigational	HY10275	 
811	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB05227	investigational	APD791	 
812	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB05316	approved; investigational	Pimavanserin	CC(C)COc1ccc(cc1)CNC(=O)N(C2CCN(C)CC2)Cc3ccc(F)cc3
813	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB05492	investigational	Epicept NP-1	Cc1cc([N+]([O-])=O)c(cc1)NCCCN
814	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB05687	investigational	BL-1020	 
815	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06016	approved; investigational	Cariprazine	CN(C)C(=O)N[C@H]1CC[C@@H](CC1)CCN2CCN(CC2)c3c(Cl)c(Cl)ccc3
816	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06077	approved; investigational	Lumateperone	C1CN(C)c(c2N13)cccc2[C@H]4[C@@H]3CCN(C4)CCCC(=O)c5ccc(F)cc5
817	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06109	investigational	YKP-1358	 
818	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06144	approved; investigational; withdrawn	Sertindole	Fc1ccc(cc1)-n2cc(c(c23)cc(Cl)cc3)C4CCN(CC4)CCN5CCNC5=O
819	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
820	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06153	approved	Pizotifen	CN1CCC(CC1)=C2c(ccs3)c3CCc(c24)cccc4
821	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
822	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06229	investigational	Ocaperidone	Cc1cccn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
823	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06288	approved; investigational	Amisulpride	CCN1CCCC1CNC(=O)c2cc(S(=O)(=O)CC)c(N)cc2OC
824	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06446	investigational	Dotarizine	c1ccccc1C2(OCCO2)CCCN3CCN(CC3)C(c4ccccc4)c5ccccc5
825	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06512	investigational	Deramciclane	C[C@@]12CC[C@@H](C1(C)C)C[C@]2(OCCN(C)C)c3ccccc3
826	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB08810	investigational	Cinitapride	CCOc1cc(N)c([N+]([O-])=O)cc1C(=O)NC2CCN(CC2)CC3CCC=CC3
827	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB08815	approved; investigational	Lurasidone	[C@@H]12[C@H]3CC[C@H](C3)[C@@H]1C(=O)N(C2=O)C[C@@H]4CCCC[C@H]4CN5CCN(CC5)c6nsc(c67)cccc7
828	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB08839	investigational; nutraceutical	Serotonin	NCCc1c[nH]c(c12)ccc(c2)O
829	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB08922	experimental	Perospirone	C1CCC[C@H]([C@H]12)C(=O)N(C2=O)CCCCN3CCN(CC3)c4nsc(c45)cccc5
830	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB08927	experimental	Amperozide	CCNC(=O)N1CCN(CC1)CCCC(c2ccc(F)cc2)c3ccc(F)cc3
831	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB09016	approved	Butriptyline	 
832	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
833	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB09128	approved; investigational	Brexpiprazole	c1cc(=O)[nH]c(c12)cc(cc2)OCCCCN3CCN(CC3)c(ccc4)c(c45)ccs5
834	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB09167	approved	Dosulepin	CN(C)CC/C=C/1c(cccc2)c2CSc(c13)cccc3
835	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB09194	withdrawn	Etoperidone	CCn1c(=O)n(nc1CC)CCCN2CCN(CC2)c3cccc(Cl)c3
836	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB09195	approved	Lorpiprazole	C1CC[C@H]([C@H]12)Cn3c2nnc3CCN4CCN(CC4)c5cccc(c5)C(F)(F)F
837	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB09223	investigational	Blonanserin	C1CCCCCc(c12)nc(N(CC3)CCN3CC)cc2-c4ccc(F)cc4
838	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB09225	approved; investigational; withdrawn	Zotepine	CN(C)CCOC1=Cc(cccc2)c2Sc(c13)ccc(Cl)c3
839	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB09286	investigational	Pipamperone	C1CCCCN1C2(C(=O)N)CCN(CC2)CCCC(=O)c3ccc(F)cc3
840	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB12163	investigational	Sarpogrelate	COc1cc(ccc1)CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O
841	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB12177	investigational	Eplivanserin	Fc1ccccc1/C(=N\OCCN(C)C)/C=C/c2ccc(O)cc2
842	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB12465	investigational	Ketanserin	Fc1ccc(cc1)C(=O)C2CCN(CC2)CCn(c3=O)c(=O)[nH]c(c34)cccc4
843	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB12555	investigational	Nelotanserin	Cn1ncc(Br)c1-c2cc(ccc2OC)NC(=O)Nc3ccc(F)cc3F
844	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB12693	investigational	Ritanserin	s1ccn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)=C(c4ccc(F)cc4)c5ccc(F)cc5
845	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB13940	experimental	2,5-Dimethoxy-4-ethylthioamphetamine	CCSc1cc(OC)c(CC(C)N)cc1OC
846	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB13948	experimental	N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine	COc1cc(C#N)c(OC)cc1CCNCc2c(O)cccc2
848	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB14010	experimental; illicit	5-methoxy-N,N-dimethyltryptamine	COc(c1)ccc(c12)[nH]cc2CCN(C)C
849	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
850	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB14185	approved; investigational	Aripiprazole lauroxil	CCCCCCCCCCCC(=O)OCN1C(=O)CCc(c12)ccc(c2)OCCCCN3CCN(CC3)c4c(Cl)c(Cl)ccc4
852	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01049	approved	Ergoloid mesylate	 
854	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB09304	experimental	Setiptiline	CN(C1)CCC(=C12)c3c(cccc3)Cc4c2cccc4
855	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
856	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB12141	approved; investigational	Gilteritinib	C1COCCC1Nc2c(CC)nc(C(=O)N)c(n2)Nc3ccc(c(c3)OC)N4CCC(CC4)N5CCN(C)CC5
857	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
858	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
860	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
861	sp|P07550|ADRB2_HU	P28223	88.86	73.0	440.0	DB06678	investigational	Esmirtazapine	C1CN(C)C[C@@H](N12)c3c(cccc3)Cc4c2nccc4
862	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
863	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB00247	approved	Methysergide	CCC(CO)NC(=O)[C@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4n(c3)C
864	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB00315	approved; investigational	Zolmitriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)C[C@H]3COC(=O)N3
865	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
866	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
867	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
868	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
869	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB14185	approved; investigational	Aripiprazole lauroxil	CCCCCCCCCCCC(=O)OCN1C(=O)CCc(c12)ccc(c2)OCCCCN3CCN(CC3)c4c(Cl)c(Cl)ccc4
870	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
871	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB01049	approved	Ergoloid mesylate	 
872	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB01239	approved; experimental; investigational; withdrawn	Chlorprothixene	CN(C)CC/C=C\1c(cccc2)c2Sc(c13)ccc(Cl)c3
873	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB09304	experimental	Setiptiline	CN(C1)CCC(=C12)c3c(cccc3)Cc4c2cccc4
874	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
875	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB12141	approved; investigational	Gilteritinib	C1COCCC1Nc2c(CC)nc(C(=O)N)c(n2)Nc3ccc(c(c3)OC)N4CCC(CC4)N5CCN(C)CC5
876	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
877	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
878	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
879	sp|P07550|ADRB2_HU	P28566	84.99	12.0	363.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
880	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00193	approved; investigational	Tramadol	COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C
881	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
882	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00247	approved	Methysergide	CCC(CO)NC(=O)[C@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4n(c3)C
883	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
884	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
885	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
886	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
887	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00370	approved	Mirtazapine	CN(C1)CCN(C12)c3c(cccn3)Cc4c2cccc4
888	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
889	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00420	approved; vet_approved	Promazine	CN(C)CCCN1c(cccc2)c2Sc(c13)cccc3
890	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00434	approved	Cyproheptadine	CN1CCC(CC1)=C2c(cccc3)c3C=Cc(c24)cccc4
891	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00458	approved	Imipramine	CN(C)CCCN1c(cccc2)c2CCc(c13)cccc3
892	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00472	approved; vet_approved	Fluoxetine	c1ccccc1C(CCNC)Oc2ccc(C(F)(F)F)cc2
893	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00477	approved; investigational; vet_approved	Chlorpromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(Cl)c3
894	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00502	approved	Haloperidol	Clc1ccc(cc1)C2(O)CCN(CC2)CCCC(=O)c3ccc(F)cc3
895	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00540	approved	Nortriptyline	CNCCC=C1c(cccc2)c2CCc(c13)cccc3
896	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
897	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00574	approved; illicit; investigational; withdrawn	Fenfluramine	CCNC(C)Cc1cccc(c1)C(F)(F)F
898	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00589	approved; investigational	Lisuride	CCN(CC)C(=O)N[C@@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4[nH]c3
899	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00623	approved	Fluphenazine	OCCN1CCN(CC1)CCCN2c(cccc3)c3Sc(c24)ccc(c4)C(F)(F)F
900	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00656	approved; investigational	Trazodone	Clc1cccc(c1)N2CCN(CC2)CCCn(c3=O)nc(n34)cccc4
901	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00696	approved	Ergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C=5)CN(C)[C@@H](C56)Cc7c8c6cccc8[nH]c7
902	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00714	approved; investigational	Apomorphine	c1cc(O)c(O)c(c12)c3c4c(ccc3)CCN(C)[C@@H]4C2
903	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00726	approved	Trimipramine	CN(C)CC(C)CN1c(cccc2)c2CCc(c13)cccc3
904	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00734	approved; investigational	Risperidone	C1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
905	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00777	approved	Propiomazine	CCC(=O)c(cc1)cc(c12)N(CC(C)N(C)C)c3c(S2)cccc3
906	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00805	approved	Minaprine	c1ccccc1-c2cc(C)c(nn2)NCCN3CCOCC3
907	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00924	approved	Cyclobenzaprine	CN(C)CCC=C1c(cccc2)c2C=Cc(c13)cccc3
908	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00934	approved; investigational	Maprotiline	CNCCCC12c3c(cccc3)C(CC1)c4c2cccc4
909	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01079	approved; investigational; withdrawn	Tegaserod	CCCCCNC(=N)N/N=C/c1c[nH]c(c12)ccc(c2)OC
910	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01142	approved; investigational	Doxepin	CN(C)CC/C=C\1c(cccc2)c2COc(c13)cccc3
911	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01149	approved; withdrawn	Nefazodone	c1ccccc1OCCn2c(=O)n(nc2CC)CCCN3CCN(CC3)c4cc(Cl)ccc4
912	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01151	approved; investigational	Desipramine	CNCCCN1c(cccc2)c2CCc(c13)cccc3
913	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01175	approved	Escitalopram	Fc1ccc(cc1)[C@]2(CCCN(C)C)OCc(c23)cc(C#N)cc3
914	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01186	approved; investigational; vet_approved; withdrawn	Pergolide	CSC[C@H](C1)CN(CCC)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
915	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01191	approved; illicit; investigational; withdrawn	Dexfenfluramine	CCN[C@@H](C)Cc1cccc(c1)C(F)(F)F
916	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01200	approved; investigational	Bromocriptine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](CC(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C=4)CN(C)[C@@H](C45)Cc6c7c5cccc7[nH]c6Br
917	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
918	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
919	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01242	approved; investigational; vet_approved	Clomipramine	CN(C)CCCN1c(cccc2)c2CCc(c13)ccc(Cl)c3
920	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01267	approved	Paliperidone	OC1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
921	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01392	approved; investigational; vet_approved	Yohimbine	COC(=O)[C@H]1[C@@H](O)CC[C@H]([C@@H]12)CN3[C@@H](C2)c4c(CC3)c5c([nH]4)cccc5
922	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01403	approved; investigational	Methotrimeprazine	COc(cc1)cc(c12)N(C[C@H](C)CN(C)C)c3c(S2)cccc3
923	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01454	experimental; illicit; investigational	Midomafetamine	CNC(C)Cc(cc1)cc(c12)OCO2
924	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01537	experimental; illicit	4-Bromo-2,5-dimethoxyphenethylamine	COc1cc(Br)c(OC)cc1CCN
925	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB04871	approved	Lorcaserin	c1c(Cl)ccc(c12)CCNC[C@@H]2C
926	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB04884	investigational	Dapoxetine	c1ccccc1[C@@H](N(C)C)CCOc2cccc(c23)cccc3
927	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB04948	approved; investigational	Lofexidine	N1CCN=C1C(C)Oc2c(Cl)cccc2Cl
928	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB05492	investigational	Epicept NP-1	Cc1cc([N+]([O-])=O)c(cc1)NCCCN
929	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB06144	approved; investigational; withdrawn	Sertindole	Fc1ccc(cc1)-n2cc(c(c23)cc(Cl)cc3)C4CCN(CC4)CCN5CCNC5=O
930	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
931	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB06153	approved	Pizotifen	CN1CCC(CC1)=C2c(ccs3)c3CCc(c24)cccc4
932	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
933	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB06229	investigational	Ocaperidone	Cc1cccn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
934	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB06446	investigational	Dotarizine	c1ccccc1C2(OCCO2)CCCN3CCN(CC3)C(c4ccccc4)c5ccccc5
935	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB06512	investigational	Deramciclane	C[C@@]12CC[C@@H](C1(C)C)C[C@]2(OCCN(C)C)c3ccccc3
936	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB06594	approved; investigational	Agomelatine	COc(cc1)cc(c12)c(ccc2)CCNC(=O)C
937	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB09014	experimental	Captodiame	CCCCSc1ccc(cc1)C(SCCN(C)C)c2ccccc2
938	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB09194	withdrawn	Etoperidone	CCn1c(=O)n(nc1CC)CCCN2CCN(CC2)c3cccc(Cl)c3
939	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB09195	approved	Lorpiprazole	C1CC[C@H]([C@H]12)Cn3c2nnc3CCN4CCN(CC4)c5cccc(c5)C(F)(F)F
940	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB12110	investigational	m-Chlorophenylpiperazine	Clc1cc(ccc1)N2CCNCC2
941	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB12163	investigational	Sarpogrelate	COc1cc(ccc1)CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O
942	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB12177	investigational	Eplivanserin	Fc1ccccc1/C(=N\OCCN(C)C)/C=C/c2ccc(O)cc2
943	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB13940	experimental	2,5-Dimethoxy-4-ethylthioamphetamine	CCSc1cc(OC)c(CC(C)N)cc1OC
944	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB14185	approved; investigational	Aripiprazole lauroxil	CCCCCCCCCCCC(=O)OCN1C(=O)CCc(c12)ccc(c2)OCCCCN3CCN(CC3)c4c(Cl)c(Cl)ccc4
945	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
946	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01049	approved	Ergoloid mesylate	 
947	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01239	approved; experimental; investigational; withdrawn	Chlorprothixene	CN(C)CC/C=C\1c(cccc2)c2Sc(c13)ccc(Cl)c3
948	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB09304	experimental	Setiptiline	CN(C1)CCC(=C12)c3c(cccc3)Cc4c2cccc4
949	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
950	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB12141	approved; investigational	Gilteritinib	C1COCCC1Nc2c(CC)nc(C(=O)N)c(n2)Nc3ccc(c(c3)OC)N4CCC(CC4)N5CCN(C)CC5
951	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
952	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
954	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
955	sp|P07550|ADRB2_HU	P28335	81.6	55.0	392.0	DB06678	investigational	Esmirtazapine	C1CN(C)C[C@@H](N12)c3c(cccc3)Cc4c2nccc4
956	sp|P07550|ADRB2_HU	P08909	82.57	54.0	395.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
957	sp|P07550|ADRB2_HU	P08909	82.57	54.0	395.0	DB00540	approved	Nortriptyline	CNCCC=C1c(cccc2)c2CCc(c13)cccc3
958	sp|P07550|ADRB2_HU	P08909	82.57	54.0	395.0	DB00656	approved; investigational	Trazodone	Clc1cccc(c1)N2CCN(CC2)CCCn(c3=O)nc(n34)cccc4
959	sp|P07550|ADRB2_HU	P08909	82.57	54.0	395.0	DB00726	approved	Trimipramine	CN(C)CC(C)CN1c(cccc2)c2CCc(c13)cccc3
960	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
961	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00247	approved	Methysergide	CCC(CO)NC(=O)[C@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4n(c3)C
962	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
963	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00315	approved; investigational	Zolmitriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)C[C@H]3COC(=O)N3
964	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
965	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
966	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
967	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00434	approved	Cyproheptadine	CN1CCC(CC1)=C2c(cccc3)c3C=Cc(c24)cccc4
968	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00458	approved	Imipramine	CN(C)CCCN1c(cccc2)c2CCc(c13)cccc3
969	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00477	approved; investigational; vet_approved	Chlorpromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(Cl)c3
970	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00502	approved	Haloperidol	Clc1ccc(cc1)C2(O)CCN(CC2)CCCC(=O)c3ccc(F)cc3
971	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
972	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00589	approved; investigational	Lisuride	CCN(CC)C(=O)N[C@@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4[nH]c3
973	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00734	approved; investigational	Risperidone	C1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
974	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00751	approved; investigational	Epinastine	NC1=NCC(N12)c3c(cccc3)Cc4c2cccc4
975	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00924	approved	Cyclobenzaprine	CN(C)CCC=C1c(cccc2)c2C=Cc(c13)cccc3
976	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00934	approved; investigational	Maprotiline	CNCCCC12c3c(cccc3)C(CC1)c4c2cccc4
977	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00988	approved	Dopamine	NCCc1cc(O)c(O)cc1
978	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB01200	approved; investigational	Bromocriptine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](CC(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C=4)CN(C)[C@@H](C45)Cc6c7c5cccc7[nH]c6Br
979	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
980	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
981	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB01267	approved	Paliperidone	OC1CCCn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
982	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB04946	approved	Iloperidone	CC(=O)c1cc(OC)c(cc1)OCCCN2CCC(CC2)c3noc(c34)cc(F)cc4
983	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB04948	approved; investigational	Lofexidine	N1CCN=C1C(C)Oc2c(Cl)cccc2Cl
984	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
985	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
986	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB06288	approved; investigational	Amisulpride	CCN1CCCC1CNC(=O)c2cc(S(=O)(=O)CC)c(N)cc2OC
987	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB08815	approved; investigational	Lurasidone	[C@@H]12[C@H]3CC[C@H](C3)[C@@H]1C(=O)N(C2=O)C[C@@H]4CCCC[C@H]4CN5CCN(CC5)c6nsc(c67)cccc7
988	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB09068	approved; investigational	Vortioxetine	Cc1ccc(c(C)c1)Sc2ccccc2N3CCNCC3
989	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB09225	approved; investigational; withdrawn	Zotepine	CN(C)CCOC1=Cc(cccc2)c2Sc(c13)ccc(Cl)c3
990	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB13988	investigational	SB-269970	CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)c3cccc(O)c3
991	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB14185	approved; investigational	Aripiprazole lauroxil	CCCCCCCCCCCC(=O)OCN1C(=O)CCc(c12)ccc(c2)OCCCCN3CCN(CC3)c4c(Cl)c(Cl)ccc4
992	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
993	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB01049	approved	Ergoloid mesylate	 
994	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB01239	approved; experimental; investigational; withdrawn	Chlorprothixene	CN(C)CC/C=C\1c(cccc2)c2Sc(c13)ccc(Cl)c3
995	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB09304	experimental	Setiptiline	CN(C1)CCC(=C12)c3c(cccc3)Cc4c2cccc4
996	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
997	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB12141	approved; investigational	Gilteritinib	C1COCCC1Nc2c(CC)nc(C(=O)N)c(n2)Nc3ccc(c(c3)OC)N4CCC(CC4)N5CCN(C)CC5
998	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
999	sp|P07550|ADRB2_HU	P34969	83.29	67.0	411.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
1000	sp|P07550|ADRB2_HU	P30872	81.6	30.0	367.0	DB06663	approved	Pasireotide	NCCNC(=O)O[C@@H](C1)C[C@H](N12)C(=O)N[C@@H](c3ccccc3)C(=O)N[C@H](Cc4c[nH]c(c45)cccc5)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C2=O)Cc6ccccc6)Cc7ccc(cc7)OCc8ccccc8
1001	sp|P07550|ADRB2_HU	P30872	81.6	30.0	367.0	DB09099	approved; investigational	Somatostatin	c1ccccc1C[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)CSSC[C@H](NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)[C@@H](C)O)CCCCN)Cc5c[nH]c(c56)cccc6
1002	sp|P07550|ADRB2_HU	P30872	81.6	30.0	367.0	DB13985	approved; investigational	Lutetium Lu 177 dotatate	NCCCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N1)Cc3c[nH]c(c34)cccc4)NC(=O)[C@@H](Cc5ccccc5)NC(=O)CN6CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC6
1003	sp|P07550|ADRB2_HU	P30872	81.6	30.0	367.0	DB15494	approved	Edotreotide gallium Ga-68	NCCCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)CO)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N1)Cc3c[nH]c(c34)cccc4)NC(=O)[C@@H](Cc5ccccc5)NC(=O)CN6CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC6
1004	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00247	approved	Methysergide	CCC(CO)NC(=O)[C@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4n(c3)C
1005	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00248	approved	Cabergoline	CN(C)CCCN(C(=O)NCC)C(=O)[C@H](C1)CN(CC=C)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
1006	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00315	approved; investigational	Zolmitriptan	CN(C)CCc1c[nH]c(c12)ccc(c2)C[C@H]3COC(=O)N3
1007	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00320	approved; investigational	Dihydroergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
1008	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00353	approved	Methylergometrine	CC[C@@H](CO)NC(=O)[C@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4[nH]c3
1009	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00508	approved; vet_approved	Triflupromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(c3)C(F)(F)F
1010	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
1011	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00574	approved; illicit; investigational; withdrawn	Fenfluramine	CCNC(C)Cc1cccc(c1)C(F)(F)F
1012	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00589	approved; investigational	Lisuride	CCN(CC)C(=O)N[C@@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4[nH]c3
1013	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00696	approved	Ergotamine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C)NC(=O)[C@H](C=5)CN(C)[C@@H](C56)Cc7c8c6cccc8[nH]c7
1014	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00714	approved; investigational	Apomorphine	c1cc(O)c(O)c(c12)c3c4c(ccc3)CCN(C)[C@@H]4C2
1015	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
1016	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00805	approved	Minaprine	c1ccccc1-c2cc(C)c(nn2)NCCN3CCOCC3
1017	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00924	approved	Cyclobenzaprine	CN(C)CCC=C1c(cccc2)c2C=Cc(c13)cccc3
1018	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB01079	approved; investigational; withdrawn	Tegaserod	CCCCCNC(=N)N/N=C/c1c[nH]c(c12)ccc(c2)OC
1019	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB01142	approved; investigational	Doxepin	CN(C)CC/C=C\1c(cccc2)c2COc(c13)cccc3
1020	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB01186	approved; investigational; vet_approved; withdrawn	Pergolide	CSC[C@H](C1)CN(CCC)[C@@H]([C@H]12)Cc3c4c2cccc4[nH]c3
1021	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB01200	approved; investigational	Bromocriptine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](CC(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C=4)CN(C)[C@@H](C45)Cc6c7c5cccc7[nH]c6Br
1022	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
1023	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB01242	approved; investigational; vet_approved	Clomipramine	CN(C)CCCN1c(cccc2)c2CCc(c13)ccc(Cl)c3
1024	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB01392	approved; investigational; vet_approved	Yohimbine	COC(=O)[C@H]1[C@@H](O)CC[C@H]([C@@H]12)CN3[C@@H](C2)c4c(CC3)c5c([nH]4)cccc5
1025	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB01454	experimental; illicit; investigational	Midomafetamine	CNC(C)Cc(cc1)cc(c12)OCO2
1026	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB04829	illicit; investigational; withdrawn	Lysergic acid diethylamide	CCN(CC)C(=O)[C@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4[nH]c3
1027	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB05461	investigational	OPC-28326	CCC(=O)Nc1c(C)cc(cc1C)C(=O)N2CCC(CC2)N(C)CCc3ccccc3
1028	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB05492	investigational	Epicept NP-1	Cc1cc([N+]([O-])=O)c(cc1)NCCCN
1029	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB05607	investigational	PRX-08066	Fc1c(C#N)cc(cc1)CN2CCC(CC2)Nc(ncn3)c(c34)cc(s4)Cl
1030	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB06016	approved; investigational	Cariprazine	CN(C)C(=O)N[C@H]1CC[C@@H](CC1)CCN2CCN(CC2)c3c(Cl)c(Cl)ccc3
1031	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
1032	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB06153	approved	Pizotifen	CN1CCC(CC1)=C2c(ccs3)c3CCc(c24)cccc4
1033	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
1034	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB06229	investigational	Ocaperidone	Cc1cccn(c12)c(=O)c(c(n2)C)CCN3CCC(CC3)c4noc(c45)cc(F)cc5
1035	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB09286	investigational	Pipamperone	C1CCCCN1C2(C(=O)N)CCN(CC2)CCCC(=O)c3ccc(F)cc3
1037	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB01049	approved	Ergoloid mesylate	 
1038	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB01239	approved; experimental; investigational; withdrawn	Chlorprothixene	CN(C)CC/C=C\1c(cccc2)c2Sc(c13)ccc(Cl)c3
1039	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB09304	experimental	Setiptiline	CN(C1)CCC(=C12)c3c(cccc3)Cc4c2cccc4
1040	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
1041	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB12141	approved; investigational	Gilteritinib	C1COCCC1Nc2c(CC)nc(C(=O)N)c(n2)Nc3ccc(c(c3)OC)N4CCC(CC4)N5CCN(C)CC5
1042	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
1043	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
1044	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB00477	approved; investigational; vet_approved	Chlorpromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(Cl)c3
1045	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
1046	sp|P07550|ADRB2_HU	P41595	90.8	41.0	416.0	DB06678	investigational	Esmirtazapine	C1CN(C)C[C@@H](N12)c3c(cccc3)Cc4c2nccc4
1047	sp|P07550|ADRB2_HU	P32745	76.03	41.0	355.0	DB06663	approved	Pasireotide	NCCNC(=O)O[C@@H](C1)C[C@H](N12)C(=O)N[C@@H](c3ccccc3)C(=O)N[C@H](Cc4c[nH]c(c45)cccc5)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C2=O)Cc6ccccc6)Cc7ccc(cc7)OCc8ccccc8
1048	sp|P07550|ADRB2_HU	P32745	76.03	41.0	355.0	DB09099	approved; investigational	Somatostatin	c1ccccc1C[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)CSSC[C@H](NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)[C@@H](C)O)CCCCN)Cc5c[nH]c(c56)cccc6
1049	sp|P07550|ADRB2_HU	P32745	76.03	41.0	355.0	DB13985	approved; investigational	Lutetium Lu 177 dotatate	NCCCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N1)Cc3c[nH]c(c34)cccc4)NC(=O)[C@@H](Cc5ccccc5)NC(=O)CN6CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC6
1050	sp|P07550|ADRB2_HU	P32745	76.03	41.0	355.0	DB15494	approved	Edotreotide gallium Ga-68	NCCCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)CO)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N1)Cc3c[nH]c(c34)cccc4)NC(=O)[C@@H](Cc5ccccc5)NC(=O)CN6CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC6
1051	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00202	approved	Succinylcholine	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
1052	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
1053	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00280	approved	Disopyramide	n1ccccc1C(C(=O)N)(CCN(C(C)C)C(C)C)c2ccccc2
1054	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00332	approved; experimental	Ipratropium	[C@@H]12CC[C@@H]([N+]1(C)C(C)C)C[C@@H](C2)OC(=O)C(CO)c3ccccc3
1055	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
1056	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00342	approved; withdrawn	Terfenadine	CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4
1057	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
1058	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00376	approved	Trihexyphenidyl	C1CCCCC1C(O)(c2ccccc2)CCN3CCCCC3
1059	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00383	approved	Oxyphencyclimine	CN1CCCN=C1COC(=O)C(O)(C2CCCCC2)c3ccccc3
1060	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00387	approved	Procyclidine	C1CCCCC1C(O)(c2ccccc2)CCN3CCCC3
1061	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00392	approved	Profenamine	CCN(CC)C(C)CN1c(cccc2)c2Sc(c13)cccc3
1062	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
1063	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00411	approved	Carbamoylcholine	C[N+](C)(C)CCOC(=O)N
1064	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00424	approved	Hyoscyamine	CN([C@@H]12)[C@H](CC1)C[C@@H](C2)OC(=O)[C@H](CO)c3ccccc3
1065	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00434	approved	Cyproheptadine	CN1CCC(CC1)=C2c(cccc3)c3C=Cc(c24)cccc4
1066	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00458	approved	Imipramine	CN(C)CCCN1c(cccc2)c2CCc(c13)cccc3
1067	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00462	approved	Methscopolamine bromide	[C@H]12C3C(O3)[C@@H]([N+]1(C)C)C[C@H](C2)OC(=O)[C@H](CO)c4ccccc4
1068	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00483	approved	Gallamine triethiodide	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC
1069	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00496	approved; investigational	Darifenacin	c1ccccc1C(C(=O)N)(c2ccccc2)[C@@H]3CCN(C3)CCc(cc4)cc(c45)CCO5
1070	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00505	withdrawn	Tridihexethyl	c1ccccc1C(O)(CC[N+](CC)(CC)CC)C2CCCCC2
1071	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00508	approved; vet_approved	Triflupromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(c3)C(F)(F)F
1072	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00517	approved	Anisotropine methylbromide	CCCC(CCC)C(=O)O[C@@H](CC12)CC(CC1)[N+]2(C)C
1073	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00572	approved; vet_approved	Atropine	CN([C@@H]12)[C@H](CC1)C[C@@H](C2)OC(=O)C(CO)c3ccccc3
1074	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00622	approved; investigational	Nicardipine	COC(=O)C1=C(C)NC(C)=C(C1c2cc([N+]([O-])=O)ccc2)C(=O)OCCN(C)Cc3ccccc3
1075	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00725	approved	Homatropine methylbromide	C[N+](C)(C12)C(CC1)CC(C2)OC(=O)C(O)c3ccccc3
1076	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00728	approved	Rocuronium	C1CCC[N+]1(CC=C)[C@H]([C@@H]2OC(=O)C)C[C@H]([C@@]23C)[C@H]4[C@H](CC3)[C@]5(C)[C@@H](CC4)C[C@H](O)[C@H](C5)N6CCOCC6
1077	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00747	approved; investigational	Scopolamine	[C@H]12[C@H]3[C@H](O3)[C@H](N1C)C[C@H](C2)OC(=O)[C@H](CO)c4ccccc4
1078	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00767	withdrawn	Benzquinamide	CCN(CC)C(=O)C(C(C1)OC(=O)C)CN(C12)CCc3c2cc(OC)c(c3)OC
1079	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00785	approved	Cryptenamine	 
1080	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00804	approved	Dicyclomine	CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
1081	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00809	approved; investigational	Tropicamide	c1cnccc1CN(CC)C(=O)C(CO)c2ccccc2
1082	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00835	approved	Brompheniramine	c1cccnc1C(CCN(C)C)c2ccc(Br)cc2
1083	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00907	approved; illicit	Cocaine	[C@@H]12CC[C@@H](N1C)[C@@H](C(=O)OC)[C@H](C2)OC(=O)c3ccccc3
1084	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00934	approved; investigational	Maprotiline	CNCCCC12c3c(cccc3)C(CC1)c4c2cccc4
1085	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00940	approved; investigational	Methantheline	CC[N+](C)(CC)CCOC(=O)C1c(cccc2)c2Oc(c13)cccc3
1086	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00986	approved; investigational; vet_approved	Glycopyrronium	C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)c3ccccc3
1087	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01019	approved	Bethanechol	NC(=O)OC(C)C[N+](C)(C)C
1088	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01036	approved; investigational	Tolterodine	CC(C)N(C(C)C)CC[C@@H](c(cc1C)c(O)cc1)c2ccccc2
1089	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01062	approved; investigational	Oxybutynin	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2
1090	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
1091	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01075	approved; investigational	Diphenhydramine	c1ccccc1C(OCCN(C)C)c2ccccc2
1092	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01085	approved; investigational	Pilocarpine	O=C1OC[C@@H]([C@@H]1CC)Cc2cncn2C
1093	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01135	approved	Doxacurium	COc(c1)c(OC)c(OC)cc1CC(c(c23)c(OC)c(OC)c(c2)OC)[N+](C)(CC3)CCCOC(=O)CCC(=O)OCCC[N+](C)(CCc(c45)cc(OC)c(OC)c5OC)C4Cc6cc(OC)c(OC)c(c6)OC
1094	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01142	approved; investigational	Doxepin	CN(C)CC/C=C\1c(cccc2)c2COc(c13)cccc3
1095	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01148	approved	Flavoxate	c1ccccc1-c(c(C)c2=O)oc(c23)c(ccc3)C(=O)OCCN4CCCCC4
1096	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01151	approved; investigational	Desipramine	CNCCCN1c(cccc2)c2CCc(c13)cccc3
1097	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
1098	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01226	approved	Mivacurium	COc(c1)c(OC)c(OC)cc1C[C@H](c(c23)cc(OC)c(c2)OC)[N+](C)(CC3)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+](C)(CCc(c45)cc(OC)c(c5)OC)[C@@H]4Cc6cc(OC)c(OC)c(c6)OC
1099	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01231	approved; investigational; withdrawn	Diphenidol	c1ccccc1C(O)(c2ccccc2)CCCN3CCCCC3
1100	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
1101	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01239	approved; experimental; investigational; withdrawn	Chlorprothixene	CN(C)CC/C=C\1c(cccc2)c2Sc(c13)ccc(Cl)c3
1102	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01336	approved	Metocurine	C1C[N+](C)(C)[C@H](c2c13)Cc4ccc(cc4)Oc5c6c(cc(OC)c5OC)CC[N+](C)(C)[C@@H]6Cc7cc(c(cc7)OC)Oc(c2)c(c3)OC
1103	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01337	approved	Pancuronium	C1CCCC[N+]1(C)[C@H]([C@@H]2OC(=O)C)C[C@H]([C@@]23C)[C@H]4[C@H](CC3)[C@]5(C)[C@@H](CC4)C[C@H](OC(=O)C)[C@H](C5)[N+]6(C)CCCCC6
1104	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01338	approved	Pipecuronium	C[N+]1(C)CCN(CC1)[C@H]([C@@H]2OC(=O)C)C[C@H]([C@@]23C)[C@H]4[C@H](CC3)[C@]5(C)[C@@H](CC4)C[C@H](OC(=O)C)[C@H](C5)N(CC6)CC[N+]6(C)C
1105	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01403	approved; investigational	Methotrimeprazine	COc(cc1)cc(c12)N(C[C@H](C)CN(C)C)c3c(S2)cccc3
1106	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01409	approved	Tiotropium	[C@@H]12[C@@H](O1)[C@@H]3C[C@@H](C[C@H]2[N+]3(C)C)OC(=O)C(O)(c4cccs4)c5cccs5
1107	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01591	approved	Solifenacin	C12CCN(CC1)C[C@@H]2OC(=O)N(CCc(c34)cccc4)[C@H]3c5ccccc5
1108	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB03128	approved; investigational	Acetylcholine	CC(=O)OCC[N+](C)(C)C
1109	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB04834	approved; withdrawn	Rapacuronium	C1CCCC[N+]1(CC=C)[C@H]([C@@H]2OC(=O)CC)C[C@H]([C@@]23C)[C@H]4[C@H](CC3)[C@]5(C)[C@@H](CC4)C[C@H](OC(=O)C)[C@H](C5)N6CCCCC6
1110	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB05752	investigational	ALKS 27	 
1111	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB06153	approved	Pizotifen	CN1CCC(CC1)=C2c(ccs3)c3CCc(c24)cccc4
1112	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB06702	approved	Fesoterodine	c1ccccc1[C@@H](CCN(C(C)C)C(C)C)c2c(OC(=O)C(C)C)ccc(c2)CO
1113	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB06787	approved	Hexocyclium	C[N+]1(C)CCN(CC1)CC(O)(C2CCCCC2)c3ccccc3
1114	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB08801	approved; investigational	Dimetindene	c1cccnc1C(C)C2=C(CCN(C)C)Cc(c23)cccc3
1115	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB08897	approved	Aclidinium	c1ccsc1C(O)(c2cccs2)C(=O)O[C@@H](C3)C(CC4)CC[N+]34CCCOc5ccccc5
1116	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB09076	approved	Umeclidinium	c1ccccc1C(O)(c2ccccc2)C34CC[N+](CC3)(CC4)CCOCc5ccccc5
1117	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB09089	approved	Trimebutine	c1ccccc1C(CC)(N(C)C)COC(=O)c2cc(OC)c(OC)c(c2)OC
1118	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB09167	approved	Dosulepin	CN(C)CC/C=C/1c(cccc2)c2CSc(c13)cccc3
1119	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB09262	investigational	Imidafenacin	Cc1nccn1CCC(C(=O)N)(c2ccccc2)c3ccccc3
1120	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB09300	approved; investigational; vet_approved	Butylscopolamine	CCCC[N+]1(C)[C@H]([C@H](O2)[C@H]2[C@H]13)C[C@@H](C3)OC(=O)[C@H](CO)c4ccccc4
1121	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB11181	approved	Homatropine	[C@@H]12CC[C@@H](N1C)C[C@@H](C2)OC(=O)C(O)c3ccccc3
1122	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB11235	approved	Thonzylamine	COc1ccc(cc1)CN(CCN(C)C)c2ncccn2
1123	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB12278	approved; investigational	Propiverine	c1ccccc1C(OCCC)(c2ccccc2)C(=O)OC3CCN(C)CC3
1124	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB13581	experimental	Rociverine	CCN(CC)CC(C)OC(=O)[C@@H](CCCC1)[C@@]1(O)C2CCCCC2
1125	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB14185	approved; investigational	Aripiprazole lauroxil	CCCCCCCCCCCC(=O)OCN1C(=O)CCc(c12)ccc(c2)OCCCCN3CCN(CC3)c4c(Cl)c(Cl)ccc4
1126	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
1127	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00340	approved	Metixene	CN1CCCC(C1)CC2c(cccc3)c3Sc(c24)cccc4
1128	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00366	approved; vet_approved	Doxylamine	c1cccnc1C(C)(OCCN(C)C)c2ccccc2
1129	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00454	approved	Meperidine	C1CN(C)CCC1(C(=O)OCC)c2ccccc2
1130	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00540	approved	Nortriptyline	CNCCC=C1c(cccc2)c2CCc(c13)cccc3
1131	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
1132	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00568	approved; investigational	Cinnarizine	c1ccccc1/C=C/CN2CCN(CC2)C(c3ccccc3)c4ccccc4
1133	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
1134	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00726	approved	Trimipramine	CN(C)CC(C)CN1c(cccc2)c2CCc(c13)cccc3
1135	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB00777	approved	Propiomazine	CCC(=O)c(cc1)cc(c12)N(CC(C)N(C)C)c3c(S2)cccc3
1136	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
1137	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB09194	withdrawn	Etoperidone	CCn1c(=O)n(nc1CC)CCCN2CCN(CC2)c3cccc(Cl)c3
1138	sp|P07550|ADRB2_HU	P08172	110.65	4.0	461.0	DB11855	approved; investigational	Revefenacin	O=C(N)C1CCN(CC1)Cc2ccc(cc2)C(=O)N(C)CCN3CCC(CC3)OC(=O)Nc4ccccc4-c5ccccc5
1141	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00193	approved; investigational	Tramadol	COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C
1142	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00295	approved; investigational	Morphine	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(C)CC2)[C@@H]3C=C[C@@H]4O
1143	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00318	approved; illicit	Codeine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(cc5)OC)O[C@H]4[C@@H](O)C=C2
1144	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
1145	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00327	approved; illicit	Hydromorphone	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(C)CC2)[C@@H]3CCC4=O
1146	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00333	approved	Methadone	c1ccccc1C(C(=O)CC)(CC(C)N(C)C)c2ccccc2
1147	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00454	approved	Meperidine	C1CN(C)CCC1(C(=O)OCC)c2ccccc2
1148	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00497	approved; illicit; investigational	Oxycodone	[C@@]123c4c5ccc(OC)c4O[C@H]1C(=O)CC[C@@]3(O)[C@@H](C5)N(C)CC2
1149	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00504	approved	Levallorphan	C1CCC[C@H]([C@@]123)[C@H](N(CC2)CC=C)Cc4c3cc(O)cc4
1150	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00514	approved	Dextromethorphan	C1CCC[C@@H]([C@]123)[C@@H](N(C)CC2)Cc4c3cc(OC)cc4
1151	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00611	approved; illicit; vet_approved	Butorphanol	C1CCC1CN(CC2)[C@@H]([C@]([C@]234)(O)CCCC3)Cc5c4cc(O)cc5
1152	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00647	approved; illicit; investigational; withdrawn	Dextropropoxyphene	c1ccccc1[C@@](OC(=O)CC)([C@H](C)CN(C)C)Cc2ccccc2
1153	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00652	approved; vet_approved	Pentazocine	CC(C)=CCN(CC1)[C@@H]([C@@H]2C)Cc(c3[C@]12C)ccc(O)c3
1154	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00704	approved; investigational; vet_approved	Naltrexone	[C@@]123[C@H]4Oc5c1c(ccc5O)C[C@H]([C@]2(O)CCC4=O)N(CC3)CC6CC6
1155	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00708	approved; investigational	Sufentanil	c1ccccc1N(C(=O)CC)C2(COC)CCN(CC2)CCc3cccs3
1156	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00802	approved; illicit	Alfentanil	CCn1nnn(c1=O)CCN(CC2)CCC2(COC)N(C(=O)CC)c3ccccc3
1157	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
1158	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00836	approved	Loperamide	c1ccccc1C(C(=O)N(C)C)(c2ccccc2)CCN(CC3)CCC3(O)c4ccc(Cl)cc4
1159	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00844	approved	Nalbuphine	[C@@]123[C@@H]4[C@@H](O)CC[C@@]2(O)[C@H](N(CC3)CC5CCC5)Cc6c1c(O4)c(O)cc6
1160	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00854	approved	Levorphanol	C1CCC[C@H]([C@@]123)[C@H](N(C)CC2)Cc4c3cc(O)cc4
1161	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00899	approved	Remifentanil	c1ccccc1N(C(=O)CC)C2(C(=O)OC)CCN(CC2)CCC(=O)OC
1162	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00904	approved	Ondansetron	c1cccc(c12)c3c(n2C)CCC(C3=O)Cn4ccnc4C
1163	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00913	approved; illicit	Anileridine	c1ccccc1C2(C(=O)OCC)CCN(CC2)CCc3ccc(N)cc3
1164	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00921	approved; illicit; investigational; vet_approved	Buprenorphine	CC(C)(C)[C@@](C)(O)[C@@H](C1)[C@](OC)(CC2)[C@@H]3Oc(c(O)cc4)c5c4C[C@H]([C@]12[C@]356)N(CC6)CC7CC7
1165	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB00956	approved; illicit; investigational	Hydrocodone	[C@@]123c4c5ccc(OC)c4O[C@H]1C(=O)CC[C@H]3[C@@H](C5)N(C)CC2
1166	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01081	approved; illicit	Diphenoxylate	c1ccccc1C2(C(=O)OCC)CCN(CC2)CCC(C#N)(c3ccccc3)c4ccccc4
1167	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01183	approved; vet_approved	Naloxone	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC=C)[C@]3(O)CCC4=O
1168	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01192	approved; investigational; vet_approved	Oxymorphone	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(C)CC2)[C@]3(O)CCC4=O
1169	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01209	approved; investigational	Dezocine	C1CCCC[C@H]([C@@H]2N)Cc(c3[C@@]12C)ccc(O)c3
1170	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
1171	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01227	approved; investigational	Levacetylmethadol	c1ccccc1C([C@H](CC)OC(=O)C)(C[C@H](C)N(C)C)c2ccccc2
1172	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
1173	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01433	experimental; illicit	Methadyl acetate	c1ccccc1C(C(CC)OC(=O)C)(CC(C)N(C)C)c2ccccc2
1174	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01439	experimental; illicit	3-Methylthiofentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2C)CCc3cccs3
1175	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01444	experimental; illicit	Dimethylthiambutene	c1ccsc1C(=CC(C)N(C)C)c2cccs2
1176	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01452	approved; illicit; investigational	Diamorphine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(cc5)OC(=O)C)O[C@H]4[C@H](C=C2)OC(=O)C
1177	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01466	experimental; illicit	Ethylmorphine	[C@@]123c4c5ccc(OCC)c4O[C@H]1[C@@H](O)C=C[C@H]3[C@@H](C5)N(C)CC2
1178	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01497	illicit; vet_approved	Etorphine	C1CN(C)[C@@H]2Cc(c3[C@@]14[C@]256)ccc(O)c3OC4C(OC)(C=C5)C(C6)C(C)(O)CCC
1179	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01535	illicit; investigational; vet_approved	Carfentanil	c1ccccc1N(C(=O)CC)C2(C(=O)OC)CCN(CC2)CCc3ccccc3
1180	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01548	illicit; vet_approved	Diprenorphine	CC(C)(O)[C@@H](C1)[C@@](CC2)(OC)[C@@H]([C@@]34[C@@]125)Oc6c3c(ccc6O)C[C@H]5N(CC4)CC7CC7
1181	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01565	experimental; illicit	Dihydromorphine	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(C)CC2)[C@@H]3CC[C@@H]4O
1182	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB01571	illicit	3-Methylfentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2C)CCc3ccccc3
1183	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB05046	investigational	V1003	 
1184	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB05492	investigational	Epicept NP-1	Cc1cc([N+]([O-])=O)c(cc1)NCCCN
1185	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB05509	investigational	LI-301	 
1186	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB06204	approved	Tapentadol	CN(C)C[C@H](C)[C@@H](CC)c1cc(O)ccc1
1187	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB06230	approved; investigational; withdrawn	Nalmefene	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC6CC6)[C@]3(O)CCC4=C
1188	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB06274	approved; investigational	Alvimopan	Oc1cccc(c1)[C@@]2(C)[C@@H](C)CN(CC2)C[C@@H](C(=O)NCC(=O)O)Cc3ccccc3
1189	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB06409	investigational	Morphine glucuronide	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(O)cc5)O[C@H]4[C@H](C=C2)O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O
1190	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB06738	investigational	Ketobemidone	C1CN(C)CCC1(C(=O)CC)c2cc(O)ccc2
1191	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB06800	approved	Methylnaltrexone	C1CC1C[N@@+](C)(CC2)[C@@H]([C@]3([C@@]245)O)Cc6c4c(c(O)cc6)O[C@H]5C(=O)CC3
1192	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB09049	approved	Naloxegol	COCCOCCOCCOCCOCCOCCOCCO[C@H]([C@H]1[C@]234)CC[C@@]3(O)[C@H](N(CC4)CC=C)Cc5c2c(O1)c(O)cc5
1193	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
1194	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB09089	approved	Trimebutine	c1ccccc1C(CC)(N(C)C)COC(=O)c2cc(OC)c(OC)c(c2)OC
1195	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB09173	illicit	Butyrfentanyl	c1ccccc1N(C(=O)CCC)C2CCN(CC2)CCc3ccccc3
1196	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB09209	approved; illicit	Pholcodine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(O[C@H]4[C@@H](O)C=C2)c(cc5)OCCN6CCOCC6
1197	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB09272	approved; investigational	Eluxadoline	Cc1cc(C(=O)N)cc(C)c1C[C@H](N)C(=O)N(Cc2cc(C(=O)O)c(cc2)OC)[C@@H](C)c3nc(c[nH]3)-c4ccccc4
1198	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB09289	investigational	Tianeptine	c1cccc(N(S2(=O)=O)C)c1C(c(c23)ccc(Cl)c3)NCCCCCCC(=O)O
1199	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB11130	approved; illicit	Opium	 
1200	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB11186	approved; investigational	Pentoxyverine	CCN(CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2
1201	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB11691	approved; investigational	Naldemedine	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC6CC6)[C@]3(O)CC(=C4O)C(=O)NC(C)(C)c7nc(no7)-c8ccccc8
1202	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB12668	investigational	Metenkefalin	CSCC[C@@H](C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc2ccc(O)cc2
1204	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
1205	sp|P07550|ADRB2_HU	P35372	77.48	67.0	387.0	DB14146	investigational	Loxicodegol	[C@@]123c4c5ccc(OC)c4O[C@H]1[C@H](CC[C@@]3(O)[C@@H](C5)N(C)CC2)OCCOCCOCCOCCOCCOCCOC
1207	sp|P07550|ADRB2_HU	P30559	90.31	12.0	385.0	DB01282	approved; investigational	Carbetocin	COc1ccc(cc1)C[C@H]2C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CSCCCC(=O)N2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N
1208	sp|P07550|ADRB2_HU	P30559	90.31	12.0	385.0	DB09059	approved; investigational	Atosiban	CCOc1ccc(cc1)C[C@@H]2C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CSSCCC(=O)N2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N
1209	sp|P07550|ADRB2_HU	P30559	90.31	12.0	385.0	DB13929	investigational	Relcovaptan	COc1ccc(cc1OC)S(=O)(=O)N2[C@H]([C@](O)(c(c23)cc(Cl)cc3)c4ccccc4Cl)C(=O)N5CCC[C@H]5C(=O)N
1210	sp|P07550|ADRB2_HU	P31391	78.45	11.0	335.0	DB09099	approved; investigational	Somatostatin	c1ccccc1C[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)CSSC[C@H](NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)[C@@H](C)O)CCCCN)Cc5c[nH]c(c56)cccc6
1211	sp|P07550|ADRB2_HU	P31391	78.45	11.0	335.0	DB13985	approved; investigational	Lutetium Lu 177 dotatate	NCCCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N1)Cc3c[nH]c(c34)cccc4)NC(=O)[C@@H](Cc5ccccc5)NC(=O)CN6CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC6
1212	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
1213	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
1214	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB00334	approved; investigational	Olanzapine	CN1CCN(CC1)C2=Nc(cccc3)c3Nc(c24)sc(c4)C
1215	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
1216	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
1217	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB00458	approved	Imipramine	CN(C)CCCN1c(cccc2)c2CCc(c13)cccc3
1218	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB00477	approved; investigational; vet_approved	Chlorpromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(Cl)c3
1219	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB00502	approved	Haloperidol	Clc1ccc(cc1)C2(O)CCN(CC2)CCCC(=O)c3ccc(F)cc3
1220	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
1221	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB00924	approved	Cyclobenzaprine	CN(C)CCC=C1c(cccc2)c2C=Cc(c13)cccc3
1222	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB01142	approved; investigational	Doxepin	CN(C)CC/C=C\1c(cccc2)c2COc(c13)cccc3
1223	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB01224	approved	Quetiapine	OCCOCCN1CCN(CC1)C2=Nc(cccc3)c3Sc(c24)cccc4
1224	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
1225	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB01488	experimental; illicit	Dimethyltryptamine	CN(C)CCc1c[nH]c(c12)cccc2
1226	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB04829	illicit; investigational; withdrawn	Lysergic acid diethylamide	CCN(CC)C(=O)[C@H](C=1)CN(C)[C@@H](C12)Cc3c4c2cccc4[nH]c3
1227	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB04946	approved	Iloperidone	CC(=O)c1cc(OC)c(cc1)OCCCN2CCC(CC2)c3noc(c34)cc(F)cc4
1228	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB05042	investigational	SGS518	 
1229	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB05993	investigational	PRX-07034	COc1c(OC)c(cc(Cl)c1)C(C)Nc2cc(ccc2S(=O)(=O)C)N3CCNCC3
1230	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB06140	investigational	SUVN-502	CN1CCN(CC1)Cc2cn(c(c23)ccc(c3)OC)S(=O)(=O)c4ccccc4Br
1231	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB06144	approved; investigational; withdrawn	Sertindole	Fc1ccc(cc1)-n2cc(c(c23)cc(Cl)cc3)C4CCN(CC4)CCN5CCNC5=O
1232	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
1233	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
1234	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB09225	approved; investigational; withdrawn	Zotepine	CN(C)CCOC1=Cc(cccc2)c2Sc(c13)ccc(Cl)c3
1235	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB14185	approved; investigational	Aripiprazole lauroxil	CCCCCCCCCCCC(=O)OCN1C(=O)CCc(c12)ccc(c2)OCCCCN3CCN(CC3)c4c(Cl)c(Cl)ccc4
1236	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB00715	approved; investigational	Paroxetine	Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc(cc3)cc(c34)OCO4
1237	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB01049	approved	Ergoloid mesylate	 
1238	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB01239	approved; experimental; investigational; withdrawn	Chlorprothixene	CN(C)CC/C=C\1c(cccc2)c2Sc(c13)ccc(Cl)c3
1239	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB09304	experimental	Setiptiline	CN(C1)CCC(=C12)c3c(cccc3)Cc4c2cccc4
1240	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB11273	approved	Dihydroergocornine	C1CCN([C@@H]1[C@@]23O)C(=O)[C@H](C(C)C)N2C(=O)[C@](O3)(C(C)C)NC(=O)[C@H](C4)CN(C)[C@@H]([C@H]45)Cc6c7c5cccc7[nH]c6
1241	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB12141	approved; investigational	Gilteritinib	C1COCCC1Nc2c(CC)nc(C(=O)N)c(n2)Nc3ccc(c(c3)OC)N4CCC(CC4)N5CCN(C)CC5
1242	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB13025	investigational	Tiapride	CCN(CC)CCNC(=O)c1cc(S(=O)(=O)C)ccc1OC
1243	sp|P07550|ADRB2_HU	P50406	77.72	29.0	350.0	DB13345	approved; experimental	Dihydroergocristine	c1ccccc1C[C@@H](C(=O)N([C@@H]2[C@@]34O)CCC2)N3C(=O)[C@](O4)(C(C)C)NC(=O)[C@H](C5)CN(C)[C@@H]([C@H]56)Cc7c8c6cccc8[nH]c7
1244	sp|P07550|ADRB2_HU	P35346	73.61	33.0	337.0	DB04894	experimental; investigational	Vapreotide	c1cccc(c12)[nH]cc2C[C@H](C(=O)N[C@H](C(=O)N[C@H]3C(C)C)CCCCN)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@H](N)Cc5ccccc5)CSSC[C@H](NC3=O)C(=O)N[C@H](C(=O)N)Cc6c[nH]c(c67)cccc7
1245	sp|P07550|ADRB2_HU	P35346	73.61	33.0	337.0	DB06663	approved	Pasireotide	NCCNC(=O)O[C@@H](C1)C[C@H](N12)C(=O)N[C@@H](c3ccccc3)C(=O)N[C@H](Cc4c[nH]c(c45)cccc5)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C2=O)Cc6ccccc6)Cc7ccc(cc7)OCc8ccccc8
1246	sp|P07550|ADRB2_HU	P35346	73.61	33.0	337.0	DB06791	approved	Lanreotide	c1cccc(c12)[nH]cc2CC(C(=O)NC3CCCCN)NC(=O)C(Cc4ccc(O)cc4)NC(=O)C(CSSCC(NC(=O)C(NC3=O)C(C)C)C(=O)NC(C(C)O)C(=O)N)NC(=O)C(N)Cc(cc5)cc(c56)cccc6
1247	sp|P07550|ADRB2_HU	P35346	73.61	33.0	337.0	DB09099	approved; investigational	Somatostatin	c1ccccc1C[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)CSSC[C@H](NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)[C@@H](C)O)CCCCN)Cc5c[nH]c(c56)cccc6
1248	sp|P07550|ADRB2_HU	P35346	73.61	33.0	337.0	DB13985	approved; investigational	Lutetium Lu 177 dotatate	NCCCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N1)Cc3c[nH]c(c34)cccc4)NC(=O)[C@@H](Cc5ccccc5)NC(=O)CN6CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC6
1249	sp|P07550|ADRB2_HU	P35346	73.61	33.0	337.0	DB15494	approved	Edotreotide gallium Ga-68	NCCCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)CO)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N1)Cc3c[nH]c(c34)cccc4)NC(=O)[C@@H](Cc5ccccc5)NC(=O)CN6CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC6
1250	sp|P07550|ADRB2_HU	P30874	79.18	27.0	354.0	DB04894	experimental; investigational	Vapreotide	c1cccc(c12)[nH]cc2C[C@H](C(=O)N[C@H](C(=O)N[C@H]3C(C)C)CCCCN)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@H](N)Cc5ccccc5)CSSC[C@H](NC3=O)C(=O)N[C@H](C(=O)N)Cc6c[nH]c(c67)cccc7
1251	sp|P07550|ADRB2_HU	P30874	79.18	27.0	354.0	DB06663	approved	Pasireotide	NCCNC(=O)O[C@@H](C1)C[C@H](N12)C(=O)N[C@@H](c3ccccc3)C(=O)N[C@H](Cc4c[nH]c(c45)cccc5)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C2=O)Cc6ccccc6)Cc7ccc(cc7)OCc8ccccc8
1252	sp|P07550|ADRB2_HU	P30874	79.18	27.0	354.0	DB06791	approved	Lanreotide	c1cccc(c12)[nH]cc2CC(C(=O)NC3CCCCN)NC(=O)C(Cc4ccc(O)cc4)NC(=O)C(CSSCC(NC(=O)C(NC3=O)C(C)C)C(=O)NC(C(C)O)C(=O)N)NC(=O)C(N)Cc(cc5)cc(c56)cccc6
1253	sp|P07550|ADRB2_HU	P30874	79.18	27.0	354.0	DB09099	approved; investigational	Somatostatin	c1ccccc1C[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)CSSC[C@H](NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)[C@@H](C)O)CCCCN)Cc5c[nH]c(c56)cccc6
1254	sp|P07550|ADRB2_HU	P30874	79.18	27.0	354.0	DB13925	approved; investigational	Dotatate gallium Ga-68	NCCCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N1)Cc3c[nH]c(c34)cccc4)NC(=O)[C@@H](Cc5ccccc5)NC(=O)CN6CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC6
1255	sp|P07550|ADRB2_HU	P30874	79.18	27.0	354.0	DB13985	approved; investigational	Lutetium Lu 177 dotatate	NCCCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N1)Cc3c[nH]c(c34)cccc4)NC(=O)[C@@H](Cc5ccccc5)NC(=O)CN6CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC6
1256	sp|P07550|ADRB2_HU	P30874	79.18	27.0	354.0	DB15494	approved	Edotreotide gallium Ga-68	NCCCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)CO)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N1)Cc3c[nH]c(c34)cccc4)NC(=O)[C@@H](Cc5ccccc5)NC(=O)CN6CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC6
1257	sp|P07550|ADRB2_HU	P41146	78.93	15.0	341.0	DB00921	approved; illicit; investigational; vet_approved	Buprenorphine	CC(C)(C)[C@@](C)(O)[C@@H](C1)[C@](OC)(CC2)[C@@H]3Oc(c(O)cc4)c5c4C[C@H]([C@]12[C@]356)N(CC6)CC7CC7
1258	sp|P07550|ADRB2_HU	P41146	78.93	15.0	341.0	DB01497	illicit; vet_approved	Etorphine	C1CN(C)[C@@H]2Cc(c3[C@@]14[C@]256)ccc(O)c3OC4C(OC)(C=C5)C(C6)C(C)(O)CCC
1259	sp|P07550|ADRB2_HU	P41146	78.93	15.0	341.0	DB05492	investigational	Epicept NP-1	Cc1cc([N+]([O-])=O)c(cc1)NCCCN
1260	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00193	approved; investigational	Tramadol	COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C
1261	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00295	approved; investigational	Morphine	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(C)CC2)[C@@H]3C=C[C@@H]4O
1262	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00318	approved; illicit	Codeine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(cc5)OC)O[C@H]4[C@@H](O)C=C2
1263	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
1264	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00327	approved; illicit	Hydromorphone	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(C)CC2)[C@@H]3CCC4=O
1265	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00333	approved	Methadone	c1ccccc1C(C(=O)CC)(CC(C)N(C)C)c2ccccc2
1266	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00497	approved; illicit; investigational	Oxycodone	[C@@]123c4c5ccc(OC)c4O[C@H]1C(=O)CC[C@@]3(O)[C@@H](C5)N(C)CC2
1267	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00514	approved	Dextromethorphan	C1CCC[C@@H]([C@]123)[C@@H](N(C)CC2)Cc4c3cc(OC)cc4
1268	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00611	approved; illicit; vet_approved	Butorphanol	C1CCC1CN(CC2)[C@@H]([C@]([C@]234)(O)CCCC3)Cc5c4cc(O)cc5
1269	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00647	approved; illicit; investigational; withdrawn	Dextropropoxyphene	c1ccccc1[C@@](OC(=O)CC)([C@H](C)CN(C)C)Cc2ccccc2
1270	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00704	approved; investigational; vet_approved	Naltrexone	[C@@]123[C@H]4Oc5c1c(ccc5O)C[C@H]([C@]2(O)CCC4=O)N(CC3)CC6CC6
1271	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00708	approved; investigational	Sufentanil	c1ccccc1N(C(=O)CC)C2(COC)CCN(CC2)CCc3cccs3
1272	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
1273	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00836	approved	Loperamide	c1ccccc1C(C(=O)N(C)C)(c2ccccc2)CCN(CC3)CCC3(O)c4ccc(Cl)cc4
1274	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00844	approved	Nalbuphine	[C@@]123[C@@H]4[C@@H](O)CC[C@@]2(O)[C@H](N(CC3)CC5CCC5)Cc6c1c(O4)c(O)cc6
1275	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00854	approved	Levorphanol	C1CCC[C@H]([C@@]123)[C@H](N(C)CC2)Cc4c3cc(O)cc4
1276	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00899	approved	Remifentanil	c1ccccc1N(C(=O)CC)C2(C(=O)OC)CCN(CC2)CCC(=O)OC
1277	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00921	approved; illicit; investigational; vet_approved	Buprenorphine	CC(C)(C)[C@@](C)(O)[C@@H](C1)[C@](OC)(CC2)[C@@H]3Oc(c(O)cc4)c5c4C[C@H]([C@]12[C@]356)N(CC6)CC7CC7
1278	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB00956	approved; illicit; investigational	Hydrocodone	[C@@]123c4c5ccc(OC)c4O[C@H]1C(=O)CC[C@H]3[C@@H](C5)N(C)CC2
1279	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01081	approved; illicit	Diphenoxylate	c1ccccc1C2(C(=O)OCC)CCN(CC2)CCC(C#N)(c3ccccc3)c4ccccc4
1280	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01183	approved; vet_approved	Naloxone	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC=C)[C@]3(O)CCC4=O
1281	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01192	approved; investigational; vet_approved	Oxymorphone	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(C)CC2)[C@]3(O)CCC4=O
1282	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
1283	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
1284	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01439	experimental; illicit	3-Methylthiofentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2C)CCc3cccs3
1285	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01444	experimental; illicit	Dimethylthiambutene	c1ccsc1C(=CC(C)N(C)C)c2cccs2
1286	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01452	approved; illicit; investigational	Diamorphine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(cc5)OC(=O)C)O[C@H]4[C@H](C=C2)OC(=O)C
1287	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01497	illicit; vet_approved	Etorphine	C1CN(C)[C@@H]2Cc(c3[C@@]14[C@]256)ccc(O)c3OC4C(OC)(C=C5)C(C6)C(C)(O)CCC
1288	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01535	illicit; investigational; vet_approved	Carfentanil	c1ccccc1N(C(=O)CC)C2(C(=O)OC)CCN(CC2)CCc3ccccc3
1289	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01548	illicit; vet_approved	Diprenorphine	CC(C)(O)[C@@H](C1)[C@@](CC2)(OC)[C@@H]([C@@]34[C@@]125)Oc6c3c(ccc6O)C[C@H]5N(CC4)CC7CC7
1290	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01565	experimental; illicit	Dihydromorphine	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(C)CC2)[C@@H]3CC[C@@H]4O
1291	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB01571	illicit	3-Methylfentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2C)CCc3ccccc3
1292	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB05050	investigational	ADL5859	 
1293	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB06204	approved	Tapentadol	CN(C)C[C@H](C)[C@@H](CC)c1cc(O)ccc1
1294	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB06230	approved; investigational; withdrawn	Nalmefene	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC6CC6)[C@]3(O)CCC4=C
1295	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB06274	approved; investigational	Alvimopan	Oc1cccc(c1)[C@@]2(C)[C@@H](C)CN(CC2)C[C@@H](C(=O)NCC(=O)O)Cc3ccccc3
1296	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB06409	investigational	Morphine glucuronide	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(O)cc5)O[C@H]4[C@H](C=C2)O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O
1297	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB06738	investigational	Ketobemidone	C1CN(C)CCC1(C(=O)CC)c2cc(O)ccc2
1298	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
1299	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB09173	illicit	Butyrfentanyl	c1ccccc1N(C(=O)CCC)C2CCN(CC2)CCc3ccccc3
1300	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB09209	approved; illicit	Pholcodine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(O[C@H]4[C@@H](O)C=C2)c(cc5)OCCN6CCOCC6
1301	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB09272	approved; investigational	Eluxadoline	Cc1cc(C(=O)N)cc(C)c1C[C@H](N)C(=O)N(Cc2cc(C(=O)O)c(cc2)OC)[C@@H](C)c3nc(c[nH]3)-c4ccccc4
1302	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB11130	approved; illicit	Opium	 
1303	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB11691	approved; investigational	Naldemedine	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC6CC6)[C@]3(O)CC(=C4O)C(=O)NC(C)(C)c7nc(no7)-c8ccccc8
1304	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB12668	investigational	Metenkefalin	CSCC[C@@H](C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc2ccc(O)cc2
1306	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
1307	sp|P07550|ADRB2_HU	P41143	77.48	29.0	349.0	DB14146	investigational	Loxicodegol	[C@@]123c4c5ccc(OC)c4O[C@H]1[C@H](CC[C@@]3(O)[C@@H](C5)N(C)CC2)OCCOCCOCCOCCOCCOCCOC
1308	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00193	approved; investigational	Tramadol	COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C
1309	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00289	approved	Atomoxetine	c1ccccc1[C@@H](CCNC)Oc2ccccc2C
1310	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00295	approved; investigational	Morphine	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(C)CC2)[C@@H]3C=C[C@@H]4O
1311	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00318	approved; illicit	Codeine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(cc5)OC)O[C@H]4[C@@H](O)C=C2
1312	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
1313	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00327	approved; illicit	Hydromorphone	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(C)CC2)[C@@H]3CCC4=O
1314	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00370	approved	Mirtazapine	CN(C1)CCN(C12)c3c(cccn3)Cc4c2cccc4
1315	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00396	approved; vet_approved	Progesterone	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
1316	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00454	approved	Meperidine	C1CN(C)CCC1(C(=O)OCC)c2ccccc2
1317	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00497	approved; illicit; investigational	Oxycodone	[C@@]123c4c5ccc(OC)c4O[C@H]1C(=O)CC[C@@]3(O)[C@@H](C5)N(C)CC2
1318	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00514	approved	Dextromethorphan	C1CCC[C@@H]([C@]123)[C@@H](N(C)CC2)Cc4c3cc(OC)cc4
1319	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00555	approved; investigational	Lamotrigine	Nc1nc(N)c(nn1)-c2c(Cl)c(Cl)ccc2
1320	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00611	approved; illicit; vet_approved	Butorphanol	C1CCC1CN(CC2)[C@@H]([C@]([C@]234)(O)CCCC3)Cc5c4cc(O)cc5
1321	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00647	approved; illicit; investigational; withdrawn	Dextropropoxyphene	c1ccccc1[C@@](OC(=O)CC)([C@H](C)CN(C)C)Cc2ccccc2
1322	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00652	approved; vet_approved	Pentazocine	CC(C)=CCN(CC1)[C@@H]([C@@H]2C)Cc(c3[C@]12C)ccc(O)c3
1323	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00704	approved; investigational; vet_approved	Naltrexone	[C@@]123[C@H]4Oc5c1c(ccc5O)C[C@H]([C@]2(O)CCC4=O)N(CC3)CC6CC6
1324	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00708	approved; investigational	Sufentanil	c1ccccc1N(C(=O)CC)C2(COC)CCN(CC2)CCc3cccs3
1325	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
1326	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00825	approved	Levomenthol	CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
1327	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00836	approved	Loperamide	c1ccccc1C(C(=O)N(C)C)(c2ccccc2)CCN(CC3)CCC3(O)c4ccc(Cl)cc4
1328	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00844	approved	Nalbuphine	[C@@]123[C@@H]4[C@@H](O)CC[C@@]2(O)[C@H](N(CC3)CC5CCC5)Cc6c1c(O4)c(O)cc6
1329	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00854	approved	Levorphanol	C1CCC[C@H]([C@@]123)[C@H](N(C)CC2)Cc4c3cc(O)cc4
1330	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00899	approved	Remifentanil	c1ccccc1N(C(=O)CC)C2(C(=O)OC)CCN(CC2)CCC(=O)OC
1331	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB00921	approved; illicit; investigational; vet_approved	Buprenorphine	CC(C)(C)[C@@](C)(O)[C@@H](C1)[C@](OC)(CC2)[C@@H]3Oc(c(O)cc4)c5c4C[C@H]([C@]12[C@]356)N(CC6)CC7CC7
1332	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB01183	approved; vet_approved	Naloxone	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC=C)[C@]3(O)CCC4=O
1333	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB01209	approved; investigational	Dezocine	C1CCCC[C@H]([C@@H]2N)Cc(c3[C@@]12C)ccc(O)c3
1334	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
1335	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
1336	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB01439	experimental; illicit	3-Methylthiofentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2C)CCc3cccs3
1337	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB01452	approved; illicit; investigational	Diamorphine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(cc5)OC(=O)C)O[C@H]4[C@H](C=C2)OC(=O)C
1338	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB01497	illicit; vet_approved	Etorphine	C1CN(C)[C@@H]2Cc(c3[C@@]14[C@]256)ccc(O)c3OC4C(OC)(C=C5)C(C6)C(C)(O)CCC
1339	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB01535	illicit; investigational; vet_approved	Carfentanil	c1ccccc1N(C(=O)CC)C2(C(=O)OC)CCN(CC2)CCc3ccccc3
1340	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB01548	illicit; vet_approved	Diprenorphine	CC(C)(O)[C@@H](C1)[C@@](CC2)(OC)[C@@H]([C@@]34[C@@]125)Oc6c3c(ccc6O)C[C@H]5N(CC4)CC7CC7
1341	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB01565	experimental; illicit	Dihydromorphine	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(C)CC2)[C@@H]3CC[C@@H]4O
1342	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB01571	illicit	3-Methylfentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2C)CCc3ccccc3
1343	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB05046	investigational	V1003	 
1344	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB05104	investigational	Asimadoline	c1ccccc1[C@@H](CN(CC2)C[C@H]2O)N(C)C(=O)C(c3ccccc3)c4ccccc4
1345	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB05155	investigational	CR665	c1cnccc1CNC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCC)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](N)Cc3ccccc3
1346	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB05443	investigational	ADL 10-0101	 
1347	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
1348	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB06204	approved	Tapentadol	CN(C)C[C@H](C)[C@@H](CC)c1cc(O)ccc1
1349	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB06230	approved; investigational; withdrawn	Nalmefene	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC6CC6)[C@]3(O)CCC4=C
1350	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB06274	approved; investigational	Alvimopan	Oc1cccc(c1)[C@@]2(C)[C@@H](C)CN(CC2)C[C@@H](C(=O)NCC(=O)O)Cc3ccccc3
1351	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB06409	investigational	Morphine glucuronide	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(O)cc5)O[C@H]4[C@H](C=C2)O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O
1352	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB06738	investigational	Ketobemidone	C1CN(C)CCC1(C(=O)CC)c2cc(O)ccc2
1353	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB06800	approved	Methylnaltrexone	C1CC1C[N@@+](C)(CC2)[C@@H]([C@]3([C@@]245)O)Cc6c4c(c(O)cc6)O[C@H]5C(=O)CC3
1354	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB09173	illicit	Butyrfentanyl	c1ccccc1N(C(=O)CCC)C2CCN(CC2)CCc3ccccc3
1355	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB09209	approved; illicit	Pholcodine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(O[C@H]4[C@@H](O)C=C2)c(cc5)OCCN6CCOCC6
1356	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB09272	approved; investigational	Eluxadoline	Cc1cc(C(=O)N)cc(C)c1C[C@H](N)C(=O)N(Cc2cc(C(=O)O)c(cc2)OC)[C@@H](C)c3nc(c[nH]3)-c4ccccc4
1357	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB11130	approved; illicit	Opium	 
1358	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB11186	approved; investigational	Pentoxyverine	CCN(CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2
1359	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB11691	approved; investigational	Naldemedine	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC6CC6)[C@]3(O)CC(=C4O)C(=O)NC(C)(C)c7nc(no7)-c8ccccc8
1360	sp|P07550|ADRB2_HU	P41145	78.45	38.0	362.0	DB14146	investigational	Loxicodegol	[C@@]123c4c5ccc(OC)c4O[C@H]1[C@H](CC[C@@]3(O)[C@@H](C5)N(C)CC2)OCCOCCOCCOCCOCCOCCOC
1361	sp|P07550|ADRB2_HU	O43614	88.62	55.0	421.0	DB09034	approved; investigational	Suvorexant	c1cc(Cl)cc(c12)nc(o2)N3CC[C@@H](C)N(CC3)C(=O)c4c(ccc(C)c4)-n5nccn5
1362	sp|P07550|ADRB2_HU	O43614	88.62	55.0	421.0	DB11951	approved; investigational	Lemborexant	Cc1ncc(c(n1)C)OC[C@@]2(c3cccc(F)c3)C[C@H]2C(=O)Nc4ncc(F)cc4
1363	sp|P07550|ADRB2_HU	P47898	81.84	17.0	355.0	DB00246	approved	Ziprasidone	O=C(N1)Cc(c12)cc(c(Cl)c2)CCN3CCN(CC3)c4nsc(c45)cccc5
1364	sp|P07550|ADRB2_HU	P47898	81.84	17.0	355.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
1365	sp|P07550|ADRB2_HU	P47898	81.84	17.0	355.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
1366	sp|P07550|ADRB2_HU	P47898	81.84	17.0	355.0	DB06216	approved	Asenapine	CN(C1)CC(C12)c3c(cccc3)Oc4c2cc(Cl)cc4
1367	sp|P07550|ADRB2_HU	P32238	86.44	33.0	390.0	DB00403	approved	Ceruletide	O=C1N[C@@H](CC1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2ccc(cc2)OS(=O)(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc3c[nH]c(c34)cccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N)Cc5ccccc5
1368	sp|P07550|ADRB2_HU	P32238	86.44	33.0	390.0	DB04856	investigational	Dexloxiglumide	CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)c1cc(Cl)c(Cl)cc1
1369	sp|P07550|ADRB2_HU	P32238	86.44	33.0	390.0	DB04867	investigational	Lintitript	c1cccc(c12)cc(n2CC(=O)O)C(=O)Nc3nc(cs3)-c4ccccc4Cl
1370	sp|P07550|ADRB2_HU	P32238	86.44	33.0	390.0	DB08862	approved; investigational	Cholecystokinin	 
1371	sp|P07550|ADRB2_HU	P37288	88.38	26.0	391.0	DB00035	approved	Desmopressin	NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CCSSC[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)C(=O)N4CCC[C@H]4C(=O)N[C@@H](C(=O)NCC(=O)N)CCCNC(N)=N
1372	sp|P07550|ADRB2_HU	P37288	88.38	26.0	391.0	DB00067	approved	Vasopressin	 
1373	sp|P07550|ADRB2_HU	P37288	88.38	26.0	391.0	DB00093	experimental	Felypressin	NCCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@H](C(=O)N2)CC(=O)N
1374	sp|P07550|ADRB2_HU	P37288	88.38	26.0	391.0	DB00872	approved; investigational	Conivaptan	Cc([nH]1)nc(c12)c3c(cccc3)N(CC2)C(=O)c4ccc(cc4)NC(=O)c5ccccc5-c6ccccc6
1375	sp|P07550|ADRB2_HU	P37288	88.38	26.0	391.0	DB02638	approved; investigational	Terlipressin	NCCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@H](C(=O)N2)CC(=O)N
1376	sp|P07550|ADRB2_HU	P37288	88.38	26.0	391.0	DB05452	investigational	PH-284	 
1377	sp|P07550|ADRB2_HU	P37288	88.38	26.0	391.0	DB06212	approved	Tolvaptan	Cc1ccccc1C(=O)Nc2cc(C)c(cc2)C(=O)N3CCC[C@@H](O)c(c34)cc(Cl)cc4
1378	sp|P07550|ADRB2_HU	P37288	88.38	26.0	391.0	DB09059	approved; investigational	Atosiban	CCOc1ccc(cc1)C[C@@H]2C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CSSCCC(=O)N2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N
1379	sp|P07550|ADRB2_HU	P37288	88.38	26.0	391.0	DB13929	investigational	Relcovaptan	COc1ccc(cc1OC)S(=O)(=O)N2[C@H]([C@](O)(c(c23)cc(Cl)cc3)c4ccccc4Cl)C(=O)N5CCC[C@H]5C(=O)N
1380	sp|P07550|ADRB2_HU	P37288	88.38	26.0	391.0	DB14642	approved	Lypressin	NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)CSSC[C@H](NC1=O)C(=O)N4CCC[C@H]4C(=O)NC(CCCCN)C(=O)NCC(=O)N
1381	sp|P07550|ADRB2_HU	Q9Y5N1	98.55	30.0	437.0	DB00768	approved	Olopatadine	CN(C)CC/C=C\1c(cccc2)c2COc(c13)ccc(c3)CC(=O)O
1382	sp|P07550|ADRB2_HU	Q9Y5N1	98.55	30.0	437.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
1383	sp|P07550|ADRB2_HU	Q9Y5N1	98.55	30.0	437.0	DB05080	investigational	OBE101	 
1384	sp|P07550|ADRB2_HU	Q9Y5N1	98.55	30.0	437.0	DB05381	approved; investigational	Histamine	NCCc1c[nH]cn1
1385	sp|P07550|ADRB2_HU	Q9Y5N1	98.55	30.0	437.0	DB06698	approved; investigational	Betahistine	CNCCc1ccccn1
1386	sp|P07550|ADRB2_HU	Q9Y5N1	98.55	30.0	437.0	DB11642	approved; investigational	Pitolisant	Clc1ccc(cc1)CCCOCCCN2CCCCC2
1387	sp|P07550|ADRB2_HU	P32239	89.35	49.0	418.0	DB00183	approved	Pentagastrin	CC(C)(C)OC(=O)NCCC(=O)N[C@@H](Cc1c[nH]c(c12)cccc2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N)Cc3ccccc3
1388	sp|P07550|ADRB2_HU	P32239	89.35	49.0	418.0	DB08862	approved; investigational	Cholecystokinin	 
1389	sp|P07550|ADRB2_HU	O43613	84.99	48.0	399.0	DB09034	approved; investigational	Suvorexant	c1cc(Cl)cc(c12)nc(o2)N3CC[C@@H](C)N(CC3)C(=O)c4c(ccc(C)c4)-n5nccn5
1390	sp|P07550|ADRB2_HU	O43613	84.99	48.0	399.0	DB11951	approved; investigational	Lemborexant	Cc1ncc(c(n1)C)OC[C@@]2(c3cccc(F)c3)C[C@H]2C(=O)Nc4ncc(F)cc4
1391	sp|P07550|ADRB2_HU	Q96RJ0	72.64	23.0	323.0	DB00182	approved; illicit; investigational	Amphetamine	CC(N)Cc1ccccc1
1392	sp|P07550|ADRB2_HU	Q96RJ0	72.64	23.0	323.0	DB01255	approved; investigational	Lisdexamfetamine	c1ccccc1C[C@H](C)NC(=O)[C@@H](N)CCCCN
1393	sp|P07550|ADRB2_HU	Q96RJ0	72.64	23.0	323.0	DB01576	approved; illicit	Dextroamphetamine	C[C@H](N)Cc1ccccc1
1394	sp|P07550|ADRB2_HU	Q96RJ0	72.64	23.0	323.0	DB01577	approved; illicit	Metamfetamine	CN[C@@H](C)Cc1ccccc1
1395	sp|P07550|ADRB2_HU	Q96RJ0	72.64	23.0	323.0	DB06714	approved	Propylhexedrine	CNC(C)CC1CCCCC1
1396	sp|P07550|ADRB2_HU	Q96RJ0	72.64	23.0	323.0	DB15665	investigational	SEP-363856	CNC[C@@H]1OCCc(c12)ccs2
1397	sp|P07550|ADRB2_HU	P21452	84.99	9.0	360.0	DB06660	investigational	Saredutant	c1ccccc1C(=O)N(C)C[C@H](c2ccc(Cl)c(Cl)c2)CCN(CC3)CCC3(NC(=O)C)c4ccccc4
1398	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB00193	approved; investigational	Tramadol	COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C
1399	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB00673	approved; investigational	Aprepitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)O[C@H]2OCCN(Cc3n[nH]c(=O)[nH]3)[C@H]2c4ccc(F)cc4
1400	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
1401	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB04894	experimental; investigational	Vapreotide	c1cccc(c12)[nH]cc2C[C@H](C(=O)N[C@H](C(=O)N[C@H]3C(C)C)CCCCN)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@H](N)Cc5ccccc5)CSSC[C@H](NC3=O)C(=O)N[C@H](C(=O)N)Cc6c[nH]c(c67)cccc7
1402	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB05072	investigational	AV608	 
1403	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB05418	investigational	GW 597599	 
1404	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB05421	investigational	CP-122721	COc1ccc(OC(F)(F)F)cc1CN[C@H]2CCCN[C@H]2c3ccccc3
1405	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB05466	investigational	R673	 
1406	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB05790	investigational	SR 140333	CC(C)Oc1cccc(c1)CC(=O)N(CCC2)C[C@@]2(c3cc(Cl)c(Cl)cc3)CC[N+]45CCC(CC4)(CC5)c6ccccc6
1407	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
1408	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB09048	approved; investigational	Netupitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)C(C)(C)C(=O)N(C)c2cnc(N3CCN(C)CC3)cc2-c4ccccc4C
1409	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB09291	approved; investigational	Rolapitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)OC[C@](CC2)(c3ccccc3)NC[C@@]24CCC(=O)N4
1410	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB11949	investigational	Vestipitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CCNC[C@@H]2c3ccc(F)cc3C
1411	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB12436	investigational	Vofopitant	FC(F)(F)c1nnnn1-c2ccc(OC)c(c2)CN[C@H]3CCCN[C@H]3c4ccccc4
1412	sp|P07550|ADRB2_HU	P25103	83.05	14.0	357.0	DB14019	approved	Fosnetupitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)C(C)(C)C(=O)N(C)c2cnc(N(CC3)CC[N+]3(C)COP([O-])(=O)O)cc2-c4ccccc4C
1413	sp|P07550|ADRB2_HU	Q969F8	81.11	15.0	350.0	DB05967	investigational	ANZ-100	 
1414	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB00201	approved	Caffeine	Cn1cnc(c12)n(C)c(=O)n(c2=O)C
1415	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB00277	approved	Theophylline	[nH]1cnc(c12)n(C)c(=O)n(C)c2=O
1416	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB00358	approved; investigational	Mefloquine	C1CCCNC1C(O)c2cc(C(F)(F)F)nc(c23)c(C(F)(F)F)ccc3
1417	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB00555	approved; investigational	Lamotrigine	Nc1nc(N)c(nn1)-c2c(Cl)c(Cl)ccc2
1418	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB00640	approved; investigational	Adenosine	n1cnc(N)c(c12)ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
1419	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB00651	approved	Dyphylline	O=c1n(C)c(=O)n(C)c(c12)ncn2CC(O)CO
1420	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB00806	approved; investigational	Pentoxifylline	Cn1cnc(c12)n(C)c(=O)n(c2=O)CCCCC(=O)C
1421	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB00824	approved; experimental	Enprofylline	[nH]1cnc(c12)n(CCC)c(=O)[nH]c2=O
1422	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB01303	approved	Oxtriphylline	[n-]1cnc(c12)n(C)c(=O)n(C)c2=O
1423	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB01412	investigational	Theobromine	Cn1cnc(c12)n(C)c(=O)[nH]c2=O
1424	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB04853	investigational	Binodenoson	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)nc(n3)N/N=C/C4CCCCC4
1426	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB05009	investigational	Apadenoson	CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)nc(n3)C#CC[C@H]4CC[C@@H](CC4)C(=O)OC
1427	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB05191	investigational	Atl146e	 
1428	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB06213	approved; investigational	Regadenoson	CNC(=O)c1cn(nc1)-c(nc2N)nc(c23)n(cn3)[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O
1429	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB08770	experimental	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	c1ccoc1-c(n2)nc(n23)nc(nc3N)NCCc4ccc(O)cc4
1430	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB09273	experimental	Doxofylline	O=c1n(C)c(=O)n(C)c(c12)ncn2CC3OCCO3
1431	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB11757	approved; investigational	Istradefylline	COc1ccc(cc1OC)/C=C/c(n2C)nc(c23)n(CC)c(=O)n(c3=O)CC
1432	sp|P07550|ADRB2_HU	P29274	71.67	12.0	308.0	DB14132	experimental	8-chlorotheophylline	[nH]1c(Cl)nc(c12)n(C)c(=O)n(C)c2=O
1433	sp|P07550|ADRB2_HU	P47901	82.08	29.0	368.0	DB00035	approved	Desmopressin	NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CCSSC[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)C(=O)N4CCC[C@H]4C(=O)N[C@@H](C(=O)NCC(=O)N)CCCNC(N)=N
1434	sp|P07550|ADRB2_HU	P47901	82.08	29.0	368.0	DB00067	approved	Vasopressin	 
1435	sp|P07550|ADRB2_HU	P47901	82.08	29.0	368.0	DB02638	approved; investigational	Terlipressin	NCCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@H](C(=O)N2)CC(=O)N
1436	sp|P07550|ADRB2_HU	P47901	82.08	29.0	368.0	DB05452	investigational	PH-284	 
1437	sp|P07550|ADRB2_HU	P47901	82.08	29.0	368.0	DB05455	investigational	SR 121463	 
1438	sp|P07550|ADRB2_HU	P47901	82.08	29.0	368.0	DB09059	approved; investigational	Atosiban	CCOc1ccc(cc1)C[C@@H]2C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CSSCCC(=O)N2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N
1439	sp|P07550|ADRB2_HU	P47901	82.08	29.0	368.0	DB14642	approved	Lypressin	NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)CSSC[C@H](NC1=O)C(=O)N4CCC[C@H]4C(=O)NC(CCCCN)C(=O)NCC(=O)N
1440	sp|P07550|ADRB2_HU	P29371	79.66	72.0	401.0	DB04872	investigational	Osanetant	c1ccccc1C2(N(C)C(=O)C)CCN(CC2)CCC[C@]3(c4cc(Cl)c(Cl)cc4)CCCN(C3)C(=O)c5ccccc5
1441	sp|P07550|ADRB2_HU	P29371	79.66	72.0	401.0	DB06429	investigational	Talnetant	c1ccccc1C(CC)NC(=O)c2c(O)c(nc(c23)cccc3)-c4ccccc4
1442	sp|P07550|ADRB2_HU	P29371	79.66	72.0	401.0	DB11692	investigational	Pavinetant	c1ccccc1[C@H](CC)NC(=O)c2c(NS(=O)(=O)C)c(nc(c23)cccc3)-c4ccccc4
1443	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB00177	approved; investigational	Valsartan	CCCCC(=O)N([C@@H](C(C)C)C(=O)O)Cc1ccc(cc1)-c2ccccc2-c3n[nH]nn3
1444	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB00275	approved; investigational	Olmesartan	CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc2ccc(cc2)-c3c(cccc3)-c4nnn[nH]4
1445	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB00678	approved	Losartan	CCCCc1nc(Cl)c(CO)n1Cc2ccc(cc2)-c3ccccc3-c4n[nH]nn4
1446	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB00796	approved	Candesartan cilexetil	C1CCCCC1OC(=O)OC(C)OC(=O)c2cccc(c23)nc(OCC)n3Cc4ccc(cc4)-c5ccccc5-c6nnn[nH]6
1447	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB00876	approved	Eprosartan	O=C(O)c1ccc(cc1)Cn2c(cnc2CCCC)/C=C(/C(=O)O)Cc3cccs3
1448	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB00966	approved; investigational	Telmisartan	c1cccc(c12)nc(n2C)-c(c3)cc(C)c(c34)nc(CCC)n4Cc5ccc(cc5)-c6ccccc6C(=O)O
1449	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB01029	approved; investigational	Irbesartan	C1CCCC12N=C(CCCC)N(C2=O)Cc3ccc(cc3)-c4ccccc4-c5n[nH]nn5
1450	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB01342	experimental	Forasartan	CCCCc1nn(c(n1)CCCC)Cc2cnc(cc2)-c3ccccc3-c4n[nH]nn4
1451	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB01347	experimental	Saprisartan	CCc1nc(C2CC2)c(C(=O)N)n1Cc(cc3)cc(c34)c(Br)c(o4)-c5ccccc5NS(=O)(=O)C(F)(F)F
1452	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB01349	experimental	Tasosartan	Cc(n1)nc(C)c(c12)CCC(=O)N2Cc3ccc(cc3)-c4ccccc4-c5n[nH]nn5
1454	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB08822	approved; investigational	Azilsartan medoxomil	O=c1oc(c(o1)C)COC(=O)c2cccc(c23)nc(OCC)n3Cc4ccc(cc4)-c5ccccc5-c6noc(=O)[nH]6
1455	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB09279	investigational	Fimasartan	CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc2ccc(cc2)-c3c(cccc3)-c4nnn[nH]4
1456	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB11842	approved; investigational	Angiotensin II	NC(N)=NCCC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)O)Cc4ccccc4
1457	sp|P07550|ADRB2_HU	P30556	80.87	21.0	355.0	DB13919	experimental	Candesartan	O=C(O)c1cccc(c12)nc(OCC)n2Cc3ccc(cc3)-c4ccccc4-c5nnn[nH]5
1458	sp|P07550|ADRB2_HU	P30518	82.81	18.0	360.0	DB00035	approved	Desmopressin	NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CCSSC[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)C(=O)N4CCC[C@H]4C(=O)N[C@@H](C(=O)NCC(=O)N)CCCNC(N)=N
1459	sp|P07550|ADRB2_HU	P30518	82.81	18.0	360.0	DB00067	approved	Vasopressin	 
1460	sp|P07550|ADRB2_HU	P30518	82.81	18.0	360.0	DB00618	approved	Demeclocycline	NC(=O)C(C1=O)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@H]3O)c(Cl)ccc4O
1461	sp|P07550|ADRB2_HU	P30518	82.81	18.0	360.0	DB00872	approved; investigational	Conivaptan	Cc([nH]1)nc(c12)c3c(cccc3)N(CC2)C(=O)c4ccc(cc4)NC(=O)c5ccccc5-c6ccccc6
1462	sp|P07550|ADRB2_HU	P30518	82.81	18.0	360.0	DB02638	approved; investigational	Terlipressin	NCCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@H](C(=O)N2)CC(=O)N
1463	sp|P07550|ADRB2_HU	P30518	82.81	18.0	360.0	DB05091	investigational	M0002	 
1464	sp|P07550|ADRB2_HU	P30518	82.81	18.0	360.0	DB05838	investigational	OPC-51803	CC(C)NC(=O)C[C@H]1CCCN(c(c12)cccc2)C(=O)c3c(Cl)cc(cc3)N4CCCC4
1465	sp|P07550|ADRB2_HU	P30518	82.81	18.0	360.0	DB06212	approved	Tolvaptan	Cc1ccccc1C(=O)Nc2cc(C)c(cc2)C(=O)N3CCC[C@@H](O)c(c34)cc(Cl)cc4
1466	sp|P07550|ADRB2_HU	P30518	82.81	18.0	360.0	DB09059	approved; investigational	Atosiban	CCOc1ccc(cc1)C[C@@H]2C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CSSCCC(=O)N2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N
1467	sp|P07550|ADRB2_HU	P30518	82.81	18.0	360.0	DB14642	approved	Lypressin	NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)CSSC[C@H](NC1=O)C(=O)N4CCC[C@H]4C(=O)NC(CCCCN)C(=O)NCC(=O)N
1468	sp|P07550|ADRB2_HU	Q99677	80.39	13.0	345.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
1469	sp|P07550|ADRB2_HU	P34981	79.18	22.0	349.0	DB09421	approved; investigational	Protirelin	O=C1N[C@@H](CC1)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N3CCC[C@H]3C(=O)N
1470	sp|P07550|ADRB2_HU	P25929	80.15	37.0	368.0	DB05004	investigational	Peptide YY (3-36)	 
1471	sp|P07550|ADRB2_HU	Q9H3N8	92.98	2.0	386.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
1472	sp|P07550|ADRB2_HU	Q9H3N8	92.98	2.0	386.0	DB00363	approved	Clozapine	CN1CCN(CC1)C2=Nc(cc(Cl)cc3)c3Nc(c24)cccc4
1473	sp|P07550|ADRB2_HU	Q9H3N8	92.98	2.0	386.0	DB00408	approved	Loxapine	CN1CCN(CC1)C2=Nc(cccc3)c3Oc(c24)ccc(Cl)c4
1474	sp|P07550|ADRB2_HU	Q9H3N8	92.98	2.0	386.0	DB00477	approved; investigational; vet_approved	Chlorpromazine	CN(C)CCCN1c(cccc2)c2Sc(c13)ccc(Cl)c3
1475	sp|P07550|ADRB2_HU	Q9H3N8	92.98	2.0	386.0	DB00543	approved	Amoxapine	C1CNCCN1C(c(c23)cc(Cl)cc2)=Nc4c(O3)cccc4
1476	sp|P07550|ADRB2_HU	Q9H3N8	92.98	2.0	386.0	DB01142	approved; investigational	Doxepin	CN(C)CC/C=C\1c(cccc2)c2COc(c13)cccc3
1477	sp|P07550|ADRB2_HU	Q9H3N8	92.98	2.0	386.0	DB01238	approved; investigational	Aripiprazole	Clc1cccc(c1Cl)N2CCN(CC2)CCCCOc(cc3)cc(c34)NC(=O)CC4
1478	sp|P07550|ADRB2_HU	Q9H3N8	92.98	2.0	386.0	DB01620	approved	Pheniramine	c1cccnc1C(CCN(C)C)c2ccccc2
1479	sp|P07550|ADRB2_HU	Q9H3N8	92.98	2.0	386.0	DB05032	investigational	REV131	 
1480	sp|P07550|ADRB2_HU	Q9H3N8	92.98	2.0	386.0	DB05381	approved; investigational	Histamine	NCCc1c[nH]cn1
1481	sp|P07550|ADRB2_HU	Q9H3N8	92.98	2.0	386.0	DB06148	approved; investigational	Mianserin	CN(C1)CCN(C12)c3c(cccc3)Cc4c2cccc4
1482	sp|P07550|ADRB2_HU	P29275	73.12	8.0	310.0	DB00201	approved	Caffeine	Cn1cnc(c12)n(C)c(=O)n(c2=O)C
1483	sp|P07550|ADRB2_HU	P29275	73.12	8.0	310.0	DB00277	approved	Theophylline	[nH]1cnc(c12)n(C)c(=O)n(C)c2=O
1484	sp|P07550|ADRB2_HU	P29275	73.12	8.0	310.0	DB00640	approved; investigational	Adenosine	n1cnc(N)c(c12)ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
1485	sp|P07550|ADRB2_HU	P29275	73.12	8.0	310.0	DB00824	approved; experimental	Enprofylline	[nH]1cnc(c12)n(CCC)c(=O)[nH]c2=O
1487	sp|P07550|ADRB2_HU	P29275	73.12	8.0	310.0	DB05936	investigational	CVT-6883	CCCn(c1=O)c(=O)n(CC)c(c12)nc([nH]2)-c3cn(nc3)Cc4cccc(c4)C(F)(F)F
1488	sp|P07550|ADRB2_HU	P49146	73.61	48.0	352.0	DB00847	approved; investigational	Cysteamine	NCCS
1489	sp|P07550|ADRB2_HU	P49146	73.61	48.0	352.0	DB05004	investigational	Peptide YY (3-36)	 
1490	sp|P07550|ADRB2_HU	P49146	73.61	48.0	352.0	DB05045	investigational	Obinepitide	Oc1ccc(cc1)C[C@@H](C(O)=N)/N=C(\O)[C@H](CCCNC(N)=N)/N=C(\O)[C@H](CCC(O)=N)/N=C(\O)[C@H](CCCNC(N)=N)/N=C(\O)[C@H]([C@@H](C)O)/N=C(\O)[C@H](CC(C)C)/N=C(\O)[C@H](CCSC)/N=C(\O)[C@H](CC(O)=N)/N=C(\O)[C@H]([C@@H](C)CC)/N=C(\O)[C@H](Cc2ccc(O)cc2)/N=C(\O)[C@H](CCCNC(N)=N)/N=C(\O)[C@H](CCCNC(N)=N)/N=C(\O)[C@H](CC(C)C)/N=C(\O)[C@H](CC(=O)O)/N=C(\O)[C@H](C)/N=C(\O)[C@H](C)/N=C(\O)[C@H](Cc3ccc(O)cc3)/N=C(\O)[C@H](CCC(O)=N)/N=C(\O)[C@H](C)/N=C(\O)[C@H](CCSC)/N=C(\O)[C@H](CCC(O)=N)/N=C(\O)[C@H](CCC(=O)O)/N=C(\O)[C@@H]4CCCN4C(=O)[C@H]([C@@H](C)O)/N=C(\O)[C@H](C)/N=C(\O)[C@H](CC(O)=N)/N=C(\O)[C@H](CC(=O)O)/N=C(\O)C/N=C(\O)[C@@H]5CCCN5C(=O)[C@H](Cc6ccc(O)cc6)/N=C(\O)[C@H](C(C)C)/N=C(\O)[C@@H]7CCCN7C(=O)[C@H](CCC(=O)O)/N=C(\O)[C@H](CC(C)C)/N=C(\O)[C@@H]8CCCN8C(=O)[C@H](C)N
1491	sp|P07550|ADRB2_HU	P30411	80.39	57.0	389.0	DB05038	investigational	Anatibant	Cc(n1)cc(C)c(c12)cccc2OCc3c(Cl)ccc(c3Cl)S(=O)(=O)N4CCC[C@H]4C(=O)NCCCNC(=O)c5ccc(cc5)C(N)=N
1492	sp|P07550|ADRB2_HU	P30411	80.39	57.0	389.0	DB06196	approved; investigational	Icatibant	NC(=N)NCCC[C@@H](C(=O)O)NC(=O)[C@H](C[C@@H]([C@@H]12)CCCC2)N1C(=O)[C@@H](Cc(c34)cccc4)N(C3)C(=O)[C@H](CO)NC(=O)[C@H](Cc5cccs5)NC(=O)CNC(=O)[C@@H]6C[C@@H](O)CN6C(=O)[C@@H]7CCCN7C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](N)CCCNC(N)=N
1493	sp|P07550|ADRB2_HU	P30411	80.39	57.0	389.0	DB06549	investigational	Labradimil	NC(N)=NCCC[C@@H](C(=O)O)NC[C@H](Cc1ccc(cc1)OC)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc3cccs3)NC(=O)CNC(=O)[C@@H]4C[C@@H](O)CN4C(=O)[C@@H]5CCCN5C(=O)[C@@H](N)CCCN=C(N)N
1494	sp|P07550|ADRB2_HU	P50052	79.66	27.0	356.0	DB01349	experimental	Tasosartan	Cc(n1)nc(C)c(c12)CCC(=O)N2Cc3ccc(cc3)-c4ccccc4-c5n[nH]nn5
1496	sp|P07550|ADRB2_HU	Q92847	77.24	44.0	363.0	DB12128	investigational	Ulimorelin	c1cccc(c12)CCCNC(=O)[C@@H](Cc3ccc(F)cc3)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C4CC4)NC[C@H](O2)C
1497	sp|P07550|ADRB2_HU	Q92847	77.24	44.0	363.0	DB13074	approved; investigational	Macimorelin	c1cccc(c12)[nH]cc2C[C@@H](NC(=O)C(C)(C)N)C(=O)N[C@@H](NC=O)Cc3c[nH]c(c34)cccc4
1498	sp|P07550|ADRB2_HU	Q92847	77.24	44.0	363.0	DB15488	experimental	Echinacoside	Oc1ccc(cc1O)CCO[C@H]2[C@H](O)[C@@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H]([C@H](O2)CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)OC(=O)/C=C/c5cc(O)c(O)cc5
1499	sp|P07550|ADRB2_HU	Q9Y271	72.64	11.0	311.0	DB00471	approved	Montelukast	OC(C)(C)c1ccccc1CC[C@@H](SCC2(CC2)CC(=O)O)c3cccc(c3)/C=C/c(cc4)nc(c45)cc(Cl)cc5
1500	sp|P07550|ADRB2_HU	Q9Y271	72.64	11.0	311.0	DB00549	approved; investigational	Zafirlukast	Cc1ccccc1S(=O)(=O)NC(=O)c2cc(OC)c(cc2)Cc3cn(C)c(c34)ccc(c4)NC(=O)OC5CCCC5
1501	sp|P07550|ADRB2_HU	Q9Y271	72.64	11.0	311.0	DB00587	experimental	Cinalukast	CCC(CC)(C(=O)O)CC(=O)Nc1cc(ccc1)/C=C/c2nc(cs2)C3CCC3
1502	sp|P07550|ADRB2_HU	Q9Y271	72.64	11.0	311.0	DB00716	approved; investigational	Nedocromil	O=C(O)c(o1)cc(=O)c(c12)cc3c(c2CCC)n(CC)c(cc3=O)C(=O)O
1503	sp|P07550|ADRB2_HU	Q9Y271	72.64	11.0	311.0	DB01411	investigational	Pranlukast	n1[nH]nnc1-c(cc2=O)oc(c23)c(ccc3)NC(=O)c4ccc(cc4)OCCCCc5ccccc5
1504	sp|P07550|ADRB2_HU	Q9Y271	72.64	11.0	311.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
1505	sp|P07550|ADRB2_HU	Q9Y271	72.64	11.0	311.0	DB11858	investigational	Leukotriene D4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@H](N)C(=O)NCC(=O)O
1506	sp|P07550|ADRB2_HU	P51582	72.88	30.0	331.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
1507	sp|P07550|ADRB2_HU	Q9NS75	75.3	13.0	324.0	DB00716	approved; investigational	Nedocromil	O=C(O)c(o1)cc(=O)c(c12)cc3c(c2CCC)n(CC)c(cc3=O)C(=O)O
1508	sp|P07550|ADRB2_HU	Q9NS75	75.3	13.0	324.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
1509	sp|P07550|ADRB2_HU	Q9NS75	75.3	13.0	324.0	DB11858	investigational	Leukotriene D4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@H](N)C(=O)NCC(=O)O
1510	sp|P07550|ADRB2_HU	P49286	74.82	33.0	342.0	DB00980	approved; investigational	Ramelteon	CCC(=O)NCC[C@@H]1CCc(c12)ccc3c2CCO3
1511	sp|P07550|ADRB2_HU	P49286	74.82	33.0	342.0	DB01065	approved; nutraceutical; vet_approved	Melatonin	COc(cc1)cc(c12)c(c[nH]2)CCNC(=O)C
1512	sp|P07550|ADRB2_HU	P49286	74.82	33.0	342.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
1513	sp|P07550|ADRB2_HU	P49286	74.82	33.0	342.0	DB06594	approved; investigational	Agomelatine	COc(cc1)cc(c12)c(ccc2)CCNC(=O)C
1514	sp|P07550|ADRB2_HU	P49286	74.82	33.0	342.0	DB09071	approved; investigational	Tasimelteon	CCC(=O)NC[C@@H]1C[C@H]1c2cccc(c23)OCC3
1515	sp|P07550|ADRB2_HU	Q99705	75.54	106.0	418.0	DB00502	approved	Haloperidol	Clc1ccc(cc1)C2(O)CCN(CC2)CCCC(=O)c3ccc(F)cc3
1516	sp|P07550|ADRB2_HU	P48039	70.46	22.0	313.0	DB00980	approved; investigational	Ramelteon	CCC(=O)NCC[C@@H]1CCc(c12)ccc3c2CCO3
1517	sp|P07550|ADRB2_HU	P48039	70.46	22.0	313.0	DB01065	approved; nutraceutical; vet_approved	Melatonin	COc(cc1)cc(c12)c(c[nH]2)CCNC(=O)C
1518	sp|P07550|ADRB2_HU	P48039	70.46	22.0	313.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
1519	sp|P07550|ADRB2_HU	P48039	70.46	22.0	313.0	DB06594	approved; investigational	Agomelatine	COc(cc1)cc(c12)c(ccc2)CCNC(=O)C
1520	sp|P07550|ADRB2_HU	P48039	70.46	22.0	313.0	DB09071	approved; investigational	Tasimelteon	CCC(=O)NC[C@@H]1C[C@H]1c2cccc(c23)OCC3
1521	sp|P07550|ADRB2_HU	P47900	78.21	31.0	354.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
1522	sp|P07550|ADRB2_HU	Q99500	77.0	40.0	358.0	DB08868	approved; investigational	Fingolimod	CCCCCCCCc1ccc(cc1)CCC(N)(CO)CO
1523	sp|P07550|ADRB2_HU	P51681	71.91	24.0	321.0	DB04835	approved; investigational	Maraviroc	CC(C)c1nnc(C)n1[C@@H](C[C@H]23)C[C@@H](CC2)N3CC[C@H](NC(=O)C(CC4)CCC4(F)F)c5ccccc5
1524	sp|P07550|ADRB2_HU	P51681	71.91	24.0	321.0	DB05501	investigational	AMD-070	n1cccc(c12)CCC[C@@H]2N(CCCCN)Cc([nH]3)nc(c34)cccc4
1527	sp|P07550|ADRB2_HU	P51681	71.91	24.0	321.0	DB06497	investigational	Aplaviroc	C1CCCCC1[C@@H](O)[C@@H](NC2=O)C(=O)N(CCCC)C23CCN(CC3)Cc4ccc(cc4)Oc5ccc(cc5)C(=O)O
1528	sp|P07550|ADRB2_HU	P51681	71.91	24.0	321.0	DB06652	investigational	Vicriviroc	FC(F)(F)c1ccc(cc1)[C@H](COC)N2CCN(C[C@@H]2C)C3(C)CCN(CC3)C(=O)c4c(C)ncnc4C
1530	sp|P07550|ADRB2_HU	P51681	71.91	24.0	321.0	DB12960	investigational	INCB-9471	FC(F)(F)c(cc1)cc(c12)C[C@@H](OCC)[C@@H]2N3CCN(C[C@@H]3C)C4(C)CCN(CC4)C(=O)c5c(C)ncnc5C
1531	sp|P07550|ADRB2_HU	P43657	70.7	11.0	303.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
1532	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB00559	approved; investigational	Bosentan	COc1ccccc1Oc2c(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)nc(-c4ncccn4)nc2OCCO
1533	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
1534	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB04674	experimental	2-HYDROXY-3,5-DIIODOBENZOIC ACID	OC(=O)c1c(O)c(I)cc(I)c1
1535	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB04883	investigational	Darusentan	COc1cc(OC)nc(n1)O[C@H](C(=O)O)C(OC)(c2ccccc2)c3ccccc3
1536	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB05290	investigational	SPP 301	 
1537	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB05367	investigational	Actelion-1	 
1538	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB06199	investigational	Atrasentan	CCCCN(CCCC)C(=O)CN1C[C@H](c(cc2)cc(c23)OCO3)[C@@H](C(=O)O)[C@@H]1c4ccc(OC)cc4
1539	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB06268	approved; investigational; withdrawn	Sitaxentan	Cc1noc(c1Cl)NS(=O)(=O)c2c(scc2)C(=O)Cc(c(C)c3)cc(c34)OCO4
1540	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB06403	approved; investigational	Ambrisentan	c1ccccc1C(OC)(c2ccccc2)[C@@H](C(=O)O)Oc3nc(C)cc(n3)C
1541	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB06460	investigational	Enrasentan	CCCOc(c1)ccc(c12)[C@H](c(c3)ccc(c34)OCO4)[C@@H](C(=O)O)[C@@H]2c5ccc(OC)cc5OCCO
1542	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB06558	investigational	Tezosentan	COc1ccccc1Oc2c(NS(=O)(=O)c3ncc(cc3)C(C)C)nc(nc2OCCO)-c4cc(ncc4)-c5n[nH]nn5
1543	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB06677	investigational	Clazosentan	COc1ccccc1Oc2c(NS(=O)(=O)c3ccc(C)cn3)nc(nc2OCCO)-c4ccnc(c4)-c5nnn[nH]5
1544	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB08932	approved	Macitentan	CCCNS(=O)(=O)Nc1c(-c2ccc(Br)cc2)c(ncn1)OCCOc3ncc(Br)cn3
1545	sp|P07550|ADRB2_HU	P25101	88.86	55.0	422.0	DB12548	investigational	Sparsentan	C1CCCC12N=C(CCCC)N(C2=O)Cc3ccc(c(c3)COCC)-c4ccccc4S(=O)(=O)Nc5noc(C)c5C
1546	sp|P07550|ADRB2_HU	P24530	81.36	85.0	421.0	DB00559	approved; investigational	Bosentan	COc1ccccc1Oc2c(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)nc(-c4ncccn4)nc2OCCO
1547	sp|P07550|ADRB2_HU	P24530	81.36	85.0	421.0	DB06138	investigational	IRL-1620	 
1548	sp|P07550|ADRB2_HU	P24530	81.36	85.0	421.0	DB06268	approved; investigational; withdrawn	Sitaxentan	Cc1noc(c1Cl)NS(=O)(=O)c2c(scc2)C(=O)Cc(c(C)c3)cc(c34)OCO4
1549	sp|P07550|ADRB2_HU	P24530	81.36	85.0	421.0	DB06403	approved; investigational	Ambrisentan	c1ccccc1C(OC)(c2ccccc2)[C@@H](C(=O)O)Oc3nc(C)cc(n3)C
1550	sp|P07550|ADRB2_HU	P24530	81.36	85.0	421.0	DB06460	investigational	Enrasentan	CCCOc(c1)ccc(c12)[C@H](c(c3)ccc(c34)OCO4)[C@@H](C(=O)O)[C@@H]2c5ccc(OC)cc5OCCO
1551	sp|P07550|ADRB2_HU	P24530	81.36	85.0	421.0	DB06558	investigational	Tezosentan	COc1ccccc1Oc2c(NS(=O)(=O)c3ncc(cc3)C(C)C)nc(nc2OCCO)-c4cc(ncc4)-c5n[nH]nn5
1552	sp|P07550|ADRB2_HU	P24530	81.36	85.0	421.0	DB08932	approved	Macitentan	CCCNS(=O)(=O)Nc1c(-c2ccc(Br)cc2)c(ncn1)OCCOc3ncc(Br)cn3
1553	sp|P07550|ADRB2_HU	P50391	75.79	37.0	350.0	DB05004	investigational	Peptide YY (3-36)	 
1554	sp|P07550|ADRB2_HU	P50391	75.79	37.0	350.0	DB05045	investigational	Obinepitide	Oc1ccc(cc1)C[C@@H](C(O)=N)/N=C(\O)[C@H](CCCNC(N)=N)/N=C(\O)[C@H](CCC(O)=N)/N=C(\O)[C@H](CCCNC(N)=N)/N=C(\O)[C@H]([C@@H](C)O)/N=C(\O)[C@H](CC(C)C)/N=C(\O)[C@H](CCSC)/N=C(\O)[C@H](CC(O)=N)/N=C(\O)[C@H]([C@@H](C)CC)/N=C(\O)[C@H](Cc2ccc(O)cc2)/N=C(\O)[C@H](CCCNC(N)=N)/N=C(\O)[C@H](CCCNC(N)=N)/N=C(\O)[C@H](CC(C)C)/N=C(\O)[C@H](CC(=O)O)/N=C(\O)[C@H](C)/N=C(\O)[C@H](C)/N=C(\O)[C@H](Cc3ccc(O)cc3)/N=C(\O)[C@H](CCC(O)=N)/N=C(\O)[C@H](C)/N=C(\O)[C@H](CCSC)/N=C(\O)[C@H](CCC(O)=N)/N=C(\O)[C@H](CCC(=O)O)/N=C(\O)[C@@H]4CCCN4C(=O)[C@H]([C@@H](C)O)/N=C(\O)[C@H](C)/N=C(\O)[C@H](CC(O)=N)/N=C(\O)[C@H](CC(=O)O)/N=C(\O)C/N=C(\O)[C@@H]5CCCN5C(=O)[C@H](Cc6ccc(O)cc6)/N=C(\O)[C@H](C(C)C)/N=C(\O)[C@@H]7CCCN7C(=O)[C@H](CCC(=O)O)/N=C(\O)[C@H](CC(C)C)/N=C(\O)[C@@H]8CCCN8C(=O)[C@H](C)N
1555	sp|P07550|ADRB2_HU	P50391	75.79	37.0	350.0	DB05085	investigational	TM30339	 
1556	sp|P07550|ADRB2_HU	Q86VZ1	78.69	4.0	329.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
1557	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB00193	approved; investigational	Tramadol	COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C
1558	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB00201	approved	Caffeine	Cn1cnc(c12)n(C)c(=O)n(c2=O)C
1559	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB00277	approved	Theophylline	[nH]1cnc(c12)n(C)c(=O)n(C)c2=O
1560	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB00555	approved; investigational	Lamotrigine	Nc1nc(N)c(nn1)-c2c(Cl)c(Cl)ccc2
1561	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB00640	approved; investigational	Adenosine	n1cnc(N)c(c12)ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
1562	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB00651	approved	Dyphylline	O=c1n(C)c(=O)n(C)c(c12)ncn2CC(O)CO
1563	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB00806	approved; investigational	Pentoxifylline	Cn1cnc(c12)n(C)c(=O)n(c2=O)CCCCC(=O)C
1564	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB00824	approved; experimental	Enprofylline	[nH]1cnc(c12)n(CCC)c(=O)[nH]c2=O
1565	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB00996	approved; investigational	Gabapentin	OC(=O)CC1(CN)CCCCC1
1566	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB01223	approved	Aminophylline	[nH]1cnc(c12)n(C)c(=O)n(C)c2=O
1567	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB01303	approved	Oxtriphylline	[n-]1cnc(c12)n(C)c(=O)n(C)c2=O
1568	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB01412	investigational	Theobromine	Cn1cnc(c12)n(C)c(=O)[nH]c2=O
1570	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB04954	investigational	Tecadenoson	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(ncn3)N[C@@H]4CCOC4
1571	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB06471	investigational	Naxifylline	[C@@H]12[C@@H](O1)[C@H]3C[C@@H]2C[C@@H]3c([nH]4)nc(c45)C(=O)C(CCC)C(=O)N5CCC
1572	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
1573	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB11757	approved; investigational	Istradefylline	COc1ccc(cc1OC)/C=C/c(n2C)nc(c23)n(CC)c(=O)n(c3=O)CC
1574	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB12569	investigational	Tonapofylline	CCCn(c1=O)c(=O)n(CCC)c(c12)nc([nH]2)C34CCC(CC3)(CC4)CCC(=O)O
1575	sp|P07550|ADRB2_HU	P30542	70.7	16.0	308.0	DB12670	investigational	Rolofylline	CCCn(c1=O)c(=O)n(CCC)c(c12)nc([nH]2)C34C5C[C@@H](C3)C[C@H](C5)C4
1577	sp|P07550|ADRB2_HU	P25116	78.21	101.0	424.0	DB05361	investigational	SR-123781A	 
1578	sp|P07550|ADRB2_HU	P25116	78.21	101.0	424.0	DB09030	approved	Vorapaxar	CCOC(=O)N[C@@H](C1)CC[C@H]([C@@H]12)[C@@H]([C@H]3[C@@H](C2)C(=O)O[C@@H]3C)/C=C/c4ccc(cn4)-c5cc(F)ccc5
1580	sp|P07550|ADRB2_HU	P46663	76.51	21.0	337.0	DB00178	approved	Ramipril	C1CC[C@H]([C@H]12)C[C@@H](C(=O)O)N2C(=O)[C@H](C)N[C@H](C(=O)OCC)CCc3ccccc3
1581	sp|P07550|ADRB2_HU	P46663	76.51	21.0	337.0	DB01197	approved	Captopril	SC[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
1582	sp|P07550|ADRB2_HU	P46663	76.51	21.0	337.0	DB01593	approved; investigational	Zinc	[Zn]
1583	sp|P07550|ADRB2_HU	P46663	76.51	21.0	337.0	DB09477	approved	Enalaprilat	OC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N[C@H](C(=O)O)CCc2ccccc2
1584	sp|P07550|ADRB2_HU	P46663	76.51	21.0	337.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
1585	sp|P07550|ADRB2_HU	P46663	76.51	21.0	337.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
1586	sp|P07550|ADRB2_HU	P46663	76.51	21.0	337.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
1587	sp|P07550|ADRB2_HU	P21453	78.93	41.0	367.0	DB08868	approved; investigational	Fingolimod	CCCCCCCCc1ccc(cc1)CCC(N)(CO)CO
1589	sp|P07550|ADRB2_HU	P21453	78.93	41.0	367.0	DB12371	approved; investigational	Siponimod	OC(=O)C1CN(C1)Cc2ccc(cc2CC)/C(C)=N/OCc3ccc(c(c3)C(F)(F)F)C4CCCCC4
1590	sp|P07550|ADRB2_HU	P21453	78.93	41.0	367.0	DB12612	approved; investigational	Ozanimod	CC(C)Oc1c(C#N)cc(cc1)-c2nc(no2)-c(ccc3)c(c34)CC[C@@H]4NCCO
1591	sp|P07550|ADRB2_HU	Q9H244	78.93	5.0	331.0	DB00208	approved	Ticlopidine	Clc1ccccc1CN(C2)CCc(c23)scc3
1592	sp|P07550|ADRB2_HU	Q9H244	78.93	5.0	331.0	DB00374	approved; investigational	Treprostinil	OC(=O)COc1cccc(c12)C[C@H]3[C@@H](C2)C[C@@H](O)[C@@H]3CC[C@@H](O)CCCCC
1593	sp|P07550|ADRB2_HU	Q9H244	78.93	5.0	331.0	DB00758	approved	Clopidogrel	c1csc(c12)CCN(C2)[C@H](C(=O)OC)c3ccccc3Cl
1594	sp|P07550|ADRB2_HU	Q9H244	78.93	5.0	331.0	DB01240	approved	Epoprostenol	OC(=O)CCC/C=C(C1)\O[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)CCCCC
1595	sp|P07550|ADRB2_HU	Q9H244	78.93	5.0	331.0	DB05553	investigational	Regrelor	c1ccccc1/C=C/[C@H](O2)O[C@@H]([C@@H]23)[C@@H](COP(=O)(O)O)O[C@H]3n4cnc(c45)c(ncn5)NC(=O)NCC
1596	sp|P07550|ADRB2_HU	Q9H244	78.93	5.0	331.0	DB06209	approved	Prasugrel	CC(=O)Oc(s1)cc(c12)CN(CC2)C(C(=O)C3CC3)c4ccccc4F
1597	sp|P07550|ADRB2_HU	Q9H244	78.93	5.0	331.0	DB06350	investigational	Elinogrel	CNc(c1)c(F)cc(c12)c(=O)n(c(=O)[nH]2)-c3ccc(cc3)NC(=O)NS(=O)(=O)c4ccc(Cl)s4
1598	sp|P07550|ADRB2_HU	Q9H244	78.93	5.0	331.0	DB06441	approved	Cangrelor	FC(F)(F)CCSc(n1)nc(NCCSC)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O
1599	sp|P07550|ADRB2_HU	Q9H244	78.93	5.0	331.0	DB08816	approved	Ticagrelor	Fc1ccc(cc1F)[C@@H]2C[C@H]2Nc3nc(SCCC)nc(c34)n(nn4)[C@@H]5C[C@@H]([C@@H](O)[C@H]5O)OCCO
1600	sp|P07550|ADRB2_HU	Q9H244	78.93	5.0	331.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
1601	sp|P07550|ADRB2_HU	Q8TDS4	75.54	15.0	327.0	DB00257	approved; vet_approved	Clotrimazole	Clc1ccccc1C(n2ccnc2)(c3ccccc3)c4ccccc4
1602	sp|P07550|ADRB2_HU	Q8TDS4	75.54	15.0	327.0	DB00627	approved; investigational; nutraceutical	Niacin	OC(=O)c1cnccc1
1603	sp|P07550|ADRB2_HU	Q8TDS4	75.54	15.0	327.0	DB08949	approved; withdrawn	Inositol nicotinate	c1ccncc1C(=O)O[C@H]2[C@H](OC(=O)c3cccnc3)[C@@H](OC(=O)c4cccnc4)[C@H](OC(=O)c5cccnc5)[C@H](OC(=O)c6cccnc6)[C@@H]2OC(=O)c7cccnc7
1604	sp|P07550|ADRB2_HU	P49019	75.3	15.0	326.0	DB00627	approved; investigational; nutraceutical	Niacin	OC(=O)c1cnccc1
1605	sp|P07550|ADRB2_HU	P49019	75.3	15.0	326.0	DB08949	approved; withdrawn	Inositol nicotinate	c1ccncc1C(=O)O[C@H]2[C@H](OC(=O)c3cccnc3)[C@@H](OC(=O)c4cccnc4)[C@H](OC(=O)c5cccnc5)[C@H](OC(=O)c6cccnc6)[C@@H]2OC(=O)c7cccnc7
1606	sp|P07550|ADRB2_HU	Q15761	102.18	20.0	442.0	DB05004	investigational	Peptide YY (3-36)	 
1607	sp|P07550|ADRB2_HU	P51686	71.19	41.0	335.0	DB15250	investigational	Vercirnon	CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2c(cc(Cl)cc2)C(=O)c3cc[n+]([O-])cc3
1608	sp|P07550|ADRB2_HU	P25105	77.24	4.0	323.0	DB02261	experimental	Platelet Activating Factor	CCCCCCCCCCCCCCCCOC[C@@H](OC(=O)C)COP([O-])(=O)OCC[N+](C)(C)C
1609	sp|P07550|ADRB2_HU	P25105	77.24	4.0	323.0	DB09166	experimental	Etizolam	Clc1ccccc1C(c(c23)cc(s2)CC)=NCc4n3c(nn4)C
1610	sp|P07550|ADRB2_HU	P25105	77.24	4.0	323.0	DB11614	approved	Rupatadine	Cc1cc(cnc1)CN2CCC(CC2)=C3c(ccc(Cl)c4)c4CCc(c35)cccn5
1611	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB00470	approved; illicit	Dronabinol	C1CC(C)=C[C@H]([C@@H]12)c3c(OC2(C)C)cc(cc3O)CCCCC
1612	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB00486	approved; investigational	Nabilone	C1CC(=O)C[C@H]([C@@H]12)c3c(OC2(C)C)cc(cc3O)C(C)(C)CCCCCC
1613	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB02955	experimental	Ricinoleic Acid	CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)O
1614	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB05077	investigational	SLV319	 
1615	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB05201	investigational	V24343	 
1616	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB05750	investigational	AVE-1625	 
1617	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB06155	approved; investigational	Rimonabant	C1CCCCN1NC(=O)c(c(C)c2-c(cc3)ccc3Cl)nn2-c4c(Cl)cc(Cl)cc4
1618	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
1619	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB09288	experimental	Propacetamol	CCN(CC)CC(=O)Oc1ccc(cc1)NC(=O)C
1620	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB11745	investigational	Otenabant	CCNC1(C(=O)N)CCN(CC1)c(ncn2)c(c23)nc(-c4ccccc4Cl)n3-c5ccc(Cl)cc5
1621	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB11755	investigational	Tetrahydrocannabivarin	CCCc(c1)cc(O)c(c12)[C@H]3[C@H](C(O2)(C)C)CCC(=C3)C
1623	sp|P07550|ADRB2_HU	P21554	75.54	112.0	424.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
1624	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB01159	approved; vet_approved	Halothane	ClC(Br)C(F)(F)F
1625	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB01646	experimental	N-Acetylmethionine	CSCC[C@@H](C(=O)O)NC(=O)C
1626	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB01728	experimental	1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine	CCCCCCCCCCCCCCCC(=O)O[C@@H](COP(=O)(O)OCCN)COC(=O)CCCCCCCCCCCCCCC
1627	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB02451	experimental	B-nonylglucoside	CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
1628	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB02482	experimental	Phosphonothreonine	OC(=O)[C@H](N)[C@H](C)OP(=O)(O)O
1629	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB03152	experimental	B-2-Octylglucoside	O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OCCCCCCCC
1630	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB03381	experimental	Hexadecanal	CCCCCCCCCCCCCCCC=O
1631	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
1632	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB04079	experimental	Heptane-1,2,3-Triol	OC[C@@H](O)[C@H](O)CCCC
1633	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB04147	experimental	Dodecyldimethylamine N-oxide	CCCCCCCCCCCC[N+]([O-])(C)C
1634	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB04233	experimental	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	CCCCCCCCOCCOCCOCCOCCO
1635	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
1636	sp|P07550|ADRB2_HU	P08100	75.3	33.0	344.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
1637	sp|P07550|ADRB2_HU	P0DMS8	73.85	12.0	317.0	DB00201	approved	Caffeine	Cn1cnc(c12)n(C)c(=O)n(c2=O)C
1638	sp|P07550|ADRB2_HU	P0DMS8	73.85	12.0	317.0	DB00640	approved; investigational	Adenosine	n1cnc(N)c(c12)ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
1639	sp|P07550|ADRB2_HU	P0DMS8	73.85	12.0	317.0	DB00824	approved; experimental	Enprofylline	[nH]1cnc(c12)n(CCC)c(=O)[nH]c2=O
1640	sp|P07550|ADRB2_HU	P0DMS8	73.85	12.0	317.0	DB01223	approved	Aminophylline	[nH]1cnc(c12)n(C)c(=O)n(C)c2=O
1641	sp|P07550|ADRB2_HU	P0DMS8	73.85	12.0	317.0	DB05511	investigational	Piclidenoson	CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(ncn3)NCc4cc(I)ccc4
1642	sp|P07550|ADRB2_HU	P0DMS8	73.85	12.0	317.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
1643	sp|P07550|ADRB2_HU	P35408	86.44	22.0	379.0	DB00917	approved	Dinoprostone	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O
1644	sp|P07550|ADRB2_HU	P35408	86.44	22.0	379.0	DB00929	approved	Misoprostol	CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC
1645	sp|P07550|ADRB2_HU	P35408	86.44	22.0	379.0	DB09211	investigational	Limaprost	CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)O
1647	sp|P07550|ADRB2_HU	P35408	86.44	22.0	379.0	DB12836	investigational; vet_approved	Grapiprant	Cc(c1)nc(C)c(c12)nc(CC)n2-c3ccc(cc3)CCNC(=O)NS(=O)(=O)c4ccc(C)cc4
1648	sp|P07550|ADRB2_HU	Q9BXA5	73.12	17.0	319.0	DB00139	approved; nutraceutical	Succinic acid	OC(=O)CCC(=O)O
1649	sp|P07550|ADRB2_HU	Q9H228	73.85	40.0	345.0	DB08868	approved; investigational	Fingolimod	CCCCCCCCc1ccc(cc1)CCC(N)(CO)CO
1650	sp|P07550|ADRB2_HU	Q9H228	73.85	40.0	345.0	DB12371	approved; investigational	Siponimod	OC(=O)C1CN(C1)Cc2ccc(cc2CC)/C(C)=N/OCc3ccc(c(c3)C(F)(F)F)C4CCCCC4
1651	sp|P07550|ADRB2_HU	Q9H228	73.85	40.0	345.0	DB12612	approved; investigational	Ozanimod	CC(C)Oc1c(C#N)cc(cc1)-c2nc(no2)-c(ccc3)c(c34)CC[C@@H]4NCCO
1652	sp|P07550|ADRB2_HU	P33032	70.46	23.0	314.0	DB11653	approved; investigational	Bremelanotide	CCCC[C@H](NC(=O)C)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c(c23)cccc3)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@@H](NC1=O)Cc5cnc[nH]5
1653	sp|P07550|ADRB2_HU	O00398	77.72	12.0	333.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
1654	sp|P07550|ADRB2_HU	Q15391	79.9	4.0	334.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
1655	sp|P07550|ADRB2_HU	O95665	84.26	29.0	377.0	DB01106	approved; investigational	Levocabastine	c1ccccc1[C@]2(C(=O)O)[C@H](C)CN(CC2)[C@@H](CC3)CC[C@@]3(C#N)c4ccc(F)cc4
1656	sp|P07550|ADRB2_HU	Q14330	73.37	18.0	321.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
1657	sp|P07550|ADRB2_HU	Q14330	73.37	18.0	321.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
1659	sp|P07550|ADRB2_HU	Q14330	73.37	18.0	321.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
1660	sp|P07550|ADRB2_HU	Q5NUL3	78.21	36.0	359.0	DB05532	investigational	BMS-488043	COc1ncc(OC)c(c12)c(c[nH]2)C(=O)C(=O)N3CCN(CC3)C(=O)c4ccccc4
1663	sp|P07550|ADRB2_HU	Q9BPV8	76.76	31.0	348.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
1664	sp|P07550|ADRB2_HU	P47775	74.09	21.0	327.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
1666	sp|P07550|ADRB2_HU	P47775	74.09	21.0	327.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
1667	sp|P07550|ADRB2_HU	Q9Y5Y4	75.79	30.0	343.0	DB00328	approved; investigational	Indomethacin	COc(cc1)cc(c12)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3
1668	sp|P07550|ADRB2_HU	Q9Y5Y4	75.79	30.0	343.0	DB00605	approved; investigational	Sulindac	c1cc(F)cc(c12)C(CC(=O)O)=C(C)/C2=C/c3ccc(cc3)S(=O)C
1669	sp|P07550|ADRB2_HU	Q9Y5Y4	75.79	30.0	343.0	DB00770	approved; investigational	Alprostadil	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O
1670	sp|P07550|ADRB2_HU	Q9Y5Y4	75.79	30.0	343.0	DB00917	approved	Dinoprostone	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O
1671	sp|P07550|ADRB2_HU	Q9Y5Y4	75.79	30.0	343.0	DB01088	approved; investigational	Iloprost	OC(=O)CCC/C=C(C1)\C[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)C(C)CC#CC
1672	sp|P07550|ADRB2_HU	Q9Y5Y4	75.79	30.0	343.0	DB02056	investigational	Prostaglandin D2	CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O
1673	sp|P07550|ADRB2_HU	Q9Y5Y4	75.79	30.0	343.0	DB04828	withdrawn	Zomepirac	OC(=O)Cc1n(C)c(c(c1)C)C(=O)c2ccc(Cl)cc2
1674	sp|P07550|ADRB2_HU	Q9Y5Y4	75.79	30.0	343.0	DB12789	approved; investigational	Dinoprost	OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCCCC
1675	sp|P07550|ADRB2_HU	Q9Y5Y4	75.79	30.0	343.0	DB13036	investigational	Ramatroban	Fc1ccc(cc1)S(=O)(=O)N[C@@H](C2)CCc(c23)n(CCC(=O)O)c4c3cccc4
1676	sp|P07550|ADRB2_HU	P43116	84.99	3.0	354.0	DB00770	approved; investigational	Alprostadil	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O
1677	sp|P07550|ADRB2_HU	P43116	84.99	3.0	354.0	DB00917	approved	Dinoprostone	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O
1678	sp|P07550|ADRB2_HU	P43116	84.99	3.0	354.0	DB00929	approved	Misoprostol	CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC
1679	sp|P07550|ADRB2_HU	P43116	84.99	3.0	354.0	DB08964	approved; withdrawn	Gemeprost	CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)OC
1680	sp|P07550|ADRB2_HU	P43116	84.99	3.0	354.0	DB09211	investigational	Limaprost	CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)O
1681	sp|P07550|ADRB2_HU	P22888	82.32	337.0	677.0	DB00014	approved	Goserelin	NC(=O)NNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c(c34)cccc4)NC(=O)[C@H](Cc5cnc[nH]5)NC(=O)[C@@H]6CCC(=O)N6
1684	sp|P07550|ADRB2_HU	P22888	82.32	337.0	677.0	DB00050	approved; investigational	Cetrorelix	CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C
1688	sp|P07550|ADRB2_HU	P34972	74.82	31.0	340.0	DB00470	approved; illicit	Dronabinol	C1CC(C)=C[C@H]([C@@H]12)c3c(OC2(C)C)cc(cc3O)CCCCC
1689	sp|P07550|ADRB2_HU	P34972	74.82	31.0	340.0	DB00486	approved; investigational	Nabilone	C1CC(=O)C[C@H]([C@@H]12)c3c(OC2(C)C)cc(cc3O)C(C)(C)CCCCCC
1690	sp|P07550|ADRB2_HU	P34972	74.82	31.0	340.0	DB02955	experimental	Ricinoleic Acid	CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)O
1691	sp|P07550|ADRB2_HU	P34972	74.82	31.0	340.0	DB06202	approved; investigational	Lasofoxifene	c1cc(O)cc(c12)CC[C@H](c3ccccc3)[C@@H]2c4ccc(cc4)OCCN5CCCC5
1692	sp|P07550|ADRB2_HU	P34972	74.82	31.0	340.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
1693	sp|P07550|ADRB2_HU	P34972	74.82	31.0	340.0	DB11755	investigational	Tetrahydrocannabivarin	CCCc(c1)cc(O)c(c12)[C@H]3[C@H](C(O2)(C)C)CCC(=C3)C
1695	sp|P07550|ADRB2_HU	P34972	74.82	31.0	340.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
1696	sp|P07550|ADRB2_HU	P43119	73.85	16.0	321.0	DB00374	approved; investigational	Treprostinil	OC(=O)COc1cccc(c12)C[C@H]3[C@@H](C2)C[C@@H](O)[C@@H]3CC[C@@H](O)CCCCC
1697	sp|P07550|ADRB2_HU	P43119	73.85	16.0	321.0	DB01088	approved; investigational	Iloprost	OC(=O)CCC/C=C(C1)\C[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)C(C)CC#CC
1698	sp|P07550|ADRB2_HU	P43119	73.85	16.0	321.0	DB01160	approved; vet_approved	Dinoprost tromethamine	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O
1699	sp|P07550|ADRB2_HU	P43119	73.85	16.0	321.0	DB01240	approved	Epoprostenol	OC(=O)CCC/C=C(C1)\O[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)CCCCC
1700	sp|P07550|ADRB2_HU	P43119	73.85	16.0	321.0	DB05229	investigational	Beraprost	[O-]C(=O)CCCc1cccc(c12)[C@H]3[C@@H](O2)C[C@@H](O)[C@@H]3/C=C/[C@@H](O)C(C)CC#CC
1701	sp|P07550|ADRB2_HU	P43119	73.85	16.0	321.0	DB11362	approved	Selexipag	c1ccccc1-c2ncc(nc2-c3ccccc3)N(C(C)C)CCCCOCC(=O)NS(=O)(=O)C
1706	sp|P07550|ADRB2_HU	P23945	77.0	345.0	663.0	DB04786	investigational	Suramin	O=S(=O)(O)c(c1)cc(S(=O)(=O)O)c(c12)c(ccc2S(=O)(=O)O)NC(=O)c3ccc(C)c(c3)NC(=O)c4cc(ccc4)NC(=O)Nc5cccc(c5)C(=O)Nc6c(C)ccc(c6)C(=O)Nc(ccc7S(=O)(=O)O)c(c78)c(S(=O)(=O)O)cc(c8)S(=O)(=O)O
1708	sp|P07550|ADRB2_HU	P43115	78.45	49.0	373.0	DB00905	approved; investigational	Bimatoprost	CCNC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc2ccccc2
1709	sp|P07550|ADRB2_HU	P43115	78.45	49.0	373.0	DB00917	approved	Dinoprostone	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O
1710	sp|P07550|ADRB2_HU	P43115	78.45	49.0	373.0	DB00929	approved	Misoprostol	CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC
1711	sp|P07550|ADRB2_HU	P43115	78.45	49.0	373.0	DB08964	approved; withdrawn	Gemeprost	CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)OC
1712	sp|P07550|ADRB2_HU	P43115	78.45	49.0	373.0	DB09211	investigational	Limaprost	CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)O
1714	sp|P07550|ADRB2_HU	Q13258	83.29	13.0	357.0	DB00716	approved; investigational	Nedocromil	O=C(O)c(o1)cc(=O)c(c12)cc3c(c2CCC)n(CC)c(cc3=O)C(=O)O
1715	sp|P07550|ADRB2_HU	P43088	73.37	20.0	323.0	DB00287	approved	Travoprost	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc2cccc(c2)C(F)(F)F
1716	sp|P07550|ADRB2_HU	P43088	73.37	20.0	323.0	DB00654	approved; investigational	Latanoprost	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2
1717	sp|P07550|ADRB2_HU	P43088	73.37	20.0	323.0	DB00905	approved; investigational	Bimatoprost	CCNC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc2ccccc2
1718	sp|P07550|ADRB2_HU	P43088	73.37	20.0	323.0	DB01160	approved; vet_approved	Dinoprost tromethamine	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O
1719	sp|P07550|ADRB2_HU	P43088	73.37	20.0	323.0	DB08819	approved	Tafluprost	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/C(F)(F)COc2ccccc2
1720	sp|P07550|ADRB2_HU	P43088	73.37	20.0	323.0	DB11660	approved; investigational	Latanoprostene bunod	c1ccccc1CC[C@H](O)CC[C@H]2[C@H](O)C[C@H](O)[C@@H]2C/C=C\CCCC(=O)OCCCCO[N+]([O-])=O
1721	sp|P07550|ADRB2_HU	P34995	80.15	36.0	367.0	DB00297	approved; investigational	Bupivacaine	CCCCN1CCCCC1C(=O)Nc2c(C)cccc2C
1722	sp|P07550|ADRB2_HU	P34995	80.15	36.0	367.0	DB00429	approved	Carboprost tromethamine	CCCCC[C@@](O)(C)/C=C/[C@H]1[C@@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)[O-]
1723	sp|P07550|ADRB2_HU	P34995	80.15	36.0	367.0	DB00770	approved; investigational	Alprostadil	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O
1724	sp|P07550|ADRB2_HU	P34995	80.15	36.0	367.0	DB00905	approved; investigational	Bimatoprost	CCNC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc2ccccc2
1725	sp|P07550|ADRB2_HU	P34995	80.15	36.0	367.0	DB00917	approved	Dinoprostone	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O
1726	sp|P07550|ADRB2_HU	P34995	80.15	36.0	367.0	DB00929	approved	Misoprostol	CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC
1727	sp|P07550|ADRB2_HU	P34995	80.15	36.0	367.0	DB01088	approved; investigational	Iloprost	OC(=O)CCC/C=C(C1)\C[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)C(C)CC#CC
1728	sp|P07550|ADRB2_HU	P34995	80.15	36.0	367.0	DB09211	investigational	Limaprost	CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)O
1729	sp|P07550|ADRB2_HU	P21731	73.85	21.0	326.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
1730	sp|P07550|ADRB2_HU	P21731	73.85	21.0	326.0	DB06739	experimental	Seratrodast	O=C(O)CCCCCC(c1ccccc1)C2=C(C)C(=O)C(C)=C(C2=O)C
1731	sp|P07550|ADRB2_HU	P21731	73.85	21.0	326.0	DB09285	experimental	Morniflumate	FC(F)(F)c1cc(ccc1)Nc2c(cccn2)C(=O)OCCN3CCOCC3
